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ABSTRACT 
Phytoalexins and phytoanticipins are antimicrobial natural products involved in 
plant defence pathways against plant pathogens and other stresses. Most cruciferous 
phytoalexins are indole containing compounds with various side chains 
(dithiocarbamates, isothiocyanate, isonitrile, acetonitriles etc.). Many phytoanticipins of 
crucifers are glucosinolates and their metabolites, which have diverse structures and 
precursors, including aliphatic, phenyl or indolyl containing amino acids. Indole 
glucosinolates are derived from tryptophan (66), which is also a biosynthetic precursor to 
cruciferous phytoalexins, however the biosynthetic relationship between cruciferous 
phytoalexins and indole glucosinolates has not been clarified.
 
In this work, investigation 
of antifungal metabolites from wild crucifers, synthesis of antifungal metabolites and 
potential perdeuterated biosynthetic precursors, biosynthesis of metabolites of salt cress 
and that of rutabaga will be described. 
Investigation of the wild crucifers Brassica tournefortii, Crambe abyssinica, 
Diplotaxis tenuifolia and Diplotaxis tenuisiliqua for production of elicited antifungal 
metabolites, resulted in the discovery of a new phytoalexin, 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-
acetonitrile (148), from D. tenuisiliqua. 1ꞌ,4ꞌ-Dimethoxyindolyl-3ꞌ-acetonitrile (148) is the 
first dimethoxy substituted phytoalexin with strong antifungal activity against plant 
fungal pathogens. The remaining plant species produced known phytoalexins which were 
initially discovered in wild and cultivated species; all of them produced arvelexin (135). 
A novel phytoalexin, isocyalexin A (104) was isolated from rutabaga roots irradiated 
with UV-light; this is the first isocyanide of plant origin. 
The second part of the thesis deals with the biosynthesis of metabolites of salt 
cress (T. salsuginea) and their biosynthetic relationships with indole glucosinolates. In 
that regard, non-isotopically labeled compounds and perdeuterated biosynthetic 
intermediates such as [2,2,4ꞌ,5ꞌ,6ꞌ,7ꞌ-2H6]glucobrassicin (57b), [
2
H3CS;4ꞌ,5ꞌ,6ꞌ,7ꞌ-
2
H4]-1ꞌ-
methoxybrassinin (105a), L-[2ꞌ,4ꞌ,5ꞌ,6ꞌ,7ꞌ-2H5]tryptophan (66a), [
2
H3CO]-1ꞌ-
methoxyindolyl-3ꞌ-acetaldoxime (74a), L-[2H3CS]methionine (97a), [4ꞌ,5ꞌ,6ꞌ,7ꞌ-
2
H4]brassinin (45a) and 1ꞌ-methoxy-2ꞌ-methylbrassinin (160) were administered to salt 
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cress leaves. For the first time, the biosynthetic relationship between indole 
glucosinolates and cruciferous phytoalexins was established. Intact incorporations of 
hexadeuterated glucobrassicin ([2,2,4ꞌ,5ꞌ,6ꞌ,7ꞌ-2H6]glucobrassicin (57b)) into wasalexins 
A (43), B (109) and biswasalexin A1 (131) and A2 (132) were observed. Based on the 
feeding experiment results, for the first time a biosynthetic route that includes both indole 
glucosinolates (glucobrassicin (57) and 1ꞌ-methoxyglucobrassicin (69)) and 1ꞌ-
methoxybrassinin was proposed. 
The third part of the thesis is about biosynthesis of metabolites of rutabaga 
(Brassica napus). Rutabaga produces phytoalexins that differ on their side chains. 
Biosynthetic origin of their side chains was investigated by administering fully labeled 
tryptophan (L-[U-
13
C11,U-
15
N2]Trp) (66b) and other perdeuterated precursors to rutabaga 
roots which revealed that the carbon and nitrogen atoms of cyclobrassinin (78), rapalexin 
A (103), isocyalexin A (104) and spirobrassinin (101) are fully derived from tryptophan 
(66), and also both rapalexin A (103) and isocyalexin A (104) incorporated deuterium 
from glucobrassicin (57). [4',5',6',7'-
2
H4]-4'-Methoxybrassinin (108a) was incorporated 
into 4ꞌ-methoxycyclobrassinin (110) and 4ꞌ-methoxydehydrocyclobrassinin (113) but not 
into rapalexin A (103), isocyalexin A (104) and isalexin (102). The biosynthetic pathway 
that leads to isalexin (102), rapalexin A (103) and isocyalexin A (104) was further 
investigated using perdeuterated biosynthetic precursors such as (R,S)-[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107b), [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-
carboxaldehyde oxime (171b), [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b) and 
etc. It has been confirmed that the pathway involves series of rearrangements that allow 
transformation of side chain of tryptophan (66) into the side chains of rapalexin A (103) 
and isocyalexin A (104) without any degradations. 
In conclusion, cruciferous phytoalexins are derived from glucobrassicin (57), 
which is a precursor for 1ꞌ- and 4ꞌ-methoxyglucobrassicins (69 and 70). 1-Methoxylated 
phytoalexins are biosynthesized through 1ꞌ-methoxyglucobrassicin (69) via 1ꞌ-
methoxybrassinin (105). Similarly, 4-methoxy phytoalexins are derived from 4ꞌ-
methoxyglucobrassicin (70) through two distinct pathways: via 4ꞌ-methoxybrassinin 
iv 
 
(108) and 4ꞌ-methoxyindolyl-3ꞌ-glycine (107), a novel pathway discovered during work 
reported in this thesis.  
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1 INTRODUCTION 
1.1 General objectives 
Plants are subjected to biotic and abiotic stresses that can result in yield losses and 
poor quality products. They use their own chemical and physiological defense 
mechanisms to protect themselves. Chemical defenses include secondary metabolites of 
which some are constitutive (phytoanticipins) and others are inducible (phytoalexins) 
(Pedras, Yaya et al., 2011; Vanetten, Mansfield et al., 1994). Brassicaceae is a plant 
family that comprises economically important crops including oilseeds, vegetables and 
condiments (Schranz, Lysak et al., 2006). Many of them are susceptible to fungal 
pathogens such as black spot, blackleg, clubroot, stem rot and root rot fungi, while some 
wild and cultivated species are reported to be resistant (Chen and Séguin-Swartz, 1999; 
Conn, Tewari et al., 1988; Pedras, Chumala et al., 2003). Some resistant wild and 
cultivated crucifers produce strong antifungal phytoalexins with diverse structures 
(Pedras, Yaya et al., 2011). Biosynthetically they are derived from L-tryptophan (66) and 
reported to share some biosynthetic intermediates with indole glucosinolates (Pedras and 
Okinyo, 2008; Pedras, Zheng et al., 2007b). Establishment of biosynthetic intermediates 
will facilitate isolation of biosynthetic enzymes and eventual transfer of related pathways 
into susceptible species.  
 
Objectives of my research project: 
1. Investigation of the wild crucifers Brassica tournefortii, Crambe abyssinica, 
Diplotaxis tenuifolia and Diplotaxis tenuisiliqua for production of antifungal 
metabolites; 
2. Isolation, characterization and  synthesis of new metabolites; 
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3. Investigation of biosynthetic pathways of phytoalexins of salt cress and 4-
methoxyphytoalexins of rutabaga, which involves: 
a. Synthesis and complete chemical characterization of deuterium labeled 
biosynthetic precursors, 
b. Feeding of labeled precursors to each species and determination of levels 
of incorporation using HPLC-DAD-ESI-MS analysis, 
c. Use incorporation results to propose complete biosynthetic pathways. 
1.2 Plant secondary metabolites 
Plants produce both primary and secondary metabolites. Primary metabolites are 
the one that are important for basic growth and development. Secondary metabolites 
include low molecular weight compounds that may not be necessary for basic growth and 
development. However, they are involved in environmental adaptation and defense from 
both biotic and abiotic stresses and are important for the fitness of the producer (Bennett 
and Wallsgrove, 1994; Dewick, 2006). Secondary metabolites mediate interactions that 
plants make with microbes, other plants, insects, parasites and predators in indirect as 
well as direct defence processes (Hartmann, 2007). Some secondary metabolites are 
produced only under specific conditions (for example by elicitation); however, all of 
them play an important role for plants that produced them (Bennett and Wallsgrove, 
1994). In addition, many of these secondary metabolites are used in pharmaceutical and 
agricultural industries. 
The origin of the major biosynthetic intermediates (precursors) of secondary 
metabolites are from acetyl coenzyme A, shikimic acid, mevalonic acid and/or 1-
deoxyxylulose-5-phosphate and different amino acids, which are used in the acetate 
pathway (e.g. fatty acids and polyketides), shikimate pathway (e.g. phenylpropanoids), 
mevalonate and deoxyxylulose phosphate pathway (e.g. terpenoids and steroids), and in 
the synthesis of alkaloids (e.g. pyrrolizidine, piperidine, indole), respectively (Dewick, 
2006). Secondary metabolites formed from the acetate pathway include phenols, 
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macrolide antibiotics and etc. while the shikimate pathway is responsible for the 
biosynthesis of phenols, cinnamic acid derivatives, lignans, and alkaloids. Terpenoids and 
steroids are biosynthesized via the mevalonate and deoxyxylulose phosphate pathways. 
The amino acids ornithine, lysine, tryptophan etc. are precursors for various types of 
alkaloid metabolites (Dewick, 2006).  
1.2.1 Non-crucifers  
1.2.1.1 Phytoanticipins and allelochemicals 
Plants produce constitutive (phytoanticipins) as well as inducible (phytoalexins) 
secondary metabolites. Phytoanticipins as defined by Vanetten et al., are ―low molecular 
weight antimicrobial secondary metabolites that are present in plants before challenge by 
microorganisms or are produced after infection solely from pre-existing constituents‖ 
(Vanetten, Mansfield et al., 1994). Constitutive secondary metabolites include saponins, 
cyanogenic glucosides and glucosinolates among others (Osbourn, 1996). As most of the 
glucosinolates that have been isolated and reported are from the family Brassicaceae, it 
will be discussed in detail in the next section (under cruciferous secondary metabolites). 
Plants interact with each other or other organisms using their chemical compounds. 
Allelopathy is a chemically mediated interaction between the same or different species of 
organisms (Bais, Weir et al., 2006). The term allelopathy is derived from the Latin words 
allelon ‗of each other‘ and pathos ‗to suffer‘ (Weir, Park et al., 2004). Allelochemicals 
(chemicals that mediate interactions) can be present in almost all plant tissues and 
emitted to the environment in different forms (Bais, Weir et al., 2006; Weir, Park et al., 
2004; Weir and Vivanco, 2008). For example methyl jasmonate (1) and α-pinene (2) are 
released as volatile components while p-hydroxybenzoic acid (3) and p-coumaric acid (4) 
are carried to the surrounding environment through leaching and decomposing residue. 
Sorgoleone (9) and (-)-catechin (8) are root exudates while quercetin (5), DIBOA (2,4-
dihydroxy-1,4-benzoxazin-3-one) (6) and juglone (7) are released as leaf, bark and root 
exudates (Weir, Park et al., 2004) (Figure 1.1). 
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Figure 1.1 Examples of allelochemicals (Weir, Park et al., 2004).  
Plants interact with their neighbouring plants or other organisms in two different 
ways. Positive interactions include those in support of one another for their survival. On 
the other hand, situations such as competition for survival, parasitism, etc. that threat 
others existence result in negative interactions (Bais, Weir et al., 2006). The mediators of 
these interactions (plant phytotoxins) have different chemical structures and functions 
(Bais, Weir et al., 2006; Weir, Park et al., 2004). The term phytotoxins used in this 
context refers to toxic secondary metabolites that are produced by plants. Acroptilon 
repens (L.) DC. (Asteraceae) produce phytotoxic compounds found to affect the normal 
growth of Arabidopsis thaliana L. seedlings (Figure 1.2) (Quintana, Weir et al., 2008). 
In these experiments isolated compounds were dissolved in methanol and given to the 
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plants through roots and significant changes were observed. For example, 1-Chloro-4-(5-
(penta-1,3-diyn-1-yl)thiophen-2-yl)but-3-yn-2-ol (10) (12.5 µg/mL) was found to reduce 
A. thaliana fresh weight by 64%. 4-(5-(Penta-1,3-diyn-1-yl)thiophen-2-yl)but-3-yne-1,2-
diol (13) decreased the fresh weight by 37% at 50 µg/mL. The polyacetylene, 2-methoxy-
6-(5-(prop-1-yn-1-yl)thiophen-2-yl)hexa-3,5-diyn-1-ylacetate (11) (25 µg/mL) decreased 
the plant fresh weight by 54.5%. Treatment of A. thaliana seedlings with 2-((5-(penta-
1,3-diyn-1-yl)thiophen-2-yl)ethynyl)oxirane (12) reduced A. thaliana growth by 45% at 
250 µg/mL (Quintana, Weir et al., 2008).  
 
Figure 1.2 Allelochemicals produced by Acroptilon repens  
On the other hand, other metabolites such as Catechin (8) produced by Centaurea 
maculosa Lam. and Sesbania virgata (Cav.) Pers. found to affect neighbouring plants 
(Simões, Du et al., 2008). Aqueous extracts of wheat (Triticum aestivum L.) affected the 
germination and growth of some plant species (Steinsiek, Oliver et al., 1982; Wu, Haig et 
al., 2000; Wu, Haig et al., 2002). Potential allelochemicals such as p-hydroxybenzoic 
acid (3), cis-p-coumaric acid (4), vanillic acid (14), syringic acid (15), trans-p-coumaric 
acid (16), naphthoic acid (17), trans-ferulic acid (18), cis-ferulic acid (19) and DIMBOA 
(2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one) (20) were detected in wheat extracts 
(Wu, Haig et al., 2002; Wu, Pratley et al., 2001) (Figure 1.3). 
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Figure 1.3 Allelochemicals produced by wheat (Triticum aestivum) 
Plant-plant interactions can also be considered positive if they can defend 
themselves because of the effect of neighbouring plants. Volatile organic compounds 
(VOC) or root exudates from a plant may trigger the nearby plants to prepare their 
defenses for immediate use when threatened by insects. For example Elytrigia repens 
(L.) Desv. ex Nevski (couch-grass) produces phytotoxic compounds including 6-
hydroxy-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (carboline) (21) (Glinwood, 
Pettersson et al., 2003) (Figure 1.4) that reduced aphid interest towards the neighbouring 
plants (Bais, Weir et al., 2006; Glinwood, Pettersson et al., 2003).  
 
Figure 1.4 An allelochemical involved in positive plant-plant interactions 
Pyrrolizidine alkaloids (PAs) produced by plants of the family Boraginaceae, 
Leguminosae, Asteraceae, and Apocynaceae are part of constitutive defence secondary 
metabolites that protect plants from plant pathogens (Hartmann, 2004). The two major 
forms of PAs are the pro-toxic free base and the non-toxic N-oxide which have different 
effects based on their oxidation state  (Hartmann, 2004) (Figure 1.5).
 
Generalist insects 
14 
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19 18 20 
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are mostly affected by the toxicity of PA free bases. On the other hand, all adapted 
(specialist) insects can control unnecessary accumulations of the free bases in their 
tissues (Hartmann and Ober, 2000; Hartmann, Theuring et al., 2005). According to 
Marcel et al., the effects of PAs on generalist insects and free leaving nematode may 
depend on (i) variations in their chemical structures and oxidation state of the PA 
molecules (ii) the insect and nematode species (iii)  the exposure period (Macel, 
Bruinsma et al., 2005). For example seneciphylline N-oxide (23) was found to be toxic to 
generalist insects that cannot stop conversion of the N-oxide into the free base 
(Narberhaus, Zintgraf et al., 2005).  
 
Figure 1.5 Detoxification of seneciphylline via N-oxidation 
Saponins are constitutive secondary metabolites that protect plants from plant 
pathogens. They contain a steroidal or triterpene core structures (Szakiel, Pączkowski et 
al., 2011) that have carbohydrate moieties attached to them. Saponins are abundant 
among plant families and have shown various biological activities (Francis, Kerem et al., 
2002; Szakiel, Pączkowski et al., 2011), including insecticidal (Chaieb, 2010; De Geyter, 
Lambert et al., 2007) and antifungal effects (e.g. steroidal saponins 24-27) (Barile, 
Bonanomi et al., 2007; Tsuzuki, Svidzinski et al., 2007; Yang, Zhang et al., 2006). 
Saponins‘ role in protecting plants from fungal attack was demonstrated (Osbourn, 
Clarke et al., 1994). Oats species that produce avenacin (28-31) (Figure 1.6) were 
resistant to Gaeumannomyces graminis (var. tritici) while Auena longiglumis that does 
not produce metabolites 28-31 was susceptible to G. graminis (Osbourn, Clarke et al., 
1994). Likewise, saponin-deficient (sad) mutants showed susceptibly to fungal pathogens 
(Papadopoulou, Melton et al., 1999). On the other hand, host oats were not infected by 
2
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fungal mutants lacking  gene encoding a saponin detoxifying enzyme (Bowyer, Clarke et 
al., 1995). 
 
Figure 1.6 Examples of antifungal saponins 
Saponins are divided into three major groups, triterpenoid, steroid or steroidal 
glycoalkaloids (Iriti and Faoro, 2009; Osbourn, 1996). Steroidal saponins (such as 
avenacoside A (32)) are biosynthetically derived from cholesterol via side chain 
modifications, while steroidal alkaloids (such as α-tomatine (33)) are nitrogen analogues 
of steroidal saponins (Figure 1.7) (Dewick, 2006). 
  
Figure 1.7  Structures of avenacoside A (32) and α-tomatine (33) 
Another group of phytoanticipins are the cyanogenic glucosides (CNGs) that are 
ecologically important and produced by different plant species (Osbourn, 1996; 
Zagrobelny, Bak et al., 2004). For example, these group of metabolites are feeding 
24 gal(4-1)glc(3-1)xyl(2-1)glc(3-1)rha 
25 gal(4-1)glc(3-1)glc(2-1)glc(3-1)rha 
26 gal (4-1)glc(3-1)xyl(2-1)glc 
27 gal(4-1)glc(3-1)xyl(2-1)glc(3-1)xyl 
(28) avenacin A-1: R
1
= OH, R
2
 = NHCH
3
 
(29) avenacin A-2: R
1
 = OH, R
2
 = H  
(30) avenacin B-1: R
1
 = H, R
2
 = NHCH
3
 
(31) avenacin B-2: R
1
 = H, R
2
 = H 
32 
33 
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deterrents and phagostimulants (Zagrobelny, Bak et al., 2004). One of the metabolic 
products of CNGs is hydrogen cyanide (HCN) which is toxic to plant pathogens 
(Osbourn, 1996; Zagrobelny, Bak et al., 2004). Specialist insect herbivores can take 
advantage of them (CNGs) by sequestering and also synthesizing them de novo 
(Zagrobelny and Møller, 2011).  
Biosyntheses of CNGs involve four major steps. The first two steps are catalyzed 
by cytochromes P450 (Bak, Paquette et al., 2006; Jørgensen, Morant et al., 2011; 
Zagrobelny, Bak et al., 2004). The first P450 catalyzes N-hydroxylation of the parent 
amino acid (34) which is followed by decarboxylation (Jørgensen, Morant et al., 2011; 
Sibbesen, Koch et al., 1994). The second cytochrome P450 converts aldoxime (35) into 
α-hydroxynitrile (36), a step involving dehydration and α-hydroxylation (Bak, Paquette et 
al., 2006). Finally, glucosylation of α-hydroxynitrile (36) is catalyzed by a UDPG-
glycosyltransferase (Scheme 1.1) (Bak, Paquette et al., 2006; Jørgensen, Morant et al., 
2011) to afford 37.  
One of the directions considered in order to enhance the self-defending ability of 
susceptible plant species was the introduction of new biosynthetic pathways. For that 
reason,  introduction of the cyanogenic glucoside biosynthetic pathways into transgenic 
plants was viewed as a useful and remarkable step in understanding the role of secondary 
metabolites in plant defense (Tattersall, Bak et al., 2001). Sorghum bicolor (L.) Moench 
produces a CNG, dhurrin (37), which is not synthesized in A. thaliana and Lotus 
japonicus (Morant, Jørgensen et al., 2007). The expression of S. bicolor CYP79A1, 
CYP71E1 and UGT85B1 in L. japonicus and A. thaliana allowed them to produce 
dhurrin (37) (Morant, Jørgensen et al., 2007; Tattersall, Bak et al., 2001; Verpoorte and 
Memelink, 2002). As a result, larvae of Phyllotreta nemorum L. refused to eat leaves 
from transgenic Arabidopsis (Tattersall, Bak et al., 2001; Verpoorte and Memelink, 
2002). The production of metabolite 37 was also demonstrated in transgenic Nicotiana 
tabacum cv Xanthi (tobacco) (Bak, Olsen et al., 2000; Morant, Jørgensen et al., 2007). 
Expression of CYP450 (CYP79A1 and CYP71E1) alone resulted in accumulation of 
intermediates and decomposition products (Bak, Olsen et al., 2000); however, 37 was 
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detected only when UGT85B1 was expressed along with CYP450s (Morant, Jørgensen et 
al., 2007) (Scheme 1.1). 
 
Scheme 1.1 Biosynthesis of dhurrin (37) (cyanogenic glucosides) 
1.2.1.2 Phytoalexins  
Phytoalexins are ―low molecular weight antimicrobial secondary metabolites that 
are produced when plants are under stress‖ (Bailey and Mansfield, 1982; Smith, 1996). 
The term phytoalexin was coined from Greek words meaning, ―warding-off agents in 
plants‖ (Bailey and Mansfield, 1982). The first phytoalexin (pisatin (51)) structure was 
reported 20 years after the first proposal of the concept of phytoalexin by Muller and 
Borger (Muller and Borger, 1941). Structurally, phytoalexins may differ from one plant 
family to another. Plants from the same family may produce structurally related 
phytoalexins (Grayer and Harborne, 1994; Hammerschmidt, 1999; Pedras, Yaya et al., 
2011). There are cases in which a single compound (e.g. resveratrol (50)) was detected in 
different plant families (Grayer and Harborne, 1994).  
The role of phytoalexins as defense metabolites was demonstrated using 
transgenic tobacco (N. tabacum). The gene for biosynthesis of stilbene phytoalexins was 
transferred from Vitis vinifera L. (grapevine) to tobacco (N. tabacum). After inoculation 
with Botrytis cinerea, the transgenic plants accumulated a phytoalexin resveratrol (50) 
with enhanced resistance to pathogens  (Hain, Reif et al., 1993).  
34 35 36 
37 
CYP79A1 CYP71E1 
UGT85B1 
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Phytoalexin precursors can be derived from shikimic acid, acetate-malonate, 
mevalonate and/or deoxyxylulose and alkaloids, or their combinations (Brooks and 
Watson, 1985; Kuc, 1995). There are quite a few phytoalexins biosynthesized in rice and 
maize plants via mevalonate pathways (Otomo, Kanno et al., 2004; Peters, 2006). 
Rishitin (38) isolated from potato tuber (Lyon, 1972), capsidiol (39) isolated from several 
plant species including tobacco and pepper and phytoalexin 40 are biosynthesized via 
mevalonate pathway (Literakova, Lochman et al., 2010) (Figure 1.8). 6-Methoxymellein 
(41), a phytoalexin isolated from carrot root infected by different fungal species, is 
biosynthesized via acetate-malonate pathway (Kurosaki and Nishi, 1983) (Figure 1.9). 
Scopoletin (42), a major phytoalexin of tobacco plants, is biosynthesized via the shikimic 
acid pathway (Ahuja, Kissen et al., 2012; Kai, Mizutani et al., 2008) (Figure 1.10). 
Benzophenanthridine alkaloids, sanguinarine (46) and macarpine (47) are phytoalexins 
biosynthesized from L-tyrosine (Angelova, Buchheim et al., 2010; Schumacher, 
Gundlach et al., 1987). Indole alkaloids (43, 44, 45) are biosynthesized from L-
tryptophan (Figure 1.11) (Pedras, Yaya et al., 2011). 
 
Figure 1.8 Phytoalexins biosynthesized through the mevalonate and/or deoxyxylulose 
pathway 
 
Figure 1.9 A phytoalexins biosynthesized through acetate-malonate pathway 
 
Figure 1.10 A phytoalexin biosynthesized through the shikimate (phenyl-propionate) 
pathway 
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Figure 1.11 Indole (43, 44, 45) and benzophenanthridine (46, 47) phytoalexins 
(alkaloids) 
Plants can biosynthesize phytoalexins through mixed biosynthetic pathways. 
Xanthotoxin (48) was shown to be biosynthesized via the combination of shikimate and 
mevalonate and/or deoxyxylulose pathways (Stanjek, Piel et al., 1999) (Figure 1.12). 
Phytoalexins biosynthesized through the combination of shikimate and acetate-malonate 
pathways are common in plant families such as Fabaceae, Vitaceae and Poaceae (Ahuja, 
Kissen et al., 2012). For example, pisatin (51) which is the main phytoalexin in pea 
(Arman, 2011), is of mixed biosynthetic origin, the shikimate and acetate-malonate 
pathway. Resveratrol (50) is a building block for the biosynthesis of stilbenoids such as 
-viniferin (49) in peanut, also biosynthesized through shikimate and acetate-malonate 
pathways (Figure 1.13) (Ahuja, Kissen et al., 2012).  
 
Figure 1.12 A phytoalexin biosynthesized through combination of shikimate and 
mevalonate and/or deoxyxylulose pathways 
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Figure 1.13 Phytoalexins biosynthesized through the combination of shikimate and 
acetate-malonate pathways 
Plants produce phytoalexins biosynthesized through shikimate, acetate-malonate 
and mevalonate and/or deoxyxylulose. These compounds are produced mostly in the 
Fabaceae (Ahuja, Kissen et al., 2012). Arachidin 1-3 (52-54), stilbenoids of peanut seeds, 
glyceollin I (55) and wighteone (56) have mixed biosynthetic origin (Sobolev, Neff et al., 
2008) (Figure 1.14). 
 
Figure 1.14 Phytoalexins biosynthesized through the combination of shikimate, 
mevalonate/deoxyxylulose and acetate-malonate pathways 
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1.2.2 Crucifers  
1.2.2.1 Phytoanticipins  
Glucosinolates are well studied, constitutive secondary metabolites containing 
nitrogen and sulphur in their functional group. They are widespread in the order 
Brassicales, mainly in members of the family Brassicaceae, including the genus Brassica 
and wild species such as A. thaliana. In this part of the thesis, the importance of 
glucosinolates in crucifers and their biosynthesis will be reviewed.  
So far, about 132 glucosinolates have been isolated and characterized (Agerbirk 
and Olsen, 2012). Research on glucosinolates has been advanced since the discovery of 
importance of their metabolic products as a remedy for human health as well as crop-
protection (Halkier and Gershenzon, 2006). Based on the parent amino acid structures, 
glucosinolates can be subdivided into three major classes: i) aliphatic glucosinolates, 
derived from aliphatic amino acids such as Ala, Leu, Ile, Val, and Met; ii) aromatic 
(phenyl) glucosinolates, derived from Phe or Tyr; and iii) indolic glucosinolates, derived 
from Trp (Halkier and Gershenzon, 2006; Iriti and Faoro, 2009; Sønderby, Geu-Flores et 
al., 2010). The final structures can be modified through oxidation, methoxylation, 
acetylation or hydroxylation of the side chain (Hopkins, van Dam et al., 2009) (Figure 
1.15).  
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Figure 1.15 Structures of representative glucosinolates (Agerbirk and Olsen, 2012) 
Very recently, the formation of unnatural selenoglucosinolates such as 3-
(methylseleno)propylglucosinolate (glucoselenoiberverin) (63), 4-
(methylseleno)butylglucosinolate (glucoselenoerucin) (64), and 5-
(methylseleno)pentylglucosinolate (glucoselenoberteroin) (65) was reported (Figure 
1.15) (Matich, McKenzie et al., 2012). They were obtained by fertilizing Brassica species 
with sodium selenite (Matich, McKenzie et al., 2012). Selenium was incorporated into 
the side chain via selenomethionine (which is equivalent to an amino acid methionine).  
 
 
Figure 1.16 Structures of selenoglucosinolates (Matich, McKenzie et al., 2012) 
Glucosinolates have great agricultural significance due to the increasing 
commercial importance of oilseed crops (mostly brassica species) (Cartea and Velasco, 
57 58 59 
61 60 62 
63 n=3 
64 n=4 
65 n=5 
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2008; Griffiths, Birch et al., 1998; Halkier and Gershenzon, 2006). Some of them are 
harmful for animal feeding (Cartea and Velasco, 2008). For example, 2-hydroxy-3-
butenylglucosinolate (94) causes goiter and other damaging effects on animals (Cartea 
and Velasco, 2008; Griffiths, Birch et al., 1998). As a result, reducing the levels of seed 
glucosinolates was required (Halkier and Gershenzon, 2006). Apart from their toxic 
nature to domestic animals, these compounds also function as defence chemicals against 
plant pathogens (Halkier and Gershenzon, 2006).  
In order to resist damage by insects, plants accumulate glucosinolates in higher 
concentrations (Halkier and Gershenzon, 2006). On the contrary, specialized insects use 
them as signals for various stimulations (Halkier and Gershenzon, 2006). Specialized 
insects may overcome the toxicity of glucosinolates and their metabolic products through 
quick excretion from their body, detoxification (metabolizing into less toxic structures), 
metabolizing into intermediates that will not give rise to toxic hydrolysis products or 
remain dormant to the toxic compounds (Halkier and Gershenzon, 2006). For example, 
the diamond back moth converts glucosinolates into their desulfo form using a sulfatase 
enzyme (Ratzka, Vogel et al., 2002). The cabbage white butterfly was able to convert 
glucosinolate hydrolysis products into nitriles and excrete them out (Wittstock, Agerbirk 
et al., 2004). Specialized herbivores can also sequester glucosinolates and use them to 
fight predators (Müller, Boevé et al., 2002; Vlieger, Brakefield et al., 2004). The aphid 
Brevicoryn brassicae L. has its own myrosinase(s) used to hydrolyze the glucosinolates 
(Bridges, Jones et al., 2002; Halkier and Gershenzon, 2006). 
Biosynthetically, glucosinolates are derived from amino acid precursors. There 
are three biosynthetic stages: (i) chain elongation (ii) formation of the functional group, 
and (iii) side chain modifications of the parent amino acid (Sønderby, Geu-Flores et al., 
2010).  
Early in vivo studies laid the foundation for studying the biosynthesis of 
metabolites through feeding experiments using radiolabeled amino acids and acetates. 
The incorporation of labeled [
14
C[acetate and [
14
C]methionine into allyl isothiocyanate of 
horseradish was reported in 1964 (Chisholm and Wetter, 1964). Incorporations of [2-
14
C]methionine and [2-
14
C]acetate into the thioglucoside progoitrin (94) were also 
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demonstrated using rutabaga leaves (Serif and Schmotzer, 1968). Later a more 
comprehensive study regarding chain elongation reactions was carried out (Graser, 
Schneider et al., 2000). Using leaves of Eruca sativa (Miller), it was demonstrated that 
the carbon atoms of 4-methylthiobutylglucosinolate (99) were derived from methionine 
(97). Feeding of [U-
13
C]methionine (97a) to leaves of E. sativa resulted in the 
incorporation of the entire carbon atoms except for the carboxylic acid carbon suggesting 
decarboxylation of the first acetate residue (Graser, Schneider et al., 2000). 
Administration of [
13
C] and [
14
C]acetate have confirmed steps in the chain elongation 
cycle (Graser, Schneider et al., 2000).  
1.2.2.1.1 Functional group biosynthesis 
Well before the discovery of biosynthetic genes, the biosynthesis of the glucosinolate 
functional group was studied through feeding experiments using labeled biosynthetic 
precursors. Those early findings laid the ground work essential to the current discoveries. 
Labeled precursors with radioisotopes 
14
C and 
3
H and cold isotopes 
2
H, 
13
C and 
15
N were 
used for feeding experiments. Biosynthetic studies of glucosinolates through feeding 
experiments started as early as 1960, as follows. 
  
Incorporation of isotopically labelled precursors 
 
The use of 
14
C, 
3
H and 
15
N was a common practice in early biosynthetic studies. 
In the biosynthetic study of indole glucosinolates functional group, one of the first 
labeled precursors used was 
14
C labeled tryptophan (66) (Kutacek, Prochazka et al., 
1960). Kutacek and coworkers investigated the biosynthetic origin of indole derived 
metabolites using (D,L)-[3-
14
C]tryptophan (66a). Tryptophan (66) was reported as the 
biosynthetic precursor of indolyl-3ꞌ-acetonitrile (67), indole-3-acetic acid and ascorbigen 
(68) (Kutacek, Prochazka et al., 1960). Years later, Kutacek and coworkers administered 
(D,L)-[3-
14
C]tryptophan (66a) to cabbage leaves and confirmed the incorporation of 
radioactive component in glucobrassicin (57) (Kutacek and Kefeli, 1970; Kutacek, 
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Prochazka et al., 1962). No incorporation of 
14
C labeled indole-3ꞌ-acetonitrile (67a) or 
ascorbigen (68) was detected in to glucobrassicin (57), suggesting the irreversibility of 
glucobrassicin (57) metabolism (Kutacek, Prochazka et al., 1962) Figure 1.17.  
 
*
C = 
14
C 
Figure 1.17 Biosynthetic relationship between tryptophan (66a), indolyl-3ꞌ-acetonitrile 
(67a), ascorbigen (68) and glucobrassicin (57a) (Kutacek, Prochazka et al., 1962).  
Schraudolf and Bergmann investigated the biosynthetic origin of indole 
glucosinolates using ring-labeled (D,L)-[
14
C]tryptophan (66a) and [
35
S]sulphate which 
revealed incorporation of 
14
C and 
35
S into glucobrassicin (57) and 1ꞌ-
methoxyglucobrassicin (69) (Schraudolf and Bergmann, 1965). Indole (120) was shown 
to be a biosynthetic precursor of tryptophan (66), glucobrassicin (57) and 1ꞌ-methoxy 
glucobrassicin (69) (Schraudolf, 1966). Administration of mixture of L-[3-
14
C]tryptophan 
(66a) and L-[
15
NH2]tryptophan (66a) to winter rape resulted in the incorporation of 
nitrogen into indole glucosinolates and derivatives (Kutacek and Kralova, 1972) (Figure 
1.18). Absence of incorporation of L-[1-
14
C]tryptophan (66a) suggested decarboxylation 
of tryptophan during the metabolism (Kutacek and Kralova, 1972).  
66a 
67a 
57a 
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C = 
14
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N 
Figure 1.18 Incorporation of L-[3-
14
C] and L-[
15
NH2]tryptophan (66a) into 
glucobrassicin (57a) (Kutacek and Kralova, 1972). 
B. napus roots infected by Plasmodiophora brassicae metabolized L-
[
14
C]tryptophan (66a) into glucobrassicin (57) and indolyl-3ꞌ-acetonitrile (67) (Rausch, 
Butcher et al., 1983). The incorporation of radioactive elements into 57 and 67 was 
higher in infected tissue. Administration of L-[2’,4’,5’,6’,7’-2H]tryptophan (66a) to UV-
elicited rutabaga roots and salt cress (T. salsuginea) leaves showed incorporation of 
deuterium into glucobrassicin (57), 1ꞌ-methoxyglucobrassicin (69), 4ꞌ-
methoxyglucobrassicin (70) and cruciferous phytoalexins (Figure 1.19) (Pedras, Okinyo 
et al., 2009; Pedras, Yaya et al., 2010).  
 
Figure 1.19 Incorporation of L-[2’,4’,5’,6’,7’-2H]tryptophan (66a) into indole 
glucosinolates (Pedras, Okinyo et al., 2009; Pedras, Yaya et al., 2010)  
Oximes were proposed and tested by Underhill as biosynthetic intermediates in 
the biosynthesis of glucosinolates (Underhil, 1967). Administration of [1-
14
C]phenylacetaldoxime (71a) to Tropaeolum majus L. shoot showed incorporation of 
14
C into glucotropaeolin (benzylglucosinolate) (58). Likewise, 3-phenyl[1-
66a 57a 
66a 57a 69a R1 = OCH
3
 
70a R2 = OCH
3
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14
C]propionaldoxime (72a) administered to Nasturtium officinale (R. Br.) was 
incorporated into gluconasturtiin (73) (Figure 1.20) (Underhil, 1967). 
  
 
Figure 1.20 Incorporation of [1-
14
C]phenylacetaldoxime (71a) and  3-phenyl[1-
14
C]propionaldoxime (72a) into the corresponding glucosinolates (58a and 73a) 
(Underhil, 1967). 
Indolyl-3ꞌ-acetaldoxime (122) was shown to be a biosynthetic precursor of 
glucobrassicin (57). Administration of tritiated indolyl-3-acetaldoxime (122) to leaves of 
woad (Isatis tinctoria L.) showed incorporation into glucobrassicin (57) (Mahadevan and 
Stowe, 1972). Cysteine was proposed to be a sulfur donor (Mahadevan and Stowe, 1972). 
Metabolism of indolyl-3ꞌ-acetaldoxime (122) by Chinese cabbage hypocotyls was 
investigated using [
14
C]indolyl-3ꞌ-acetaldoxime (122a). Incorporation of the precursor 
into indolyl-3ꞌ-acetonitrile (67), glucobrassicin (57) and desulfoglucobrassicin (80) was 
detected (Helmlinger, Rausch et al., 1985). [
2
H3O,4ꞌ,5ꞌ,6ꞌ,7ꞌ]-1ꞌ-Methoxyindolyl-3ꞌ-
acetaldoxime (74a) was shown to be a biosynthetic precursor of 1ꞌ-
methoxyglucobrassicin (69) (Pedras, Okinyo et al., 2009). Similarly, [
2
H3C]-1ꞌ-
methylindolyl-3ꞌ-acetaldoxime (75a) was metabolized to 1ꞌ-methylglucobrassicin (76) 
(Figure 1.21) (Pedras, Okinyo et al., 2009), suggesting the non-selective nature of the 
post-aldoxime enzymes in the biosynthetic pathway of indole glucosinolates (Halkier and 
Gershenzon, 2006; Pedras, Okinyo et al., 2009) 
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Figure 1.21 Incorporation of substituted indolyl-3ꞌ-acetaldoximes (74a and 75a) into 
1-substituted glucobrassicins (69a and 76a) (Pedras, Okinyo et al., 2009) 
Administration of a mixture of [1-
14
C]sodium phenylacetothiohydroximate (77a) 
and [
35
S]sodium phenylacetothiohydroximate (77a) to T. majus shoot resulted in 
incorporation of the precursor into benzylglucosinolate (58). The stage at which 
glucosylation occurred was investigated using [G-
14
C]-1-thioglucose and [G-
14
C]-D-
glucose (Underhil and Wetter, 1969). In the study of biosynthetic intermediates of indole 
glucosinolates, 
2
H and 
34
S labeled indolyl-3ꞌ-acetothiohydroxamic acid (79) was prepared 
and administered to UV-irradiated roots of rutabaga (Pedras and Okinyo, 2008), and the 
intact incorporation of [4ꞌ,5ꞌ,6ꞌ,7ꞌ-2H4]indolyl-3ꞌ-[
34
S]acetothiohydroxamic acid (79a) into 
glucobrassicin (57) and cruciferous phytoalexins was demonstrated (Figure 1.22). 
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Figure 1.22 Incorporation of [4ꞌ,5ꞌ,6ꞌ,7ꞌ-2H4]indolyl-3ꞌ-[
34
S]acetothiohydroxamic acid 
(79a) into glucobrassicin (57a) and cyclobrassinin (78a) (Pedras and Okinyo, 2008); and 
[1-
14
C]sodium phenylacetothiohydroximate (77a) and [
35
S]sodium 
phenylacetothiohydroximate (77b) into the corresponding benzylglucosinolate (58a) 
(Underhil and Wetter, 1969) 
Recently, desulfoglucobrassicin (80a) was shown to be a biosynthetic precursor 
of glucobrassicin (57), 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-methoxyglucobrassicin (70). 
Feeding of perdeuterated 80a showed incorporation into indole glucosinolates (Pedras 
and Yaya, 2013). It is worthy to mention that glucobrassicin (57) is a biosynthetic 
precursor of 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-methoxyglucobrassicin (70). 
Administration of hexadeuterated glucobrassicin (57b) to leaves of salt cress (T. 
salsuginea) and rutabaga roots showed intact incorporations into 1ꞌ-
methoxyglucobrassicin (69) and 4ꞌ-methoxyglucobrassicin (70) (Figure 1.23) (Pedras 
and Yaya, 2013; Pedras, Yaya et al., 2010). 
 
Figure 1.23 Incorporation of [4ꞌ,5ꞌ,6ꞌ,7ꞌ-2H4]desulfoglucobrassicin (80a) into indole 
glucosinolates (Pedras and Yaya, 2013; Pedras, Yaya et al., 2010) 
 S= 
34
S 
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Molecular genetics 
 
It has been noted that the transformation of an amino acid to the final 
glucosinolate includes intermediates such as N-hydroxy amino acids, aldoximes, aci-nitro 
or nitrile oxides, S-alkyl thiohydroximates, thiohydroximic acids, and 
desulfoglucosinolates (Halkier and Gershenzon, 2006). The first two steps are catalyzed 
by cytochrome P450 enzymes (CYP79 and CYP83). Conversion of amino acid (81) into 
the corresponding aldoxime (82) is catalyzed by CYP79 (Mikkelsen, Hansen et al., 
2000). Tryptophan (66) was found to be metabolized by both CYP79B2 and CYP79B3 
(Sønderby, Geu-Flores et al., 2010), while CYP79A2 converts Phe into benzyl 
glucosinolates (Wittstock and Halkier, 2000). CYP79F1 and CYP79F2 use Met derived 
aliphatic amino acids as their substrates (Chen, Glawischnig et al., 2003; Sønderby, Geu-
Flores et al., 2010).  
The second step in the biosynthesis of the glucosinolate functional group involves 
the oxidation of aldoxime (82) into nitrile oxide (83) by CYP83. The CYP83A1 and 
CYP83B1 were demonstrated to transform several aldoximes: aliphatic, aromatic and 
indolic (Bak and Feyereisen, 2001; Halkier and Gershenzon, 2006; Hansen, Du et al., 
2001; Naur, Petersen et al., 2003; Sønderby, Geu-Flores et al., 2010).  
The mechanism by which nitrile oxide (83) can be conjugated to glutathione 
(GSH) is not yet clear. However, there are two hypotheses that the reaction can either be 
happening spontaneously or through a reaction catalyzed by enzymes of the family GST 
(GSTF9, GSTF10) (Geu-Flores, Møldrup et al., 2011; Sønderby, Geu-Flores et al., 2010). 
The metabolism of the GSH conjugate (84) to the Cys-Gly conjugate (85) is catalyzed by 
γ-glutamyl peptidases (GGP1 and GGP3), and the Cys-Gly conjugate is further converted 
by a carboxypeptidase to yield a Cys-conjugate (86) (Geu-Flores, Møldrup et al., 2011). 
The C–S lyase called SUR1 was identified as an enzyme that catalyzes the conversion of 
alkylthiohydroximate (86) to thiohydroximic acid (87) (Sønderby, Geu-Flores et al., 
2010). The formation of desulfoglucosinolate (88) is catalyzed by glucosyltransferases 
(UGT74) (Grubb, Zipp et al., 2004; Sønderby, Geu-Flores et al., 2010) (Scheme 1.2). 
The final step in the biosynthesis of the glucosinolate functional group, the O-sulfation of 
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desulfoglucosinolate (88), is catalyzed by AtST5a, AtST5b and AtST5c (Piotrowski, 
Schemenewitz et al., 2004) (Scheme 1.2). 
 
Scheme 1.2 Biosynthesis of the glucosinolate functional group (Geu-Flores, Møldrup 
et al., 2011; Sønderby, Geu-Flores et al., 2010) 
1.2.2.1.2 Side chain modifications 
The major differences among glucosinolates arise from their side chain 
appearances (derived from amino acid precursors) that determine their biological 
activities (Hopkins, van Dam et al., 2009; Sønderby, Geu-Flores et al., 2010). Changes on 
the side chains may affect their activity as well as the activity of the hydrolysis products 
(Halkier and Gershenzon, 2006; Pedras and Hossain, 2011). Some of these changes 
comprise oxidations, hydroxylations, alkenylations, methoxylations and benzoylations. In 
Arabidopsis, GS-ELONG, GS-OX, GS-AOP and GS-OH genes play major roles in 
81 82 83 
89 
84 
85 
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modifying structures of aliphatic glucosinolates (Kliebenstein, Kroymann et al., 2001; 
Sønderby, Geu-Flores et al., 2010). The conversion of methylthioalkyls (90) into 
methylsulfinylalkyl glucosinolates (91) is catalyzed by flavin monooxygenase FMOGS-
OX1. This was confirmed by either knocking out the gene or overexpressing it 
(Sønderby, Geu-Flores et al., 2010). Substrate specificity of the FMOGS-OXs was also 
determined (Hansen, Kliebenstein et al., 2007; Li, Hansen et al., 2008). AOP2 and AOP3 
catalyze the formation of two distinct products from a single substrate (Sønderby, Geu-
Flores et al., 2010). AOP2 catalyzes the cleavage of methylsulfoxide moiety to form 
alkenyl glucosinolates (92) (Scheme 1.3), whereas, AOP3 catalyzes the cleavage of 
methylsulfoxide moiety and then hydroxylation of the side chain to form hydroxyalkyl 
glucosinolates (93). Knocking out the genes resulted in the accumulation of the precursor 
methylsulfinylalkyl glucosinolates (91) (Kliebenstein, Lambrix et al., 2001). The GS-OH 
catalyzes a hydroxylation reaction, which was confirmed by in vivo feeding experiments 
(Sønderby, Geu-Flores et al., 2010) (Scheme 1.3).  
 
Scheme 1.3 Side chain modification of aliphatic glucosinolates (Sønderby, Geu-Flores 
et al., 2010). 
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The four common indolic glucosinolates are glucobrassicin (57), 1ꞌ-
methoxyglucobrassicin (69), 4ꞌ-hydroxyglucobrassicin (96) and 4ꞌ-methoxyglucobrassicin 
(70). Biosynthetically, metabolites 69, 70 and 96 are likely derived from 57 via side chain 
modifications (Pedras and Yaya, 2013; Pedras, Yaya et al., 2010). So far, the only 
identified gene encodes an enzyme catalyzing the 4ꞌ-hydroxylation of glucobrassicin (57) 
(Sønderby, Geu-Flores et al., 2010). A transgenic plant devoid of the gene CYP81F2 
resulted in a decreased accumulation of 4ꞌ-hydroxyglucobrassicin (96) and 4ꞌ-
methoxyglucobrassicin (70) when compared to the wild type (Scheme 1.4) (Sønderby, 
Geu-Flores et al., 2010). The essential role of 4ꞌ-methoxyglucobrassicin (70) in the 
defense against powdery mildew was proposed based on the susceptibility of the plant in 
which the gene responsible for the production of 4ꞌ-methoxyglucobrassicin (70) was 
knocked out (Sønderby, Geu-Flores et al., 2010). However, it has been shown that indole 
glucosinolates do not have anti-fungal effects but, hydrolysis products of indole 
glucosinolates (indolyl-3ꞌ-acetonitriles 135, 67, 136) inhibited fungal mycelial growth of 
plant pathogens (Pedras and Hossain, 2011).  
Recently, the biosynthetic relationship between indole glucosinolates and 
cruciferous phytoalexins was demonstrated (Pedras and Yaya, 2013; Pedras, Yaya et al., 
2010). Cruciferous phytoalexins were shown to be derived from indole glucosinolates; 4-
methoxy phytoalexins were proposed to derive from glucobrassicin (57) via 4ꞌ-
methoxyglucobrassicin (70) (Pedras and Yaya, 2013). 4-Methoxylated phytoalexins were 
shown to be potent against different fungal pathogens (Pedras and Sarma-Mamillapalle, 
2012; Pedras and Yaya, 2012). This suggests that the activity of 4ꞌ-
methoxyglucobrassicin against powdery mildew may be attributed to the involvement of 
4-methoxylated metabolic products of 4ꞌ-methoxyglucobrassicin (70), including 4-
methoxylated phytoalexins. 
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Scheme 1.4 Side chain modification of indole glucosinolates (Sønderby, Geu-Flores et 
al., 2010) 
1.2.2.1.3 Pathway engineering  
The dietary importance of crucifers is partly due to metabolic (hydrolysis) 
products of glucosinolates, as some of them have the potential of reducing the risk of 
developing cancer. Recent advances in engineering the glucosinolate pathway in non-
cruciferous plant was viewed as a major success in the field (Mikkelsen, Olsen et al., 
2010). The glucoraphanin (100) pathway was expressed in N. benthamiana (tobacco): the 
side chain elongation of the parent amino acid, methionine (97), to get the corresponding 
elongated intermediate, dihomo-methionine (98), was the first step in a series of reactions  
catalyzed by five enzymes (i-v) (BCAT4, MAM1, AC, IPM and BCAT3) of the chain-
elongation pathway (Mikkelsen, Olsen et al., 2010). After transferring genes into N. 
benthamiana, plants were incubated for 7 days, extracted and analyzed for the detection 
of dihomo-methionine (98) (Mikkelsen, Olsen et al., 2010). In the second stage of the 
biosynthetic pathway (functional group formation), the conversion of dihomo-methionine 
(98) to 4-methylthiobutylglucosinolate (99) was facilitated by the involvement of seven 
enzymes (vi-xi) (CYP79F1, CYP83A1, GSTF11, SUR1/GGP1, UGT74C1 and AtST5b). 
The final step, the secondary modification of the side chain, was catalyzed by (xii) FMO 
95 57 96 
70 69 
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to yield metabolite 100 (Mikkelsen, Olsen et al., 2010) (Scheme 1.5). In different 
experiment, the conversion of phenylacetothiohydroxamate (77) to benzylglucosinolate 
(58) was also demonstrated using transgenic tobacco in which the last three steps of 
benzylglucosinolate (58) biosynthetic pathway were transferred to (Geu-Flores, Olsen et 
al., 2009).  
 
Scheme 1.5 Biosynthetic pathway of glucoraphanin (100), engineered in tobacco 
(Mikkelsen, Olsen et al., 2010)  
1.2.2.2 Phytoalexins  
Of the vast number of cruciferous plants species, only a limited number of (ca. 
30) have been investigated for phytoalexin production. The majority cruciferous 
phytoalexins have been isolated from Brassica species (Pedras, Yaya et al., 2011). Since 
the first isolation of the cruciferous phytoalexins brassinin (45), cyclobrassinin (78) and 
1ꞌ-methoxybrassinin (105) from Chinese cabbage inoculated with the bacterium 
Pseudomonas cichorii (Swingle) (Takasugi, Katsui et al., 1986), 45 cruciferous 
phytoalexins have been isolated and characterised (Pedras and Yaya, 2012; Pedras, Yaya 
et al., 2011). This group of metabolites are antimicrobial secondary metabolites which do 
not exist in healthy plant tissue. They are produced when plants are under stress either 
due to abiotic stress, such as metal salts (CuCl2, AgCl, Cu2SO4) and UV-radiation, or 
biotic stress inflicted by microbes (Pedras, Yaya et al., 2011; Smith, 1996). Recently, a 
comprehensive review on their chemical synthesis, biosynthesis, metabolism by plant 
fungal pathogens and biological activities, has been published (Pedras, Yaya et al., 2011). 
Biosynthesis of cruciferous phytoalexins, pertinent to this thesis work, will be reviewed.  
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Figure 1.24 Examples of cruciferous phytoalexins  
1.2.2.2.1 Biosynthesis 
Most cruciferous phytoalexins are derived from the amino acid L-tryptophan (66) 
(Pedras, Yaya et al., 2011), which in turn is biosynthesized from anthranilic acid through 
the shikimate pathway (Dewick, 1998). The phytoalexins can be classified into four 
groups: non-methoxylated, 1-methoxylated, 4-methoxylated and a newly identified 1,4-
dimethoxylated. The first biosynthetic study of cruciferous phytoalexins was conducted 5 
years after the first isolation, revealing L-tryptophan (66) as the biosynthetic building 
block (Monde and Takasugi, 1991). The origin of the indole group was confirmed 
through feeding experiments using L-[4'-
2
H]tryptophan (66a) (Monde and Takasugi, 
1991), in which 18% deuterium incorporation was measured into spirobrassinin (101). 
The biosynthetic relationship between brassinin (45), cyclobrassinin (78) and 1ꞌ-
methoxybrassinin (105) was investigated using Japanese radish roots incubated with 
[
2
H3CS]brassinin (45a) and [
2
H3CS]-1ꞌ-methoxybrassinin (105a). Brassinin (45) was not 
incorporated into 1ꞌ-methoxybrassinin (105), which in turn was not incorporated into 
cyclobrassinin (78). Therefore, it was suggested that cyclobrassinin (78) was not 
biosynthesized from 1ꞌ-methoxybrassinin (105) and that 105 was not derived from 
brassinin (45) (Monde, Tamura et al., 1995). Absence of incorporation of brassinin (45) 
into 1ꞌ-methoxybrassinin (105) suggested that they are likely derived from different 
biosynthetic precursors/intermediates, indolyl-3ꞌ-acetaldoxime (122) and 1ꞌ-
methoxyindolyl-3ꞌ-acetaldoxime (74), respectively (Pedras, Zheng et al., 2007b). 
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[
2
H3CS]Brassinin (45a) was shown to be a biosynthetic precursor of spirobrassinin (101) 
and cyclobrassinin (78) (Monde and Takasugi, 1991) (Scheme 1.6). Brassilexin (117) 
was shown to be derived from Brassinin (45) and cyclobrassinin (78) (Pedras, Loukaci et 
al., 1998; Pedras, Yaya et al., 2011). Similarly, in rutabaga roots, cyclobrassinin (78) was 
shown to be a biosynthetic precursor of rutalexin (116) (Pedras, Montaut et al., 2004; 
Pedras, Yaya et al., 2011) (Scheme 1.6). 
Recently, indole glucosinolates were identified as biosynthetic intermediates 
between tryptophan (66) and cruciferous phytoalexins (Pedras and Yaya, 2013; Pedras, 
Yaya et al., 2010). Glucobrassicin (57) as a common biosynthetic precursor for other 
indole glucosinolates and most of cruciferous phytoalexins was discovered, for the first 
time, in UV elicited leaves of salt cress (T. salsuginea) (Pedras, Yaya et al., 2010). The 
consistency of this discovery was further proven in rutabaga roots irradiated with UV, in 
which phytoalexins and indole glucosinolates incorporated glucobrassicin (57) (Pedras 
and Yaya, 2013). This suggests that indole glucosinolates and cruciferous phytoalexins 
may have some biosynthetic connections. Prior to the above discovery, a major 
breakthrough was achieved when indolyl-3ꞌ-thiohydroxamic acid (79) was incorporated 
into indole glucosinolates and cruciferous phytoalexins (Pedras and Okinyo, 2008). 
Desulfoglucobrassicin (80) was also incorporated into rutabaga phytoalexins (Pedras and 
Yaya, 2013), consistent with the incorporation of glucobrassicin (57) into the 
phytoalexins (Pedras and Yaya, 2013). The biosynthetic intermediate between 
glucobrassicin (57) and T. salsuginea phytoalexins (wasalexins A (43) and B (109) and 
biswasalexins A1 (131) and A2 (132)) was examined using heptadeuterated 1ꞌ-
methoxybrassinin (105a) that was incorporated into T. salsuginea phytoalexins (Pedras, 
Yaya et al., 2010), suggesting 105 is a biosynthetic precursor of the phytoalexins 43, 109, 
131 and 132. However, administration of brassinin (45) to T. salsuginea leaves did not 
show incorporation (Pedras, Yaya et al., 2010), suggesting 1-methoxylated phytoalexins 
are derived from glucobrassicin (57) through 1ꞌ-methoxyglucobrassicin (69) (Scheme 
1.6), which is consistent with lack of incorporation of brassinin (45) into 1ꞌ-
methoxybrassinin (105) (Monde, Tamura et al., 1995). In agreement with the above 
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findings, 1ꞌ-methoxyindolyl-3ꞌ-acetaldoxime (74) was incorporated into 105 and 69 
(Scheme 1.6) (Pedras and Montaut, 2004; Pedras, Okinyo et al., 2009).   
 
 
Scheme 1.6 Biosynthetic map of cruciferous phytoalexins (Pedras, Okinyo et al., 2009; 
Pedras and Yaya, 2013; Pedras, Yaya et al., 2011; Pedras, Yaya et al., 2010). 
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The incorporation of 1ꞌ-methoxybrassinin (105) and sinalbin B (106) into 1-
methoxylated phytoalexins in E. gallicum showed that erucalexin (114) and 1ꞌ-
methoxyspirobrassinin (115) are derived from 1ꞌ-methoxybrassinin 105 via sinalbin B 
(106) (Pedras and Okinyo, 2006a). Feeding experiments carried out with rutabaga roots 
revealed an incorporation of brassinin (45) into brassicanal A (111) and brassicanate A 
(112). The lack of incorporation of compound 78 into 111 and 112 suggested that 111, 
112 and 78 are likely share the same biosynthetic precursor (brassinin (45)) (Pedras, 
Montaut et al., 2004; Pedras, Yaya et al., 2011) (Scheme 1.6). 
The biosynthetic pathway of 4-methoxy phytoalexins was investigated using 
rutabaga roots (Pedras and Yaya, 2013). The incorporation of glucobrassicin (57) into 4-
methoxy phytoalexins including rapalexin A (103) suggested the involvement of 4ꞌ-
methoxyglucobrassicin (70) as an intermediate. 4ꞌ-Methoxybrassinin (108), a proposed 
biosynthetic intermediate between metabolite 70 and 4-methoxy phytoalexins, was 
incorporated into 4ꞌ-methoxycyclobrassinin (110) and 4ꞌ-methoxydehydrocyclobrassinin 
(113), but not into rapalexin A (103) and isocyalexin A (104) (Pedras and Yaya, 2013).  
Rapalexin A (103), the first aromatic isothiocyanate, was isolated from canola 
leaves infected by Albugo candida (Pedras, Zheng et al., 2007a). It was later detected in 
rutabaga, turnip and A. thaliana (Pedras and Adio, 2008; Pedras, Okinyo et al., 2009); 
biosynthetically it is derived from tryptophan (66) (Pedras, Okinyo et al., 2009). Both L 
and D-tryptophan were incorporated into rapalexin A (103) suggesting isomerization of 
D- to L-tryptophan before the metabolism. By analogy to other phytoalexins, 
glucosinolate (118) was proposed to be a biosynthetic intermediate (Pedras, Zheng et al., 
2007a) (Scheme 1.7). 
 
 
Scheme 1.7 Proposed biosynthetic precursor of rapalexin A (103) (Pedras, Zheng et 
al., 2007a) 
118 119 103 
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Most recently, isocyalexin A (104), the first isocyanide of plant origin, was 
isolated from rutabaga roots irradiated by UV (Pedras and Yaya, 2012). The biosynthetic 
intermediate was proposed based on the isocyanide functional group that likely derived 
from 118 or an activated 4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (121) (Pedras and 
Yaya, 2012) (Scheme 1.8). The biosynthetic intermediates of rapalexin A (103) and 
isocyalexin A (104) are the main subject of this thesis. It is described in detail in the 
results and discussion and experimental sections of this thesis. 
 
Scheme 1.8 Proposed biosynthetic intermediates of isocyalexin A (104) (Pedras and 
Yaya, 2012) 
Camalexin (44) is a phytoalexin produced by the model plant A. thaliana whose 
biosynthetic pathway has been investigated more widely than that of cultivated plants. 
Most of its biosynthetic genes have been cloned (Geu-Flores, Møldrup et al., 2011; 
Pedras, Yaya et al., 2011). The initial step in the biosynthesis of camalexin (44) is 
common to indole glucosinolates and other cruciferous phytoalexins. The transformation 
of L-tryptophan (66) to indolyl-3ꞌ-acetaldoxime (122) is catalyzed by cytochrome P450 
enzymes of the family CYP79 (CYP79B2 and CYP79B3) (Mikkelsen, Hansen et al., 
2000). It was confirmed using a double knockout mutant (cyp79b2/cyp79b3) which was 
unable to synthesize camalexin (44) (Glawischnig, Hansen et al., 2004). The 
transformation of indolyl-3ꞌ-acetaldoxime (122) to indolyl-3ꞌ-acetonitrile (67) is catalyzed 
by CYP71A13. The ability of the knockout mutant cyp71a13 to produce camalexin was 
reduced (Nafisi, Goregaoker et al., 2007; Pedras, Yaya et al., 2011). Further confirmation 
was made by expressing CYP71A13 in Escherichia coli. Transformation of tryptophan 
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(66) into indolyl-3ꞌ-acetonitrile (67) was achieved when CYP79B2 along with 
CYP71A13 were expressed in N. benthamiana (Nafisi, Goregaoker et al., 2007). The 
GSTF6 enzyme catalyzes the coupling of activated indolyl-3ꞌ-acetonitrile (67) to GSH to 
yield a GS-IAN (123) conjugate (Su, Xu et al., 2011). This transformation was confirmed 
by overexpressing GSTF6, using transgenic plants, as well as expressing the enzyme in 
yeast cells (Su, Xu et al., 2011). Xu and co-workers proposed that the hydrolysis of GS-
IAN (123) to Cys-IAN (125) might be carried out by γ-glutamyl transpeptidases GGT1 
and GGT2 and the phytochelatin synthase PCS1. Later GGPs involvement in camalexin 
biosynthesis was demonstrated by Geu-Flores and co-workers that GGP1 and GGP3 
hydrolyze GS-IAN (123) to Cys-Gly-IAN (124) conjugate (Geu-Flores, Møldrup et al., 
2011). Mutants lacking these genes accumulated lower amounts of camalexin (44), while 
the concentration of the intermediate (GS-IAN) was increased compared to the wild type. 
The hydrolysis of Cys-Gly-IAN (124) to Cys-IAN (125) was proposed to be catalyzed by 
carboxypeptidase (Geu-Flores, Møldrup et al., 2011). Lastly, the multifunctional 
CYP71B15 catalyzes the cyclization as well as oxidative decarboxylation steps (Scheme 
1.9) (Geu-Flores, Møldrup et al., 2011; Pedras, Yaya et al., 2011). 
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Scheme 1.9 Biosynthetic pathway of camalexin (44) (Geu-Flores, Møldrup et al., 
2011; Pedras, Yaya et al., 2011).  
1.2.3 Wild crucifers 
The plant family Brassicaceae (Cruciferae) comprises a large number of 
agriculturally important crops including oilseeds, vegetables and condiments (Pedras, 
2008; Schranz, Lysak et al., 2006). Brassicas are cultivated and consumed on all over the 
world. Oilseed crucifers (mainly Brassica species) are sources of edible vegetable oils. 
Apart from this, some wild species are good sources of industrial oils (Cromack, 1998; 
Warwick and Gugel, 2003). Crambe abyssinica (R.E.Fr) is a wild crucifer endemic to 
East Africa and the Red Sea region with high industrial potential (Gupta, 2009; Warwick 
and Gugel, 2003). C. abyssinica is resistant to drought and colder weather (Gupta, 2009), 
tolerant to heavy metals (Paulose, Kandasamy et al., 2010), contains  high erucic acid and 
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glucosinolate levels (Mustakas, Kirk et al., 1976; Vaughn and Berhow, 1998), and has 
insecticidal activity (Peterson, Cossé et al., 2000). Epiprogoitrin (94) is one of the major 
glucosinolates detected in C. abyssinica that hydrolyzes to give toxic 2-hydroxy-3-
butenenitrile (127) (Bellostas, Bjergegaard et al., 2007; Gupta, 2009; Mustakas, Kirk et 
al., 1976).  
 
The genus Diplotaxis from the tribe Brassicaceae comprises about 34 species 
(Pignone and Martínez-Laborde, 2011), of which some are important sources of food 
(vegetable and salad) (Pignone and Martínez-Laborde, 2011; Scherrer, Motti et al., 2005) 
and forage for animals (Gupta, 2009). They are also known for their chemo-preventive 
(e.g. D. tenuifolia) (Melchini and Traka, 2010) and anti-inflammatory properties 
(Scherrer, Motti et al., 2005). D. tenuifolia showed strong resistance to a plant pathogen 
Leptosphaeria maculans (Chen and Séguin-Swartz, 1999). 
The genus Brassica consists of economically important and commercially 
valuable species. Cultivated Brassica species are good sources of industrial and edible 
oils, vegetables and condiments. B. tournefortii (Gouan.) (a wild crucifer) native to 
northern Africa, the Middle East, eastern Pakistan, and the Mediterranean region (Gupta, 
2009) is well adapted to the dry environments (Prakash, 1974) and has allelopathic 
properties (Gupta, 2009). It is resistant to acetolactate synthase (ALS)-inhibiting 
herbicides (Boutsalis, Karotam et al., 1999). 
Different studies have indicated that some cultivated crucifers show resistance to 
destructive fungal pathogens (Pedras, Yaya et al., 2011; Pedras, Yaya et al., 2010). 
Similarly, a number of wild crucifers have been reported to show resistance to a variety 
of crucifer pathogens (Chen and Séguin-Swartz, 1999; Conn, Tewari et al., 1988; Pedras, 
Chumala et al., 2003). Their ability to resist disease can be attributed to complex 
metabolic processes involving the participation of secondary metabolites, including 
phytoanticipins and phytoalexins. When compared to cultivated species, the number of 
wild species investigated for the production of phytoalexins is much lower. Those 
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investigated have demonstrated the ability to produce phytoalexins in some cases unique 
to wild crucifers (e.g. camalexin (44) and wasalexins (43, 109, 131 and 132)) (Table 
1.1). Most of these metabolites have been isolated characterised and reported. However, 
the chemical structure of 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile from D. muralis was 
proposed based on 
1
H-NMR data only, no other data (
13
C, HRMS, UV, IR) were 
available (Sarwar, 2007). As this group of metabolites have a major role to play in 
defending plants from plant pathogens, investigations of wild crucifers for additional 
metabolites with diverse chemical structure are important. Wild crucifers that have been 
reported to produce phytoalexins are summarised in the table below (Table 1.1).  
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Table 1.1 Phytoalexins from wild crucifers reported to date.  
Species (common 
name) 
Phytoalexins References 
Arabidopsis thaliana 
(mouse-ear cress) 
Camalexin (44) (Tsuji, Jackson et al., 
1992) 
Arabis lyrata (lyrata 
rock cress) 
Camalexin (44) (Zook, Leege et al., 
1998) 
Brassica adpressa Brassinin (45), cyclobrassinin (78), 
cyclobrassinin sulfoxide (128), 1ꞌ-
methoxybrassinin (105) 
(Rouxel, Kollmann et 
al., 1991) 
B. atlantica Brassinin (45), cyclobrassinin (78), 
1ꞌ-methoxybrassinin (105) 
(Rouxel, Kollmann et 
al., 1991) 
B. carinata 
(Abyssinian cabbage) 
Brassilexin (117), cyclobrassinin 
(78), cyclobrassinin sulfoxide (128), 
1ꞌ-methoxybrassinin (105), 
spirobrassinin (101) 
(Rouxel, Kollmann et 
al., 1991; Storck and 
Sacristan, 1995) 
B. montana  Brassilexin (117), cyclobrassinin 
(78), 1ꞌ-methoxybrassinin (105),   
(Rouxel, Kollmann et 
al., 1991) 
Camelina sativa 
(false flax) 
Camalexin (44), 6-
methoxycamalexin(130) 
(Browne, Conn et al., 
1991) 
Capsella bursa-
pastoris (shepherde‘s 
purse) 
Camalexin (44), 6-methoxycamalexin 
(130), 1-methylcamalexin (129) 
(Jimenez, Ayer et al., 
1997) 
C. abyssinica 
(Abyssinian mustard) 
Rapalexin B (134), arvelexin (135) (Sarwar, 2007) 
D. muralis (wall 
rocket) 
Arvelexin (135), rapalexin A (103) (Sarwar, 2007) 
Erucastrum gallicum 
(dog mustard) 
Arvelexin (135), indolyl-3ꞌ-
acetonitrile (67), erucalexin (114), 1-
methoxyspirobrassinin (115) 
(Pedras, Suchy et al., 
2006) 
Sysimbrium officinale 
(hedge mustard) 
Indolyl-3ꞌ-acetonitrile (67), methyl-
1ꞌ-methoxyindolyl-3ꞌ-carboxylate 
(133) 
(Sarwar, 2007) 
Thlaspi arvense 
(stinkweed) 
Arvelexin (135), wasalexin A (43) (Pedras, Chumala et al., 
2003; Pedras, Sorensen 
et al., 1999) 
Thellungiella 
salsuginea (salt cress) 
Wasalexin A (43), B (109), 
biswasalexin A1(131), A2 (132), 
methoxybrassenin B (137), rapalexin 
A (103) 
(Pedras and Adio, 2008; 
Pedras, Zheng et al., 
2009) 
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Figure 1.25 Phytoalexins isolated from wild crucifers: cyclobrassinin (78), 
cyclobrassinin sulfoxide (128), camalexin (44), 1-methylcamalexin (129), 6-
methoxycamalexin (130), wasalexin A (43), wasalexin B (109), biswasalexin A1 (131), 
biswasalexin A2 (132), methyl 1ꞌ-methoxyindole-3ꞌ-carboxylate (133), rapalexin B (134), 
rapalexin A (103), 1ꞌ-methoxybrassinin (105), brassinin (45), erucalexin (114), (R)-1ꞌ-
methoxyspirobrassinin (115), (S)-spirobrassinin (101), indolyl-3ꞌ-acetonitrile (67), 
arvelexin (135), caulilexin C (136), 1ꞌ-methoxybrassenin B (137), brassilexin (117) 
(Pedras, Yaya et al., 2011). 
78 128 44 129 130 
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1.3 Myrosinases 
Hydrolysis of glucosinolates is facilitated by a group of enzymes called 
myrosinases (thioglucosidases, EC 3.2.1.147) (Bor, Ozkur et al., 2009; Zhang, 
Pontoppidan et al., 2002).  
 
Myrosinase isoenzymes present in the Brassicaceae family are proteins containing 
oligosaccharide chains. Their degrees of glycosylation and isoelectric points are different 
depending on the species and the organs in which they are produced (Bellostas, Petersen 
et al., 2008; Bones, 1990; Zhou, Tokuhisa et al., 2012). Myrosinases are abundant in all 
plant species producing glucosinolates (Bones and Rossiter, 1996) and have been purified 
and characterized from various organs of Brassicaceae species: seeds of Sinapis alba L. 
(Bjorkman and Janson, 1972), roots of Rapahnus sativa L., B. campestris L. and W. 
japonica (Matsum.) (Hara, Eto et al., 2001), B. napus L. (Härtel and Brandt, 2002), seeds 
of B. carinata (A. Braun) and B. oleracea var. capitata L. (Bellostas, Petersen et al., 
2008) (Table 1.2). Myrosinases are disulfide-linked dimers of 75 kDa subunits 
coordinated by a zinc atom (Bones and Slupphaug, 1989; Eriksson, Andreasson et al., 
2002; Lonnerda and Janson, 1973) that can further link with myrosinase binding proteins 
and form complexes of higher molecular weights (Eriksson, Andreasson et al., 2002; 
Geshi, Andreasson et al., 1998) ranging from 140-600 kDa (Bellostas, Petersen et al., 
2008). Plant myrosinases are encoded by the ―thioglucoside glucohydrolase (TGG)‖ 
(Bor, Ozkur et al., 2009) of which six (TGG1-TGG6) have been identified in A. thaliana 
(Andersson, Chakrabarty et al., 2009). Some of them share up to 73% amino acid identity 
with distinct physicochemical properties (Zhou, Tokuhisa et al., 2012). The myrosinases 
characterised and reported to date from Brassicaceae are listed in Table 1.2.  
glucosinolate
s 
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Table 1.2 Myrosinases from Brassicaceae 
Plant species Thioglucosidases 
(isolated, characterised, 
cloned) 
References 
A. thaliana TGG1-TGG5 isolated, 
characterized; 
TGG1,3,4,5 cloned 
(Andersson, Chakrabarty et al., 
2009; Zhang, Pontoppidan et al., 
2002; Zhou, Tokuhisa et al., 2012) 
Armoracia rusticana Isolated, characterized (Li and Kushad, 2005) 
B. carinata Isolated, characterized  (Bellostas, Petersen et al., 2008; 
Bellostas, Sørensen et al., 2006) 
B. napus MA, MB, MC isolated, 
characterized; 
MA, MB cloned 
(Borgen, Thangstad et al., 2010; 
Härtel and Brandt, 2002; Lonnerda 
and Janson, 1973; Thangstad, Winge 
et al., 1993) 
B. oleracea var. 
capitata 
Isolated, characterized (Bellostas, Petersen et al., 2008; 
Pe as, Frias et al., 2011) 
C. abyssinica Isolated, characterized (Bernardi, Finiguerra et al., 2003) 
Lepidium sativum  Isolated, characterized (Durham and Poulton, 1989; Iversen 
and Baggerud, 1980) 
R. sativa Isolated, characterized (Shikita, Fahey et al., 1999) 
Sinapis alba   SA, SB, SC isolated, 
characterized 
(Bjorkman and Janson, 1972; 
Björkman and Lönnerdal, 1973; 
Eriksson, Ek et al., 2001; Iversen 
and Baggerud, 1980) 
T. halophila TGG1, TGG2 detected (Pang, Chen et al., 2009) 
 
Myrosinases and glucosinolates are stored in separate compartments called 
myrosin cells and vacuole respectively (Bones and Iversen, 1985; Bones and Rossiter, 
2006; Kissen, Rossiter et al., 2009). They come in contact when tissue damage occurs 
that gives rise to hydrolysis of glucosinolates to form glucose and an unstable aglycone 
(138). Intermediate 138 rearranges itself spontaneously to release sulfate and other 
products such as isothiocyanates (139), thiocyanates (140), nitriles (141), 
oxazolidinethiones (142), 1-cyano-2,3-epithiopropane (143) and other more (Scheme 
1.10) (Bones and Rossiter, 2006; Halkier and Gershenzon, 2006; Yang, Wang et al., 
2012) Their formation mainly depends on the chemical structure of the parent amino acid 
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and other factors (Bones and Rossiter, 1996; Hopkins, van Dam et al., 2009). For 
example, isothiocyanates (139) are formed at neutral pH, while nitrile (141) formation 
requires low pH conditions. In the presence of epithiospecifier proteins, epithionitriles are 
more favoured products (Bones and Rossiter, 1996; Hopkins, van Dam et al., 2009). In 
the case of indole glucosinolates (e.g. glucobrassicin (57)) the enzymatic hydrolysis 
products include unstable indolyl-3ꞌ-isothiocyanate (144), indolyl-3ꞌ-methanol (145), 
indolyl-3ꞌ-acetonitrile (67) and 3,3'-diindolylmethane (146) (Bones and Rossiter, 1996; 
Bones and Rossiter, 2006) (Figure 1.26). 
 
 
Scheme 1.10 Hydrolysis products of glucosinolates (Bones and Rossiter, 2006) 
 
Figure 1.26 Glucobrassicin hydrolysis products: 144 is unstable and has never been 
isolated (Bones and Rossiter, 2006)  
Certain hydrolysis products of glucosinolates such as sulforaphane 4-
(methylsulfinyl)butylisothiocyanate (147), have cancer chemo-preventive activities 
(Abbaoui, Riedl et al., 2012; Li, Karagöz et al., 2012) and neuro-protective effects 
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(Benedict, Mountney et al., 2012). In plant-pathogen interactions, hydrolysis products of 
glucosinolates play a great role in protecting plants from plant pathogens. For example, 
long chain aliphatic isothiocyanates are toxic to plant pathogens (Kurt, Güneş et al., 
2011; Stotz, Sawada et al., 2011). Indolyl-3ꞌ-acetonitriles (67), a hydrolysis product of 
glucobrassicin (57), deters oviposition by insects (De Vos, Kriksunov et al., 2008). Indole 
glucosinolates are also biosynthetic precursors for cruciferous phytoalexins, which are 
plant defence antimicrobial secondary metabolites (Pedras, Yaya et al., 2011; Pedras, 
Yaya et al., 2010). Therefore, the glucosinolate-myrosinase system can be regarded as a 
plant defence mechanism against different stresses. 
   
1.4 Conclusion 
Crucifers, one of the agro-economically important plant species, are sources of 
vegetables, condiment and oils (edible and industrial) (Schranz, Lysak et al., 2006). 
Worldwide yield loss is mainly caused by biotic and abiotic stresses. Crucifers produce a 
variety of defense metabolites including indole glucosinolates (Agerbirk and Olsen, 
2012; Pedras, Yaya et al., 2011). Their concentration increases when plants are under 
stress or attacked by pathogen which shows their role in plant defences. The three major 
indole glucosinolates are glucobrassicin (57), 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-
methoxyglucobrassicin (70). Their metabolic products are found to be active against 
different microbes (Pedras and Hossain, 2011).  
Indole glucosinolates are biosynthesized from tryptophan (66) and are 
intermediates in the biosynthesis of cruciferous phytoalexins (Pedras and Yaya, 2013). 
Most biosynthetic intermediates and biosynthetic genes involved in the biosynthesis of 
indole glucosinolates have been identified (Halkier and Gershenzon, 2006; Sønderby, 
Geu-Flores et al., 2010). Of 45 cruciferous phytoalexins that have been isolated, most are 
147 
44 
 
from cultivated species (Pedras, Yaya et al., 2011). Because of the availability of A. 
thaliana mutants, only the genes of camalexin (44) biosynthesis have been isolated and 
cloned (Geu-Flores, Møldrup et al., 2011; Pedras, Yaya et al., 2011). No gene has been 
isolated or cloned for the rest of the 44 cruciferous phytoalexins. The structural diversity 
of cruciferous phytoalexins is an indication of complex biosynthetic pathways, where 
unique enzymes are yet to be discovered.  
A tremendous amount of work has been done in understanding biosynthetic 
intermediates of cruciferous phytoalexins through feeding experiments. Different 
2
H, 
13
C 
and 
15
N labeled intermediates have been used to elucidate the biosynthetic map (Pedras 
and Yaya, 2010; Pedras, Yaya et al., 2011; Pedras, Zheng et al., 2007b). Most 
biosynthetic intermediates linking tryptophan (66) to cruciferous phytoalexins have been 
proposed (Pedras, Yaya et al., 2011). Brassinin (45) is a biosynthetic precursor for most 
non methoxylated phytoalexins. 1ꞌ- and 4ꞌ-methoxybrassinins (105 and 108) are proposed 
to be biosynthetic precursors for most of 1- and 4-methoxylated phytoalexins, 
respectively (Pedras and Yaya, 2013; Pedras, Yaya et al., 2011). Unlike other 4-
methoxylated phytoalexins, rapalexin A (103), isocyalexin A (104) and isalexin (102) 
follow a different biosynthetic route (Pedras and Yaya, 2013). The recent discovery of 4ꞌ-
methoxyindolyl-3ꞌ-glycine (107), as an intermediate in the biosynthesis of 103, 104 and 
102 is regarded as a great achievement in mapping cruciferous phytoalexin biosynthetic 
pathways. Determination of such biosynthetic intermediates will facilitate the isolation of 
biosynthetic enzymes, and the cloning of biosynthetic genes, which is important for 
genetic manipulations of the susceptible species (Pedras and Yaya, 2013). 
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2 RESULTS AND DISCUSSION 
2.1. Investigation of elicited metabolites of wild crucifers 
Elicitation of plant secondary metabolites can be carried using either biotic (e.g. 
pathogens) or abiotic (e.g. UV radiation, salt solutions) stresses (Pedras, Yaya et al., 
2011). The type and amounts of elicited metabolites depend on the type of elicitor used 
and the environmental conditions. Elicitation can cause leaf necrosis to mild leaf damage 
and even no macroscopic symptoms. To investigate the production of elicited metabolites 
by the wild crucifers Brassica tournefortii, Crambe abyssinica, Diplotaxis tenuifolia and 
Diplotaxis tenuisiliqua, solutions of CuCl2 were sprayed on potted plants. Plants were 
sprayed with 2, 5, 10, 15 and 20 mM CuCl2 solutions to determine the concentration that 
induced macroscopic damage. B. tournefortii, C. abyssinica and D. tenuifolia showed 
severe damage on the leaves when sprayed with 5 mM or higher; CuCl2 concentrations 
lower than 10 mM did not cause substantial damage on leaves of D. tenuisiliqua. 
Therefore, B. tournefortii, C. abyssinica and D. tenuifolia were sprayed with 2 mM 
solutions while D. tenuisiliqua was sprayed with 10 mM solution of CuCl2. Prior to this 
work, C. abyssinica was investigated and found to produce elicited indole derived 
metabolites: arvelexin (135) and rapalexin B (134) (Sarwar, 2007); however, no elicited 
metabolites were reported from B. tournefortii, D. tenuifolia and D. tenuisiliqua. 
Therefore, further investigations were carried out using CuCl2 solutions as described 
above.  
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2.1.1 Diplotaxis tenuisiliqua 
2.1.1.1 Time-course analysis, isolation and structural elucidation 
Phytoalexin production in D. tenuisiliqua was elicited by spraying 4-week-old 
plants with CuCl2 (10 mM) solution to the point of run-off. Control leaves were sprayed 
with water in a similar way. After 24 h of incubation, leaves were excised and the excised 
leaves were frozen in liquid nitrogen, ground and extracted with methanol as summarised 
in Figure 2.1. The plant tissue was filtered off and the solvent evaporated; the residue 
(extract) was washed with CH2Cl2 to yield the CH2Cl2 extract and the MeOH residue.  
The CH2Cl2 was evaporated and the residue dissolved in CH3CN and subjected to HPLC-
DAD analyses. The methanolic extract was dissolved in water-methanol (1:1) and 
analyzed by HPLC-DAD. Additional leaves, harvested from elicited and control plants at 
72, 120 and 168 hours, were also extracted and analyzed by HPLC-DAD as described 
above.  
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Figure 2.1 Flow chart for time-course analysis of elicited plants 
Metabolite profiles of elicited leaf extracts were compared against control leaf 
extracts. The extracts of elicited leaves showed peaks at tR = 13.8 and 19.7 min that were 
absent in extracts of control leaves. Comparison of retention times and UV spectra of 
elicited metabolite peaks with the phytoalexin database available in Dr. Pedras‘ group 
revealed that the peak at tR = 13.8 min was arvelexin (135). However, no UV spectrum 
match was found for the peak at tR = 19.7 min. The methanolic extracts were also 
analyzed by HPLC-DAD for the detection of indole glucosinolates (glucobrassicin (57), 
1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-methoxyglucobrassicin (70)). No indole 
glucosinolates were detected in either control or elicited leaf extracts (Table 2.1).  
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To isolate the new metabolite present in CH2Cl2 extracts, elicited leaves (300 g) 
were cut and frozen in liquid nitrogen, crushed and extracted with CH3OH (1 L). The 
mixture was filtered, the leaf pieces were discarded and the solvent was evaporated. The 
crude extract was washed with CH2Cl2 and the solvent was evaporated. The CH2Cl2 
extract was subjected to flush column chromatography (FCC) (Hex-EtOAc; 80:20-
0:100), fractions were analyzed by thin layer chromatography (TLC) and those fractions 
containing identical components were combined. The combined fractions were analyzed 
by HPLC-DAD and the fraction containing elicited compounds (fraction-1) (Figure 2.2) 
was further purified by FCC (Hex-EtOAc; 90:10-70:30) to yield six fractions; fractions 
were analyzed by HPLC-DAD and fraction-2 was found to contain the elicited compound 
at tR = 19.7 min. This fraction (fraction-2) was subjected to PTLC (Hex-EtOAc; 85:15) to 
afford six bands that were eluted and analyzed by HPLC-DAD and the least polar (Rf = 
0.5) band contained the desire compound X (0.8 mg) with tR = 19.7 min (Figure 2.2). 
Compound X was characterized by 
1
H-NMR and HR-EI-MS.  
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Figure 2.2 Isolation of UV-elicited metabolites from leaves of Diplotaxis tenuisiliqua 
The HR-EI-MS of compound X showed a molecular ion at m/z [M]
+
 216.0897 
consistent with the molecular formula C12H12N2O2 (calcd. 216.0899). Consistent with the 
HR-EI-MS data, the 
1
H-NMR spectrum showed 12 protons: a singlet at  7.19 (1H), a 
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doublet of doublets at  7.17 (1H), two doublets at  7.02 (1H) and  6.50 (1H), two 
methyl singlets at  4.06 and 3.92 and a singlet at  4.02 (2H). The presence of four 
protons in the aromatic region (7.19-6.50) suggested the presence of an indole ring 
substituted at N-1, C-3 and either C-4 or C-7. The two methyl singlets (and 3.92) 
were most likely due to methoxy groups attached to the indole ring at C-4 and N-1, by 
analogy to other indolic structures. The remaining substituent CH2-CN was likely located 
at C-3. Based on these data, the structure of the compound X (tR = 19.7 min) was 
assigned as 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (148) (Figure 2.3). This structure was 
confirmed by synthesis. 
 
Figure 2.3 Elicited metabolites of Diplotaxis tenuisiliqua. 
Table 2.1 Time-course HPLC analysis (using method A) of metabolites of 
Diplotaxis tenuisiliqua. 
Metabolites- tR (min) Incubation 
period (h) 
Total amount of metabolites 
(nmol/ g of fresh tissue ± STD)
a
 
arvelexin (135): 13.8 24 
72 
120 
168 
0.3 ± 0.0 
1.3 ± 0.2 
1.2 ± 0.6 
0.4 ± 0.1 
1ꞌ,4ꞌ-dimethoxyindolyl-
3ꞌ-acetonitrile (148): 
19.7  
24 
72 
120 
168 
0.1 ± 0.0 
0.2 ± 0.0 
0.1 ± 0.0 
0 
a
Amounts of arvelexin (135) and 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (148) determined 
by HPLC-DAD using calibration curves. Values are the averages of one experiment 
conducted in triplicate ± standard deviation (STD). 
148 135 
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2.1.1.2 Synthesis of 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (148) 
1ꞌ,4ꞌ-Dimethoxyindolyl-3ꞌ-acetonitrile (148) was prepared from commercially 
available 4-methoxyindole (149). 4-Methoxyindole (149) was reduced to the 
corresponding 4-methoxyindoline (150) with NaCNBH3 in AcOH (Wang, Gao et al., 
2009), which was then oxidized with Na2WO4.2H2O/H2O2 and methylated with 
(CH3O)2SO2 (Somei and Kawasaki, 1989) to yield 1,4-dimethoxyindole (151) in 41% 
yield. Formylation of 151 was accomplished via a Vilsmeier-Haak reaction that yielded 
1ꞌ,4ꞌ-dimethoxyindole-3ꞌ-carboxaldehyde (152) in 81% yield. Condensation of 1ꞌ,4ꞌ-
dimethoxyindole-3ꞌ-carboxaldehyde (152) with excess nitromethane in the presence of 
ammonium acetate under reflux (Canoira, Rodriguez et al., 1989; Somei, Sato et al., 
1985) yielded 1,4-dimethoxy-3-nitrovinyl indole (153), which was used without further 
purification. Compound 153 was reduced with sodium borohydride in THF in the 
presence of methanol to yield 1,4-dimethoxy-3-(2ꞌ-nitroethyl)indole (154) in moderate 
yield (Robertson and Botting, 1999). The final step, the transformation of  1,4-
dimethoxy-3-(2ꞌ-nitroethyl)indole (154) into 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile 
(148), was accomplished in 77% yield by treating 154 with carbon disulfide in the 
presence of triethylamine in a sealed reaction vial at 40 ºC (Scheme 2.1). 
 
Scheme 2.1 Synthesis of 148. Reagents and conditions: i) NaCNBH3, AcOH; ii) 
Na2WO4, H2O2, K2CO3, (CH3)2SO4 41%; iii) POCl3, DMF; iv) CH3NO2, NH4OAc, 105 
ºC; v) NaBH4, THF, MeOH; vi) CS2, Et3N , 40 ºC 77%. 
148 
149 151  150  152  
153  154  
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Compound 148 was assayed against the plant pathogenic fungi A. brassicicola, 
L. maculans, R. solani and S. sclerotiorum. At the highest concentration, 0.5 mM, the 
mycelial growth of A. brassicicola, R. solani and S. sclerotiorum were completely 
inhibited (Table 2.2). Therefore, considering that 148 is an elicited metabolite and 
displays antifungal activity, it is a phytoalexin for which the name tenualexin is 
proposed. 
Table 2.2 Inhibitory activity of 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (148) against 
mycelia
a
 of plant pathogenic fungi Alternaria brassicicola, Leptosphaeria maculans, 
Rhizoctonia solani and Sclerotinia sclerotiorum. 
1ꞌ,4ꞌ-dimethoxyindolyl-
3ꞌ-acetonitrile (148)b 
A. brassicicola 
(% inh.) 
L. maculans 
(% inh.) 
R. solani 
(% inh.) 
S. sclerotiorum 
(% inh.) 
5.0 × 10
-4 
M 
2.0 × 10
-4 
M
 
1.0 × 10
-4 
M
 
100 ± 0 
47 ± 4 
31 ± 4 
69 ± 4 
31 ± 4 
18 ± 4 
100 ± 0 
86 ± 0 
67 ± 4 
100 ± 0 
57 ± 2 
23 ± 2 
a 
Percentage of inhibition = 100 – [{(growth on medium containing compound-
plug
c
)/growth on control medium-plug
c
)} × 100)] ± standard deviation. Results are the 
averages ± standard deviations of independent experiments conducted in triplicate. 
b
Compound was dissolved in DMSO and added to potato dextrose agar medium. 
c
Plug diameter = 4 mm 
2.1.2 Brassica tournefortii 
2.1.2.1 Time-course analysis 
An investigation of the production of elicited metabolites in B. tournefortii was 
carried out after spraying 3-week-old plants with CuCl2 (2 mM) solution as described in 
Figure 2.1. The metabolite profiles of elicited leaf extracts were compared against those 
of control leaves.  Extracts of elicited leaves showed five peaks that were absent in 
extracts of control leaves at tR 12.0, 13.8, 14.5, 19.9 and 25.2 min. A comparison of 
HPLC-DAD and HPLC-ESI-MS data with those of compounds available in Dr. Pedras‘ 
group revealed that the peaks at tR = 12.0 min corresponded to spirobrassinin (101), tR = 
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13.8 min to arvelexin (135), tR = 14.5 min to rutalexin (116), tR = 19.9 min to 4ꞌ-
methoxybrassinin (108) and tR = 25.2 min to cyclobrassinin (78). The amount of each 
metabolite was determined using calibration curves built with synthetic samples (Table 
2.3). Production of these metabolites from cultivated Brassica species has been reported 
(Pedras, Yaya et al., 2011).  
The methanolic extracts were also analyzed by HPLC-DAD for the detection of 
indole glucosinolates (glucobrassicin (57), 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-
methoxyglucobrassicin (70)). The HPLC-DAD and HPLC-ESI-MS data indicated that 
glucobrassicin (57) and 4ꞌ-methoxyglucobrassicin (70) were produced by the plant. 
However, 1ꞌ-methoxyglucobrassicin (69) was not detected in the polar extract (Table 
2.3). These results suggest that both wild and cultivated species of Brassica share 
pathways that are responsible for phytoalexin biosynthesis. 
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Table 2.3 Time-course HPLC analysis (using method A for phytoalexins and 
method B for indole glucosinolates) of metabolites of Brassica tournefortii. 
Metabolites; tR (min) Incubation period 
(h) 
Total amount of metabolites 
(nmol/ g of fresh tissue ± STD)
a
 
spirobrassinin (101); 12.0 24 
72 
120 
5.6 ± 0.9 
4.6 ± 0.3 
4.6 ± 0.2 
arvelexin (135); 13.8 24 
72 
120 
0.5 ± 0.1 
1.2 ± 0.5 
0.7 ± 0.3 
rutalexin (116); 14.5 24 
72 
120 
1.0 ± 0.1 
1.0 ± 0.1 
1.1 ± 0.0 
4ꞌ-methoxybrassinin 
(108); 19.9 
24 
72 
120 
1.0 ± 0.1 
0.1 ± 0.0 
0 
cyclobrassinin (78); 25.2 24 
72 
120 
3.2 ± 0.4 
0.6 ± 0.0 
0.4 ± 0.0 
glucobrassicin (57); 19.6 24 
72 
120 
18.5 ± 4.4 
9.0 ± 5.0 
5.8 ± 1.0 
4ꞌ-methoxyglucobrassicin 
(70); 26.2 
24 
72 
120 
3.4 ± 1.0 
2.0 ± 1.1 
1.0 ± 0.3 
a
Amounts of spirobrassinin (101), arvelexin (135), rutalexin (116), 4ꞌ-methoxybrassinin 
(108), cyclobrassinin (78), glucobrassicin (57) and 4ꞌ-methoxyglucobrassicin (70) 
determined by HPLC-DAD using calibration curves. Values are the averages of one 
experiment conducted in triplicate ± standard deviation (STD). 
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Figure 2.4 Elicited and constitutive metabolites of Brassica tournefortii. 
2.1.3 Crambe abyssinica 
2.1.3.1 Time-course analysis 
C. abyssinica (17-days-old) was sprayed with CuCl2 (2 mM) solution and 
incubated. Control leaves were sprayed with water in a similar fashion and analyzed as 
described in Figure 2.1. The metabolite profiles of elicited leaf extracts were compared 
against control leaves.  Extracts of elicited leaves showed three peaks at tR 11.7, 13.6 
and 24.7 min which were absent from extracts of control leaves. The HPLC-DAD, 
HPLC-ESI-MS data and comparison with UV and MS libraries of compounds available 
in Dr. Pedras‘ group revealed that the peaks at tR = 11.7 min corresponded to 
spirobrassinin (101), tR = 13.8 min to arvelexin (135) and tR = 24.7 min to 
cyclobrassinin (78). The amounts of induced metabolites were determined using 
calibration curves (Table 2.4). Analysis of the polar extracts showed absence of 4ꞌ-
methoxyglucobrassicin (70) and 1ꞌ-methoxyglucobrassicin (69), while glucobrassicin 
(57) was detected in the polar extract (Table 2.4). 
  
101 116 78 
108 
135 
57 70 
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Table 2.4 Time-course HPLC analysis (using method A for phytoalexins and 
method B for indole glucosinolates) of metabolites of Crambe abyssinica. 
Metabolites; tR (min) Incubation period 
(h) 
Total amount of metabolites 
(nmol/ g of fresh tissue ± 
STD)
a
 
spirobrassinin (101); 11.7 24 
72 
120 
4.1 ± 0.1 
3.3 ± 0.5 
2.9 ± 0.9 
arvelexin (135); 13.6 24 
72 
120 
0.6 ± 0.0 
7.3 ± 2.9 
9.5 ± 4.7 
cyclobrassinin (78); 24.7 24 
72 
120 
1.9 ± 0.3 
0.7 ± 0.1 
0 
glucobrassicin (57); 19.6 24 
72 
120 
3.8 ± 1.6 
6.1 ± 3.0 
2.5 ± 0.4 
a
Amounts of spirobrassinin (101), arvelexin (135), cyclobrassinin (78) and glucobrassicin 
(57) determined by HPLC-DAD using calibration curves. Values are the averages of one 
experiment conducted in triplicate ± standard deviation (STD). 
2.1.4 Diplotaxis tenuifolia 
2.1.4.1 Time-course analysis 
D. tenuifolia (24-days-old) was sprayed with CuCl2 (2 mM) solution and 
analyzed as described in Figure 2.1. The metabolite profiles of elicited leaves extracts 
were compared against control leaves.  Extracts of elicited leaves showed a peak at tR = 
13.6 min which was absent from extracts of control leaves. The HPLC-DAD, HPLC-
ESI-MS data and comparison with compounds in Dr. Pedras‘ group UV and MS 
libraries revealed that the peak at tR = 13.6 min corresponded to arvelexin (135). The 
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amount of arvelexin produced was determined using a HPLC-DAD calibration curve 
(Table 2.5). The methanolic extracts were analyzed by HPLC-DAD for the detection of 
indole glucosinolates: glucobrassicin (57), 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-
methoxyglucobrassicin (70). The polar extracts showed metabolite peaks corresponded 
to glucobrassicin (57) and 4ꞌ-methoxyglucobrassicin (70). No 1ꞌ-methoxyglucobrassicin 
was detected (Table 2.5).  
Table 2.5 Time-course HPLC analysis (using method A for phytoalexins and 
method B for indole glucosinolates) of metabolites of Diplotaxis tenuifolia. 
Metabolites; tR (min) Incubation period 
(h) 
Total amount of metabolites 
(nmol/ g of fresh tissue ± 
STD)
a
 
arvelexin (135); 13.6 24 
72 
120 
168 
1.6 ± 0.3 
6.8 ± 3.9 
11.1 ± 6.1 
9.3 ± 1.2 
glucobrassicin (57); 19.6 24 
72 
120 
168 
0.7 ± 0.5 
2.6 ± 0.9 
1.2 ± 0.7 
1.5 ± 0.3 
4ꞌ-methoxyglucobrassicin (70); 
26.2 
24 
72 
120 
168 
0.5 ± 0.2 
1.0 ± 0.7 
0.3 ±0.1 
0.3 ± 0.1 
a
Amounts of arvelexin (135), glucobrassicin (57) and 4ꞌ-methoxyglucobrassicin (70) 
determined by HPLC-DAD using calibration curves. Values are the averages of one 
experiment conducted in triplicate ± standard deviation (STD). 
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2.1.5 Conclusion 
The number of cruciferous species is estimated to be around 3700; however, only a 
limited number of species (ca. 30) have been investigated for production of phytoalexins, 
the majority of which are Brassica spp. Most cruciferous phytoalexins have been isolated 
from Brassica species, mostly from cultivated species (Pedras, Yaya et al., 2011). In this 
thesis, the wild crucifers B. tournefortii, C. abyssinica, D. tenuifolia and D. tenuisiliqua 
were investigated for the production of elicited metabolites after treatment with CuCl2 
solution. All species produced arvelexin (135) (Pedras, Chumala et al., 2003). Arvelexin 
(135) was the only phytoalexin detected in D. tenuifolia, while in D. tenuisiliqua, 
arvelexin (135) was produced together with another elicited metabolite, 1ꞌ,4ꞌ-
dimethoxyindolyl-3ꞌ-acetonitrile (148). Compound 148 was detected in D. muralis treated 
with CuCl2 solution, and its structure had been proposed based on 
1
H-NMR data only 
(Sarwar, 2007). In this work, the same compound was isolated from D. tenuisiliqua, fully 
characterized and its structure was confirmed by chemical synthesis. It is the first 
cruciferous phytoalexin ever reported with dimethoxy substitution for which the name 
tenualexin is proposed. Its antifungal activity was determined against the plant pathogens 
A. brassicicola, L. maculans, R. solani and S. sclerotiorum. At the highest concentration 
(0.5 mM), 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (148) completely inhibited mycelial 
growth of A. brassicicola, R. solani and S. sclerotiorum. Previously it was reported that, 
at the highest concentration, 1ꞌ-methoxyindolyl-3ꞌ-acetonitrile (136) inhibited mycelial 
growth of A. brassicicola and S. sclerotiorum by 43 and 54% respectively while 4ꞌ-
methoxyindolyl-3ꞌ-acetonitrile (67) inhibited mycelial growth of A. brassicicola and S. 
sclerotiorum by 59 and 77% respectively (Pedras and Hossain, 2011).  
In crucifers, indolyl-3ꞌ-acetonitriles are derived from indole glucosinolates through 
enzymatic processes that involve myrosinase and nitrile-specifier proteins (Kissen and 
Bones, 2009; Williams, Critchley et al., 2009). Glucobrassicin (57) is a precursor of 
indolyl-3ꞌ-acetonitrile (67), while 4ꞌ-methoxyglucobrassicin (70) is a precursor of 4ꞌ-
methoxyindolyl-3ꞌ-acetonitrile (135). In the case of 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile 
(148), 1ꞌ,4ꞌ-dimethoxyglucobrassicin (62), isolated for the first time from roots of 
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Barbarea vulgaris ssp. arcuata (Agerbirk, Petersen et al., 2001), is likely to be its 
biosynthetic precursor. C. abyssinica produced the phytoalexins spirobrassinin (101), 
cyclobrassinin (78) and arvelexin (135), which were initially isolated from cultivated 
species (Pedras, Yaya et al., 2011; Takasugi, Kawashima et al., 1987). The metabolic 
profile of B. tournefortii resembles that of cultivated Brassica species. It produced the 
phytoalexins spirobrassinin (101), arvelexin (135), rutalexin (116), 4ꞌ-methoxybrassinin 
(108) and cyclobrassinin (78). This shows overlap of the biosynthetic pathways of 
cruciferous phytoalexins in cultivated and some wild species. As crucifers produce a 
mixture of phytoalexins, whose composition and amounts depend on the type of stress 
(Pedras and Yaya, 2010; Pedras, Yaya et al., 2011; Pedras, Zheng et al., 2007b), it is 
worthy to investigate different plant tissues using different elicitation techniques. The 
absence of additional phytoalexins in, for example, elicited leaves of D. tenuifolia 
suggests the need to try different elicitation strategies, including UV-light and other 
heavy metal salt solutions. Especially wild crucifers are likely to produce biologically 
active new metabolites, as most of them are not yet investigated 
2.2 Biosynthesis of cruciferous phytoalexins 
The biosynthesis of secondary metabolites occurs either under normal growth 
conditions or when plants are stressed by external factors such as pathogens, salinity, UV 
light, drought, etc. A number of cruciferous plants have been reported to show resistance 
to a variety of crucifer pathogens. For example, Camelina sativa L. (false flax), Capsella 
bursa-pastoris L. (Shepherd‘s purse) and Eruca sativa Mill. (rocker) were reported to 
display resistance against A. brassicae (Conn, Tewari et al., 1988). Their ability to defend 
themselves may be partly due to the production of secondary metabolites including 
phytoalexins and phytoanticipins. Unlike phytoanticipins, phytoalexins are 
biosynthesized when plants are under stress (Bailey and Mansfield, 1982; Pedras, Yaya et 
al., 2011; Vanetten, Mansfield et al., 1994). Knowledge of the biosynthetic pathways of 
phytoalexins and phytoanticipins will facilitate the identification of plant defense genes 
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and the potential breeding of plants producing more potent antifungal metabolites. 
Biosynthetic studies require a proposal of biosynthetic intermediates, their retro-
biosynthetic analysis, chemical syntheses and administration of isotopically labeled 
precursors to different plant tissues. Finally, the level of incorporation is determined 
using spectroscopic techniques such as NMR and MS.  
2.2.1 Thellungiella salsuginea (salt cress) 
T. salsuginea is a wild crucifer extremophile resistant to a variety of abiotic 
stresses, such as high salinity, low humidity and frost (Gong, Li et al., 2005; Inan, 
Zhang et al., 2004). It is a model plant whose genome is being sequenced (Wu, Zhang et 
al., 2012). When under stress, it produces phytoalexins that are structurally unique, the 
wasalexins A (43) and B (109) and biswasalexins A1 (131) and A2 (132) (Pedras, 
Sorensen et al., 1999; Pedras and Zheng, 2010; Pedras, Zheng et al., 2009). The 
methoxy substituent at N-1 of the indole ring and their side chains suggest that they 
have a relationship with 1ꞌ-methoxybrassinin (105), a phytoalexin of Brassica species 
(Scheme 2.2) (Pedras, Yaya et al., 2010). Thus, a biosynthetic study of the phytoalexins 
of T. salsuginea was carried out using perdeuterated biosynthetic intermediates: 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57b), [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin 
(105a), L-[2',4',5',6',7'-
2
H5]tryptophan (66a), [
2
H3CO]-1'-methoxyindolyl-3'-
acetaldoxime (74a), L-[
2
H3CS]methionine (97a), [4',5',6',7'-
2
H4]brassinin (45a), 1'-
methoxy-2'-methylbrassinin (160)  and 1'-methylindolyl-3'-acetaldoxime (75)  (Table 
2.6). Labeled compounds, except tryptophan and methionine, used in this section were 
synthesized in Dr. Pedras‘ lab according to references shown in Table 2.6.  
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Table 2.6  Perdeuterated compounds used in precursor administration experiments.  
Deuterated compound (#)
a
 Origin  
[
2
H3CS, 4',5',6',7'-
2
H4]-1ꞌ-methoxybrassinin  (105a)  synthetic (Pedras and Okinyo, 
2006c) 
[4',5',6',7'-
2
H4]brassinin  (45a)  synthetic  (Pedras and 
Okinyo, 2006c) 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57b)  synthetic (Pedras, Yaya et al., 
2010) 
[
2
H3CO]-1ꞌ-methoxyindolyl-3ꞌ-acetaldoxime (74a) synthetic (Pedras and Okinyo, 
2006c) 
L-[2',4',5',6',7'-
2
H5]tryptophan (66a) commercial (Cambridge 
Isotope Laboratories) 
L-[
2
H3CS]methionine (97) Commercial (C/D/N Isotopes)  
1'-methoxy-2'-methylbrassinin (160) synthetic (Pedras, Okinyo et 
al., 2009) 
1'-methylindolyl-3'-acetaldoxime (75) synthetic (Pedras, Okinyo et 
al., 2009)  
a 
Deuterated compounds are referred to by a number followed by the letter a or b. 
 
Scheme 2.2 Retro-biosynthetic analysis of wasalexin A (43), B (109) and biswasalexin 
A1 (131) and A2 (132) (Pedras, Yaya et al., 2010) 
131 
43/109 
132 
105 69 57 66 
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2.2.1.1 Incorporation experiments using synthetic and commercially available 
compounds  
 In order to investigate the biosynthetic pathway of wasalexin A (43), wasalexin B 
(109), biswasalexin A1 (131) and biswasalexin A2 (132), previously reported growth and 
analysis conditions were used (Pedras and Zheng, 2010; Pedras, Zheng et al., 2009). For 
feeding experiments, 4-week-old potted plants were irradiated with UV for 60 min. After 
UV-elicitation, plants were allowed to stand in a laminar flow cabinet under fluorescent 
light for 3 h, and then were uprooted, the leaves were cut at the base of the petioles and 
were immediately immersed in tubes containing an aqueous solution of the precursor (4 
mL, 5×10
-4
 M). Following the uptake of each precursor solution (ca. 12 h), the tubes were 
filled with H2O and leaves were further incubated for 48 h under continuous fluorescent 
light. After the incubation period was over, leaves were frozen in liq. nitrogen, extracted 
with methanol; the methanol extract was filtered and was concentrated to dryness. The 
methanolic residue was rinsed with CH2Cl2, the CH2Cl2 fraction was concentrated under 
reduced pressure, and the residue was dissolved in acetonitrile to yield the non-polar 
fraction containing mostly phytoalexins for HPLC-ESI-MS analysis as summarized in 
Figure 2.5. The insoluble residue was dissolved in MeOH–H2O (1:1) and was filtered to 
yield the polar fraction for HPLC-ESI-MS analysis (Pedras, Yaya et al., 2010). 
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Figure 2.5 Summary of elicitation, extraction and analysis of phytoalexins and indole 
glucosinolates produced in Thellungiella salsuginea 
The percentage of deuterium (
2
H) incorporation was established using intensity of 
peaks obtained in ESI-MS positive or negative modes, according to the equation: % of 
incorporation = [M ± 1 + n]
±
/([M ± 1]
±
 + [M ± 1 + n]
±
) × 100 (n = 3, …), n is the number 
of deuteria and M is the peak intensity of each ion [M – 1]- or [M + 1]+. 
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2.2.1.1.1 Incorporation of L-[2',4',5',6',7'-2H5]tryptophan (66a) 
Leaves of 4-weeks-old plants of T. salsuginea were prepared for the feeding 
experiment as described above (Figure 2.5). Commercially available L-[2',4',5',6',7'-
2
H5]tryptophan (66a) dissolved in water (4 mL, 5×10
-4 
M) was administered to UV-
elicited petiolated  leaves of T. salsuginea and worked up followed as shown in Figure 
2.5. Control leaves fed with naturally occurring L-tryptophan (66) or carrier solution were 
treated in a similar way. HPLC-ESI-MS (positive mode) of the CH2Cl2 fractions that 
contained phytoalexins showed the wasalexin A (43) peak at tR = 21.6 min containing 
two ions: [M + 1]
+
 at m/z 295 and the corresponding [M + 1 + 4]
+
 at m/z 299, the latter 
resulting from incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a). The ion with m/z 
299 was not detected in the control sample that was fed with non-labeled L-tryptophan 
(66). Peak intensities of the natural abundance and of the deuterated ions were used to 
determine the percentage of deuterium incorporation as indicated above (% of 
2
H 
incorporation = {[M + 1 + 4]
+
/([M + 1]
+
 + [M + 1 + 4]
+
)} × 100 ± standard deviation 
(Pedras, Yaya et al., 2010). Accordingly, the percentage of deuterium incorporation was 
determined to be 4.6 ± 0.8% (Table 2.7). Similarly, the wasalexin B (109) peak at tR = 
19.3 min showed two ions: [M + 1]
+
 at m/z 295 and the corresponding [M + 1 + 4]
+
 at m/z 
299. The percentage of deuterium incorporation into wasalexin B (109) was calculated to 
be 2.8 ± 0.3% (Table 2.7; Figure 2.6). 
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Table 2.7  Metabolites of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) in UV-irradiated 
leaves of Thellungiella salsuginea.  
Metabolites isolated (nmoles / g of fresh tissue)
a
  % Incorporation of 
deuterium ± Std 
[4',5',6',7'-
2
H4]wasalexin A (43a) (280 ± 14) 4.6 ± 0.8
b
 
[4',5',6',7'-
2
H4]wasalexin B (109a) (16 ± 3) 2.8 ± 0.3
b
 
[4',5',6',7'-
2
H4]biswasalexin A1 (131a) (60 ± 4) 2.5 ± 1.9
b
 
[4',5',6',7'-
2
H4]biswasalexin A2 (132a) (≤0.5) NI
d
 
[2',4',5',6',7'-
2
H5]glucobrassicin (57a) (≤1) 11.1 ± 2.7
c
 
[2',4',5',6',7'-
2
H5]-1'-methoxyglucobrassicin (69a) (118 ± 6) 22.8 ± 2.6
c
 
[2',5',6',7'-
2
H4]-4'-methoxyglucobrassicin (70a) (412 ± 24) 11.9 ± 2.5
c
 
a 
Deuterated compounds are referred to by a number followed by the letter a; nmoles = 
total amount of deuterated plus non-deuterated compound.. 
b 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); % 
of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 4) ± Std 
(standard deviation), where n = number of deuterium atoms. 
c 
Negative ion mode. % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M - 1 + n]
−
)} × 100 
(n = 4 or 5) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium 
The biswasalexin A1 (131) peak at tR = 29.7 min showed two ions: [M + 1]
+
 at 
m/z 589 and the corresponding [M + 1 + 4]
+
 at m/z 593, that resulted from the 
incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a). The percentage of deuterium 
incorporation into biswasalexin A1 (131) was calculated as indicated above to be 2.5 ± 
1.9% (Table 2.7). In the case of biswasalexin A2 (132) peak at tR = 32.7 min, only one 
ion with m/z 589 due to [M + 1]
+
 was detected (Table 2.7; Figure 2.6).  
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Figure 2.6 Deuterated phytoalexins obtained from feeding of L-[2',4',5',6',7'-
2
H5]tryptophan (66a)  to UV-irradiated leaves of Thellungiella salsuginea: [4',5',6',7'-
2
H4]wasalexin A (43a)  (4.6 ± 0.8%), [4',5',6',7'-
2
H4]wasalexin B (109a) (2.8 ± 0.3%) and 
[4',5',6',7'-
2
H4]biswasalexin A1 (131a) (2.5 ± 1.9%). 
 Incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) into indole glucosinolates 
(glucobrassicin (57), 4ꞌ-methoxyglucobrassicin (70) and 1ꞌ-methoxyglucobrassicin (69)) 
produced in T. salsuginea was also determined. Methanolic extracts of leaves were 
dissolved in water-methanol (50:50) and analyzed by HPLC-DAD and HPLC-ESI-MS. 
The HPLC-ESI-MS analysis of the polar extracts showed the glucobrassicin (57) peak at 
tR = 5.3 min containing two ions (negative mode): [M]
-
 at m/z 447 and the corresponding 
ion [M + 5]
-
 at m/z 452, that resulted from incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan 
(66a). The percentage of incorporation of deuterium into glucobrassicin (57) was 
calculated to be 11.1 ± 2.7% (Table 2.7). From analysis of the HPLC-ESI-MS of the 4ꞌ-
methoxyglucobrassicin (70) peak at tR = 6.9 min two ions were observed in the negative 
mode: [M]
-
 at m/z 477 and the corresponding [M + 4]
-
 at m/z 481. The percentage of 
deuterium incorporation was calculated to be 11.9 ± 2.5% (Table 2.7). In a similar 
fashion, HPLC-ESI-MS analysis of the polar extract showed the 1ꞌ-methoxy 
glucobrassicin (69) peak at tR = 9.4 min containing two ions in the negative mode: [M]
-
 at 
66a 109a 
131a 
43a 
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m/z 477 and the corresponding [M + 5]
-
 at m/z 482. The percentage of deuterium 
incorporation was measured to be 22.8 ± 2.6% (Table 2.7, Figure 2.7). 
 Incorporation of L-tryptophan (66) into wasalexin A (43), wasalexin B (109) 
biswasalexin A1 (131), glucobrassicin (57), 4ꞌ-methoxyglucobrassicin (70) and 1ꞌ-
methoxyglucobrassicin (69) shows that they are biosynthesized from L-tryptophan (66) 
(Figures 2.6 and 2.7). This result is consistent with previously reported data, 
demonstrating the incorporation of L-tryptophan 66 into cruciferous phytoalexins 
(Pedras, Yaya et al., 2011; Pedras, Zheng et al., 2007b) and indole glucosinolates 
(Kutacek and Kralova, 1972; Kutacek, Prochazka et al., 1962; Pedras, Okinyo et al., 
2009). 
 
Figure 2.7 Deuterated indole glucosinolates obtained from feeding of L-[2',4',5',6',7'-
2
H5]tryptophan (66a)  to UV-irradiated leaves of Thellungiella salsuginea: [2',4',5',6',7'-
2
H5]glucobrassicin (57a) (11.1 ± 2.7%), [2',5',6',7'-
2
H4]-4'-methoxyglucobrassicin (70a) 
(11.9 ± 2.5%) and [2',4',5',6',7'-
2
H5]-1'-methoxyglucobrassicin (69a) (22.8 ± 2.6%). 
2.2.1.1.2 Incorporation of [2,2,4',5',6',7'-2H6]glucobrassicin (57b) 
Biosynthetic relationships among indole glucosinolates and cruciferous 
phytoalexins were investigated by using hexadeuterated [2,2,4',5',6',7'-
2
H6]glucobrassicin 
(57b). Feeding experiments were conducted using 4-week-old plants of T. salsuginea. A 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) solution (4 mL, 5 × 10
-4
 M) was administered to 
UV-elicited petiolated  leaves and analyzed as described in Figure 2.5. HPLC-ESI-MS 
57a 
70a 
69a 66a 
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(positive mode) of the nonpolar fractions that contained phytoalexins showed a wasalexin 
A (43) peak at tR = 21.6 min containing two ions: [M + 1]
+
 at m/z 295 and the 
corresponding [M + 1 + 5]
+
 at m/z 300, that resulted from the incorporation of 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57b). The ion with m/z 300 was not detected in the 
control sample that was fed with non-labeled glucobrassicin (57). Peak intensities of the 
natural abundance and of the deuterated ions were used to determine the percentage of 
deuterium incorporation as indicated in Table 2.8. Accordingly, the percentage of 
deuterium incorporation was determined to be 3.7 ± 1.0%. Similarly, the wasalexin B 
(109) peak at tR = 19.3 min showed two ions: [M + 1]
+
 at m/z 295 and the corresponding 
[M + 1 + 5]
+
 at m/z 300 that resulted from incorporation of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b). The percentage of deuterium incorporation into wasalexin B 
(109) was determined to be 2.4 ± 0.6% (Table 2.8). 
Table 2.8 Metabolites of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) in UV-irradiated 
leaves of Thellungiella salsuginea.  
Metabolites isolated (nmoles / g of fresh tissue)
a 
 % Incorporation of 
deuterium
  
± Std 
[1,4',5',6',7'-
2
H5]wasalexin A (43a) (550 ± 36) 3.7 ± 1.0%
b
 
[1,4',5',6',7'-
2
H5]wasalexin B (109a) (54 ± 6) 2.4 ± 0.6%
b
 
[1,4',5',6',7'-
2
H5]biswasalexin A1 (131a) (128 ± 18) 2.0 ± 0.6%
b
 
[1,4',5',6',7'-
2
H5]biswasalexin A2 (132a) (≤0.5) NI
d
 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) (≤1) 77.5 ± 13.8%
c
 
[2,2,4',5',6',7'-
2
H6]-1'-methoxyglucobrassicin (69a) (154 ± 10) 4.7 ± 1.6%
c
 
[2,2,5',6',7'-
2
H5]-4'-methoxyglucobrassicin (70a) (366 ± 21) 13.9 ± 2.6%
c
 
a 
All deuterated compounds are referred to by a number followed by the letter a or b; 
conc. = total concentration of deuterated plus non-deuterated compound. 
b 
Positive ion mode. Incorporations calculated from HPLC-ESI -MS (peak intensities); % 
of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 5) ± Std 
(standard deviation), where n = number of deuterium atoms.
 
 
c
Negative ion mode. Incorporations calculated from HPLC-ESI -MS; % of 
2
H 
incorporation = {[M + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 5 or 6) ± Std (standard 
deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium 
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The biswasalexin A1 (131) peak at tR = 29.7 min showed two ions: [M + 1]
+
 at 
m/z 589 and the corresponding [M + 1 + 5]
+
 at m/z 594, that resulted from the 
incorporation of deuterium of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b). The percentage of 
deuterium incorporation into biswasalexin A1 (131) was calculated to be 2.0 ± 0.6%. In 
the case of biswasalexin A2 (132) peak at tR = 32.7 min, only one ion with m/z 589 due to 
[M + 1]
+
 was detected (Table 2.8; Figure 2.8).  
 
Figure 2.8 Deuterated phytoalexins obtained from feeding of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) to UV-irradiated leaves of Thellungiella salsuginea: 
[1,4',5',6',7'-
2
H5]wasalexin A (43a) (3.7 ± 1%), [1,4',5',6',7'-
2
H5]wasalexin B (109a) (2.4 
± 0.6%) and [1,4',5',6',7'-
2
H5]biswasalexin A1 (131a) (2.0 ± 0.6%). 
The incorporation of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) into the indole 
glucosinolates (4'-methoxyglucobrassicin (70) and 1'-methoxyglucobrassicin (69)) 
produced in T. salsuginea was investigated. Methanolic extracts of leaves were dissolved 
in water-methanol (50:50) and analyzed by HPLC-DAD and HPLC-ESI-MS. The HPLC-
ESI-MS analysis of the polar extracts showed the 4'-methoxyglucobrassicin (70) peak at 
tR = 6.9 min containing two ions (negative mode): [M]
-
 at m/z 477 and the corresponding 
[M + 5]
-
 at m/z 482, that resulted from incorporation of [2,2,4',5',6',7'-
2
H6]glucobrassicin 
(57b). The percentage of deuterium incorporation was calculated as indicated above to be 
13.9 ± 2.6% Table 2.8. In a similar fashion, the HPLC-ESI-MS analysis of the polar 
extracts showed the 1'-methoxyglucobrassicin (69) peak at tR = 9.4 min containing two 
57b 43a 
131a 
109a 
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ions: [M]
-
 at m/z 477 and the corresponding [M + 6]
-
 at m/z 483. Thus, the percentage of 
deuterium incorporation was determined to be 4.7 ± 1.6% (Table 2.8; Figure 2.9).  
This is the first report showing a biosynthetic relationship between indole 
glucosinolates and cruciferous phytoalexins. It suggested that cruciferous phytoalexins 
are derived from indole glucosinolates. Incorporation of glucobrassicin into wasalexins A 
(43) and B (109) and biswasalexin A1 (131) was proposed (retro-biosynthetic analysis) to 
pass through 1'-methoxyglucobrassicin (69) (Scheme 2.2). N-oxidation and then 
methylation occur during the transformation of 57 to 69 (Scheme 2.2). 
 
Figure 2.9 Deuterated indole glucosinolates obtained from feeding of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) to UV-irradiated leaves of Thellungiella salsuginea: 
[2,2,5',6',7'-
2
H5]-4'-methoxyglucobrassicin (70a) (13.9 ± 2.6%) and [2,2,4',5',6',7'-
2
H6]-1'-
methoxyglucobrassicin (69a) (4.7 ± 1.6%). 
2.2.1.1.3 Incorporation of [2H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a) 
The incorporation of deuterated 1'-methoxybrassinin (105a), a likely precursor of 
wasalexins, was investigated. Feeding experiments were carried out using UV-elicited 
leaves of T. salsuginea as described in Figure 2.5. The HPLC-ESI-MS (positive mode) 
analysis of the nonpolar fractions that contained phytoalexins showed the wasalexin A 
(43) peak at tR = 21.6 min containing two ions: [M + 1]
+
 at m/z 295 and the corresponding 
[M + 1 + 7]
+
 at m/z 302, that resulted from incorporation of [
2
H3CS,4',5',6',7'-
2
H4]-1'-
methoxybrassinin (105a). The ion m/z 302 was not detected in control sample that was 
fed with non-labeled 1-methoxybrassinin (105). Peak intensities of the natural abundance 
and of the deuterated ions were used to determine the percentage of deuterium 
incorporation as indicated in Table 2.9. Thus, the percentage of deuterium incorporation 
was determined to be 19.2 ± 3.9%. The wasalexin B (109) peak at tR = 19.3 min showed 
57b 70a 69a 
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two ions as well: [M + 1]
+
 at m/z 295 and the corresponding [M + 1 + 7]
+
 at m/z 302, that 
resulted from incorporation of [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a). The 
percentage of deuterium incorporation into wasalexin B (109) was calculated to be 16.7 ± 
4.3% (Table 2.9; Figure 2.10).  
Table 2.9 Metabolites of [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a) in UV-
irradiated leaves of Thellungiella salsuginea.  
Metabolites isolated (nmoles ± Std / g of fresh tissue)
a 
 % Incorporation of 
deuterium
 
±Std 
[
2
H3CS,4',5',6',7'-
2
H4]wasalexin A (43a) (794 ± 54) 19.2 ± 3.9%
b
 
[
2
H3CS,4',5',6',7'-
2
H4]wasalexin B (109a) (103 ± 16) 16.7 ± 4.3%
b
 
[
2
H3CS,4',5',6',7'-
2
H4]biswasalexin A1 (131a) (129 ± 38) 10.7 ± 1.6%
b
 
[
2
H3CS,4',5',6',7'-
2
H4]biswasalexin A2 (132a) (<0.5) 8.1 ± 0.4%
b
 
glucobrassicin (57a)  NI (≤0.1%)d 
1'-methoxyglucobrassicin (69a) NI (≤0.1%)d 
4'-methoxyglucobrassicin (70a) NI (≤0.1%)d 
a 
Deuterated compounds are referred to by a number followed by the letter a; nmoles = 
total amount of deuterated plus non-deuterated compound; n.d.=not determined. 
b 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); % 
of 
2
H incorporation = {[M + 1+ n]
+
 /([M + 1]
+
 + [M +1 + n]
+
)} × 100 (n = 7) ± Std 
(standard deviation), where n = number of deuterium atoms. 
d 
NI=no incorporation implies ≤0.1% deuterium 
 
Similarly, the biswasalexin A1 (131) peak at tR = 29.7 min showed two ions: [M + 
1]
+
 at m/z 589 and the corresponding [M + 1 + 7]
+
 at m/z 596, that resulted from the 
incorporation of [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a). The percentage of 
deuterium incorporation into biswasalexin A1 was determined as described above to be 
10.7 ± 1.6% Table 2.9. The biswasalexin A2 (132) peak at tR = 32.7 min showed two 
ions as well: [M + 1]
+
 at m/z 589 and the corresponding [M + 1 + 7]
+
 at m/z 596. The 
percentage of deuterium incorporation into biswasalexin A2 (132) was determined to be 
8.1 ± 0.4% (Table 2.9; Figure 2.10). 
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Figure 2.10 Deuterated phytoalexins obtained from feeding of [
2
H3CS,4',5',6',7'-
2
H4]-
1'-methoxybrassinin (105a) to UV-irradiated leaves of Thellungiella salsuginea: 
[
2
H3CS,4',5',6',7'-
2
H4]wasalexin A (43a) (19.2 ± 3.9%),  [
2
H3CS,4',5',6',7'-
2
H4]wasalexin 
B (109a) (16.7 ± 4.3%), [
2
H3CS,4',5',6',7'-
2
H4]biswasalexin A1 (131a) (10.7 ± 1.6%), 
[
2
H3CS,4',5',6',7'-
2
H4]biswasalexin A2 (132a)  (8.1 ± 0.4%). 
To determine the rate of incorporation of deuterium from feeding of 
[
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a) into indole glucosinolates, polar 
fractions containing indole glucosinolates were analyzed as described above. The HPLC-
ESI-MS analysis (negative mode) showed the glucobrassicin (57) peak at tR = 5.3 min 
containing an ion at m/z 447, the 4ꞌ-methoxyglucobrassicin (70) peak at tR = 6.9 min 
containing an ion at m/z 477 and the 1ꞌ-methoxyglucobrassicin (69) peak at tR = 9.4 min 
containing an ion at m/z 477. From comparisons of HPLC-ESI-MS data of the 
experimental and control samples, it was concluded that there was no incorporation of 
deuterium of [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a) (Table 2.9). 
As it was proposed (Scheme 2.2), 1'-methoxybrassinin (105) was incorporated 
into 43, 109, 131 and 132 suggesting that phytoalexins produced by the wild crucifer, T. 
salsuginea, share biosynthetic intermediates with cultivated species (Pedras, Yaya et al., 
2011; Pedras, Zheng et al., 2007b). High level of incorporation and structural similarity 
105a 43a 
132a 
109a 
131a 
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suggested that 105 is a close biosynthetic precursor of 43, 109, 131 and 132. Hence, 105 
is a likely biosynthetic intermediated located between 1'-methoxyglucobrassicin (69) and 
1-methoxylated phytoalexins (Pedras, Yaya et al., 2010).  
2.2.1.1.4 Incorporation of [2H3CO]-1'-methoxyindolyl-3'-acetaldoxime (74a) 
The incorporation of deuterated 1'-methoxyindolyl-3'-acetaldoxime (74a), a likely 
precursor of wasalexins and 1ꞌ-methoxyglucobrassicin (69), was investigated. Feeding 
experiments were carried out using UV-elicited leaves of T. salsuginea as described in 
Figure 2.5. The HPLC-ESI-MS (positive mode) analysis of the nonpolar fractions 
showed the wasalexin A (43) peak at tR = 21.6 min, wasalexin B (109) peak at tR = 19.3 
min, biswasalexins A1 peak at tR = 29.7 (131) and A2 (132) peak at 32.7 min, but no 
incorporation of deuterium was detected.  
Incorporation of [
2
H3CO]-1'-methoxyindolyl-3'-acetaldoxime (74a) into 1'-
methoxyglucobrassicin (69) produced in leaves of T. salsuginea was investigated. 
Methanolic extracts of leaves were dissolved in water-methanol (50:50) and analyzed as 
described above. The HPLC-ESI-MS analysis of the polar extracts showed the 1ꞌ-
methoxy glucobrassicin peak at tR = 9.4 min containing two ions: [M]
-
 at m/z 477 and the 
corresponding [M + 3]
-
 at m/z 480, that resulted from incorporation of [
2
H3CO]-1'-
methoxyindolyl-3'-acetaldoxime (74a). The percentage of deuterium incorporation into 
1'-methoxyglucobrassicin (69) was calculated to be 3.4 ± 0.9% (Table 2.10; Figure 
2.11).  
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Table 2.10  Metabolites of [
2
H3CO]-1'-methoxyindolyl-3'-acetaldoxime (74a) in UV-
irradiated leaves of Thellungiella salsuginea.  
Metabolites isolated (nmoles/g of fresh tissue)
a 
 % Incorporation of 
deuterium
 
± Std 
wasalexin A (43) (501 ± 32) NI
d
 
wasalexin B (109) (56 ± 2) NI
d
 
biswasalexin A1 (131) (152 ± 39) NI
d
 
biswasalexin A2 (132) (<0.5) NI
d
 
glucobrassicin (57) (≤1 nmoles) NId 
[
2
H3CO]-1'-methoxyglucobrassicin (69a) (49 ± 6) 3.4 ± 0.9
c
 
4-methoxyglucobrassicin (70) (423 ± 52) NI
d
 
a
 Deuterated compounds are referred to by a number followed by the letter a; nmoles = 
total amount of deuterated plus non-deuterated compound. 
c
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); % 
of 
2
H incorporation = {[M + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 3) ± Std (standard 
deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium 
Previously, 1'-methoxyindolyl-3ꞌ-acetaldoxime (74) was reported as a 
biosynthetic precursor for 1ꞌ-methoxybrassinin (105) and 1ꞌ-methoxyglucobrassicin (69) 
(Pedras, Okinyo et al., 2009). However, 74 was not incorporated into wasalexins A (43), 
B (109) and biswasalexins A1 (131) and A2 (132), perhaps due to low level 
incorporation. Compound 74 is likely used in another biosynthetic route apart from 
transformation into 69. At this point, the relationship between 74 and 105 was not 
confirmed, as T. salsuginea does not produce detectable amounts of 105. 
 
Figure 2.11  Deuterated indole glucosinolate obtained from feeding of [
2
H3CO]-1'-
methoxyindolyl-3ꞌ-acetaldoxime (74a) to UV-irradiated leaves of Thellungiella 
salsuginea: [
2
H3CO]-1'-methoxy glucobrassicin (69a) (3.4 ± 0.9%). 
74a 69a 
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2.2.1.1.5 Incorporation of L-[2H3CS]methionine (97a) 
The biosynthetic origin of the methyl groups of wasalexins and 
methoxyglucobrassicins was investigated using L-[
2
H3CS]methionine (97a) as described 
in Figure 2.5. The HPLC-ESI-MS (positive mode) analysis of the nonpolar fractions that 
contained phytoalexins showed the wasalexin A (43) peak at tR = 21.6 min containing 
four ions: [M + 1]
+
 at m/z 295, [M + 1 + 3]
+
 at m/z 298, [M + 1 + 6]
+
 at m/z 301 and [M + 
1 + 9]
+
 at m/z 304. The ions with m/z 298, 301 and 304 were not detected in the control 
sample that was fed with non-labeled L-methionine (97). Peak intensities of the natural 
abundance and of the deuterated ions were used to determining the level of deuterium 
incorporation. Accordingly, the percentage of deuterium incorporation was calculated to 
be 7.6 ± 2.3% for n=3, 3.7 ± 1.2% for n=6 and 1.6 ± 0.4% for n=9.  Similarly, the 
wasalexin B (109) peak at tR = 19.3 min showed four ions as well: [M + 1]
+
 at m/z 295, 
[M + 1 + 3]
+
 at m/z 298, [M + 1 + 6]
+
 at m/z 301 and [M + 1 + 9]
+
 at m/z 304. The ions 
m/z 298, 301 and 304 were not detected in the control sample that was fed with non-
labeled L-methionine (97). The percentage of deuterium incorporation was calculated to 
be 5.6 ± 1.8% for n=3, 2.7 ± 0.9% for n=6 and 1.3 ± 0.3% for n=9 (Table 2.11; Figure 
2.12).     
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Table 2.11 Metabolites of L-[
2
H3CS]methionine (97a) in UV-irradiated leaves of 
Thellungiella salsuginea.   
Metabolites isolated (nmoles / g of fresh tissue)
a 
 % Incorporation of 
deuterium
 
± Std 
[x
 2
H3C]wasalexin A (43a) (612 ± 38) x=1 => 
2
H3 7.6 ± 2.3
b
  
x=2 => 
2
H6 3.7 ± 1.2
b 
x=3 => 
2
H9 1.6 ± 0.4
b 
[x
 2
H3C]wasalexin B (109a) (91 ± 4) x=1 => 
2
H3 5.6 ± 1.8
b 
x=2 => 
2
H6 2.7 ± 0.9
b 
x=3 => 
2
H9 1.3 ± 0.3
b
 
[x
 2
H3C]biswasalexin A1 (131a) (223 ± 10) x=1 => 
2
H3 4.6 ± 1.8
b 
x=2 => 
2
H6 1.6 ± 0.6
b
 
[x 
2
H3C]biswasalexin A2 (132a) (<0.5) x=1 => 
2
H3 2.3 ± 0.6
b
 
Glucobrassicin (57) (≤1) NId 
[
2
H3CO]-1'-methoxyglucobrassicin (69a) (129 ± 30) 8.1 ± 1.6%
c
 
[
2
H3CO]-4'-methoxyglucobrassicin (70a) (321 ± 53) 12.5 ± 1.6%
c
 
a
 Deuterated compounds are referred to by a number followed by the letter a; nmoles = 
total amount of deuterated plus non-deuterated compound. 
b
 Positive ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); % 
of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 3, 6 or 9) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Negative ion mode. Incorporations calculated from HPLC-ESI-MS; % of 
2
H 
incorporation = {[M-1+ n]
-
/([M-1]
-
 + [M-1 + n]
-
)} × 100 (n = 3) ± Std (standard 
deviation). 
d 
NI= no incorporation implies ≤0.1% deuterium 
X= number of deuterium labeled methyl groups  
The HPLC-ESI-MS (positive mode) analysis of the nonpolar fractions that 
contained phytoalexins showed the biswasalexin A1 (131) peak at tR = 29.7 min 
containing three ions: [M + 1]
+
 at m/z 589, [M + 1 + 3]
+
 at m/z 592 and [M + 1 + 6]
+
 at 
m/z 595. The ions at m/z 592 and 595 were not detected in the control sample that was fed 
with non-labeled L-methionine (97). Accordingly, the percentage of deuterium 
incorporations were calculated to be 4.6 ± 1.8% for n=3 and 1.6 ± 0.6% for n=6. The 
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biswasalexin A2 (132) peak at tR = 32.7 min showed two ions: [M + 1]
+
 at m/z 589 and 
[M + 1 + 3]
+
 at m/z 592. The ion at m/z 592 was not detected in the control sample that 
was fed with non-labeled L-methionine (97). The percentage of deuterium incorporation 
was calculated to be 2.3 ± 0.6% (Table 2.11; Figure 2.12). 
 
Figure 2.12 Deuterated phytoalexins obtained from feeding of L-[
2
H3CS]methionine 
(97a) to UV-irradiated leaves of Thellungiella salsuginea: [3×
2
H3]wasalexin A 
(43a),[3×
2
H3]wasalexin B (109a),  [2×
2
H3]biswasalexin A1 (131a), [
2
H3]biswasalexin A2 
(132a). 
In order to determine the rate of the incorporation of deuterium from feeding of L-
[
2
H3CS]methionine (97a), polar fractions containing indole glucosinolates were analyzed. 
The HPLC-ESI-MS analysis of the polar extract (negative mode) showed 4ꞌ-
methoxyglucobrassicin peak (70) at tR = 6.9 min containing two ions: [M]
-
 at m/z 477 and 
the corresponding [M + 3]
-
 at m/z 480, that resulted from incorporation of L-
[
2
H3CS]methionine (97a). The percentage of deuterium incorporation was calculated to 
be 12.5 ± 1.6%. Similarly, the HPLC-ESI-MS analysis of the polar extract showed the 1ꞌ-
methoxyglucobrassicin (69) peak at tR = 9.4 min containing two ions: [M]
-
 at m/z 477 and 
the corresponding [M + 3]
-
 m/z 480. The percentage of deuterium incorporation was 
measured to be 8.1 ± 1.6% (Scheme 2.10; Figure 2.13). 
97a 
109a 43a 
132a 131a 
78 
 
As expected, all methyl groups of cruciferous phytoalexins (43, 109, 131 and 132) 
and indole glucosinolates (70 and 69) are derived from L-methionine (97) via methyl 
donor (S-adenosyl methionine) (Pedras, Yaya et al., 2010)  
 
Figure 2.13 Deuterated indole glucosinolates obtained from feeding of L-
[
2
H3CS]methionine (97a) to UV-irradiated leaves of Thellungiella salsuginea:: [
2
H3OC]-
1'-methoxyglucobrassicin (69a) (8.1 ± 1.6%) and [
2
H3OC]-4'-methoxyglucobrassicin 
(70a) (12.5 ± 1.6%) 
2.2.1.1.6 Incorporation of [4',5',6',7'-2H4]brassinin (45a) 
The metabolism of [4',5',6',7'-
2
H4]brassinin (45a) in T. salsuginea leaves was 
investigated. A solution of [4',5',6',7'-
2
H4]brassinin (45a) was administered to UV elicited 
petiolated leaves of T. salsuginea and leaves were extracted as described in Figure 2.5. 
The HPLC-ESI-MS (positive mode) analysis of the nonpolar fractions showed the 
wasalexin A (43) peak at tR = 21.6 min containing [M + 1]
+
 at m/z 295, the wasalexin B 
(109) peak at tR = 19.3 min containing [M + 1]
+
 at m/z 295, the biswasalexin A1 (131) 
peak at tR = 29.7 min containing [M + 1]
+
 at m/z 589 and the biswasalexin A2 (132) peak 
at tR = 32.7 min containing [M + 1]
+
 at m/z 589. No corresponding ions due to deuterium 
incorporation were detected. These results suggest that brassinin is not a biosynthetic 
precursor of wasalexins and biswasalexins.  
On the other hand, analysis of HPLC chromatograms of samples fed with 
deuterated brassinin and control (fed with carrier solution) revealed the presence of 
additional peaks in the samples treated with deuterated brassinin. To identify the peaks, 
mass spectra of deuterated samples (fed with deuterated brassinin (45a)) were compared 
against those of nondeuterated samples (fed with nondeuterated brassinin (45)). The 
peaks detected in deuterated samples showed masses four units higher than those detected 
in samples treated with nondeuterated brassinin (45). Comparison of the retention times 
70a 97a 69a 
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and the mass spectra of these products with UV and MS libraries (Dr. Pedras group) 
revealed that three of the six compounds were known metabolites: spirobrassinin (101), 
brassitin (155) and indolyl-3-carboxylic acid (156) (Pedras, Yaya et al., 2010). The 
remaining three metabolites at 14.8, 16.0, and 17.0 minutes were deduced by comparing 
their mass fragments with mass fragments of wasalexins A (43) and B (109). Two of the 
three compounds showed identical masses: [M + 1]
+
 at m/z 265 which was 30 units lower 
than that of wasalexins A (43) and B (109), while the third peak showed [M + 1]
+
 at m/z 
267. Based on these mass fragments, the hypothetical compounds were synthesized (for 
details see 2.2.1.2) and their masses and retention times were compared against the 
metabolic products of brassinin (45) and were confirmed to be demethoxywasalexins A 
(157), B (158) and demethoxydihydrowasalexin (159) respectively (Figure 2.14).  
A lack of incorporation of brassinin (45) into 43, 109, 131 and 132 indicates that 
there is no biosynthetic relationship between brassinin (45) and 1ꞌ-methoxybrassinin 
(105) (Monde, Tamura et al., 1995). On the other hand, deuterium incorporations into 
metabolites 157, 158, 159, 101, 155 and 156 were ≥ 99%, suggesting these metabolites 
are derived solely from brassinin (45) (Pedras, Yaya et al., 2010). Metabolites 157, 158, 
159, 101, 155 and 156 were not detected in non-fed plants, which might be due to the 
presence of non-selective enzymes that can take and metabolize brassinin (45). 
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Figure 2.14 Deuterated metabolites and metabolic products from feeding of [4',5',6',7'-
2
H4]brassinin (45a) to elicited leaves of Thellungiella salsuginea: [4',5',6',7'-
2
H4]spirobrassinin (101a), [4',5',6',7'-
2
H4]brassitin (155a), [4',5',6',7'-
2
H4]indolyl-3'-
carboxylic acid (156a), [4',5',6',7'-
2
H4]demethoxywasalexins A (157a), B (158a), 
[4',5',6',7'-
2
H4]demethoxydihydrowasalexin (159a). 
2.2.1.1.7 Metabolism of 1'-methoxy-2'-methyl brassinin (160) 
 The potential metabolism of 1'-methoxy-2'-methylbrassinin (160) was 
investigated as described above in Figure 2.5. Comparison of the HPLC-DAD and 
HPLC-ESI-MS data of fed samples against the controls (fed with carrier solution) 
revealed a similar profile. These results suggest that T. salsuginea was not able to 
metabolize compound 160, indicating the importance of H-2 of the indole ring in 
formation of wasalexins from 1ꞌ-methoxybrassinin (105).  
155a 
45a 
157a  158a 
101a 156a 
159a 
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2.2.1.2 Synthesis of new compounds 
Demethoxywasalexin A (157) and B (158) were prepared from 2-oxindole (161). 
A solution of 161 in DMF was added to a solution of POCl3 in DMF and stirred at 45 ºC 
for 30 min, after which NH4OH (28%) at 0 ºC was added; the reaction mixture was 
stirred at rt for 1 h (Pedras and Jha, 2005; Pedras and Suchy, 2006; Pedras and Zaharia, 
2001) to yield 3-aminomethylene-2-oxindole (162) in 67%. A solution of 162 was treated 
with CS2 in the presence of NaH to generate a dithiocarbamate salt which was treated 
with methyl iodide to yield crude (E,Z)-methyl((2-oxoindolin-3-
ylidene)methyl)carbamodithioate (163). The crude solution of 163 was further treated 
with methyl iodide in the presence of pyridine and Et3N and stirred for 14 h at rt to yield 
demethoxywasalexins A (157) and B (158) (yellow solid, mixture of E and Z isomers 
4:1) in 53% yield (Pedras, Yaya et al., 2010) (Scheme 2.3). 
 
Scheme 2.3 Synthesis of 157 and 158. Reagents and conditions:  i) DMF, POCl3, 45 
ºC, (aq. NH3, 28%) 67%; ii) NaH, CS2, MeI, THF, 0 ºC; iii) pyridine, Et3N, MeI, CH2Cl2 
53%.  
160 
161  162  163  
157, 158  
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Demethoxydihydrowasalexin was synthesized from methyl((2-oxoindolin-3-
ylidene)methyl)carbamodithioate (163), which was treated with NaBH3CN in the 
presence of AcOH to yield methyl ((2-oxoindolin-3-yl)methyl)carbamodithioate (164) in 
55%. Methylation of compound 164 was achieved using dimethylsulfate in the presence 
of K2CO3 to yield the final product, demethoxydihydrowasalexin (159) in moderate yield 
(Pedras, Yaya et al., 2010) (Scheme 2.4). 
 
Scheme 2.4 Synthesis of 159. Reagents and conditions: i) DMF, POCl3, 45 ºC, (aq. 
NH3, 28%); ii) NaH, CS2, MeI, THF, 0 ºC; iii) NaCNBH3, AcOH, 60 ºC, 55%; (iv) 
K2CO3, (CH3O)2SO2, acetone, 30 ºC, 58%. 
2.2.1.3 Conclusion 
T. salsuginea, an extremophile resistant to salinity, drought and frost (Williams, 
Critchley et al., 2009), produces a group of phytoalexins with unique structural features 
(Pedras and Zheng, 2010; Pedras, Zheng et al., 2009) not produced in the other Brassica 
species. For this reason, the biosynthetic pathway of the phytoalexins was investigated 
using perdeuterated compounds. The biosynthetic origin of wasalexins A (43), B (109) 
and biswasalexins A1 (131) and A2 (132) was confirmed by administering L-
[2',4',5',6',7'-
2
H5]tryptophan (66a) to leaves of T. salsuginea, which showed incorporation 
of deuterium of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) into the phytoalexins (Pedras, Yaya 
et al., 2010). They share the same biosynthetic building block (L-tryptophan (66)) as 
161  162  163  
164  159  
83 
 
other cruciferous phytoalexins (Pedras and Yaya, 2010; Pedras, Yaya et al., 2011; Pedras, 
Zheng et al., 2007b) and indole glucosinolates (Kutacek and Kralova, 1972; Kutacek, 
Prochazka et al., 1962). Incorporation of [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin 
(105a) into wasalexins A (43), B (109) and biswasalexins A1 (131) and A2 (132) 
suggests that 105 is a close biosynthetic precursor that upon successive oxidations of the 
indole ring (C-2) and the side chain and thiomethylation can give 43 and 109 (Scheme 
2.5). A major breakthrough was achieved when [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) 
showed unprecedented incorporation into the cruciferous phytoalexins 43, 109, 131 and 
132. It suggested that the biosynthetic pathway of wasalexins requires indole 
glucosinolates as intermediates. This was the first report showing the biosynthetic 
relationship between cruciferous phytoalexins and indole glucosinolates (Pedras, Yaya et 
al., 2010). The first step in the metabolism of 1ꞌ-methoxyglucobrassicin (69) into 1ꞌ-
methoxybrassinin (105) could be deglucosylation of the glucosinolate by a hydrolase 
enzyme. The resulting aglycone (138), which is unstable, could spontaneously rearrange 
into the corresponding 1ꞌ-methoxyindolyl-3ꞌ-methylisothiocyanate (165) (Pedras, Yaya et 
al., 2010) which, in the presence of thiomethyl donor (S-adenosylmethionine), could give 
rise to 1ꞌ-methoxybrassinin (105) (Scheme 2.5). 
The observed absence of incorporation of [4',5',6',7'-
2
H4]brassinin (45a) into  43, 
109, 131 and 132 was consistent with a methoxylation of glucobrassicin (57) before 
functional group modifications. Nevertheless, the detection of metabolites 157, 158, 159 
and metabolic products 101, 155, 156 deriving from [4',5',6',7'-
2
H4]brassinin (45a) 
suggests that the enzymes can metabolize brassinin similarly to 1ꞌ-methoxybrassinin. 
Stages at which oxidations could occur were probed by administering 1'-methoxy-2'-
methyl brassinin (160). Interestingly, no metabolic products were detected, which 
suggested the importance of H-2 of indole for the oxidation of the ring and side chain. L-
methionine was found to be a methyl source for the phytoalexins as well as indole 
glucosinolates (Pedras, Yaya et al., 2010). 
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Scheme 2.5 Proposed biosynthetic pathway of wasalexins (Pedras, Yaya et al., 2010) 
2.2.2 Brassica napus (rutabaga)  
Rutabaga roots were used to investigate biosynthetic pathway(s) of crucifer 
phytoalexins, indole glucosinolates and their biosynthetic relationships (roots are 
available in fresh produce markets year-round). The roots of rutabaga after elicitation 
using UV radiation produce a variety of indole phytoalexins and indole glucosinolates 
(Pedras and Montaut, 2004; Pedras, Montaut et al., 2004; Pedras and Yaya, 2012). 
Biosynthetic intermediates of 1-methoxylated and non-methoxylated cruciferous 
phytoalexins were elucidated using rutabaga roots (Pedras, Montaut et al., 2004; Pedras 
and Okinyo, 2008; Pedras, Okinyo et al., 2009). Production of the 4-methoxylated 
69 
105 
57  122  66  
43,109 
132  
131  
165  
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phytoalexins, 4ꞌ-methoxybrassinin (108), rapalexin A (103), isocyalexin A (104) 4ꞌ-
methoxycyclobrassinin (110), 4ꞌ-methoxydehydrocyclobrassinin (113) and isalexin (102) 
by rutabaga roots suggested the need for further biosynthetic studies.  
2.2.2.1 Isolation of new elicited metabolites  
During biosynthetic studies of phytoalexins and indole glucosinolates produced in 
UV-irradiated rutabaga roots, two potentially new metabolites with tR 7.2 and 13.0 min 
were detected. Comparison of their UV spectra, HPLC retention times and HPLC-ESI-
MS data with those available in Dr. Pedras‘ libraries showed no matches. After testing 
different elicitation times, an increase from 60 min to 90 min led to the production of the 
two metabolites in reasonable amounts (Pedras and Yaya, 2012). Next, a large scale 
experiment was conducted to isolate both metabolites using ca. 4 kg of rutabaga roots. 
The roots were sliced (10-15 mm disc), holes were made on the upper surface of the 
slices using a cork-borer and slices were incubated for 1 day, UV-irradiated (90 min), and 
kept in the dark for 1 day. Water was added to the wells, followed by incubation for 2 
additional days. Next, the water from each well was collected, freeze-dried to reduce the 
volume, and extracted with EtOAc. The organic extracts were combined, dried over 
Na2SO4 and concentrated to dryness. The crude extract was separated by FCC (CH2Cl2-
EtOAc 100:0 to 80:20). After HPLC-DAD analysis of each fraction, fractions containing 
elicited new metabolites were combined and fractionated by preparative TLC (silica gel 
developing twice with CH2Cl2, 100%).  The metabolite at tR = 13.0 min was isolated from 
fractions and characterized. The HREI-MS showed a M
+ 
at m/z 172.0633 (calcd. for 
C10H8N2O 172.0632 (100%)) indicating eight degrees of unsaturation. Consistent with 
the HRMS, the 
1
H-NMR revealed a total of eight protons of which five were in the 
aromatic region and one of them was D2O exchangeable. The remaining three protons 
were assigned to a methoxy group. Based on the spectral data, the structure was proposed 
as 4-methoxyindole with a substitution at position C-3ꞌ; however, it was not clear if this 
substituent was a nitrile or an isonitrile. 4-Methoxyindole-3-carbonitrile was synthesized 
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and the data was compared with those of the isolated compound, but it did not match. 
Next, 4ꞌ-methoxyindole-3ꞌ-isonitrile (104) was synthesized (Scheme 2.6) and comparison 
of its data with that of the natural product confirmed its identity. The second metabolite 
was also isolated, purified and characterized as 4ꞌ-methoxyindolyl-3ꞌ-formamide (168). 
The structure was confirmed by chemical synthesis (Pedras and Yaya, 2012) (Scheme 
2.6). 
2.2.2.2 Synthesis of new metabolites and analogues 
4ꞌ-Methoxyindolyl-3ꞌ-isonitrile (104) and 4ꞌ-methoxyindolyl-3ꞌ-formamide (168) 
3-Nitroindole (166) was prepared, as previously reported, by nitration of indole 
in the presence of AgNO3 and PhCOCl (Bahekar, Jain et al., 2007). Methoxylation of 3-
nitroindole (166) was initiated by reacting 166 in TFA with thallium (III) 
trifluoroacetate, followed by treatment with iodine in the presence of CuI and NaOCH3 
to yield 4-methoxy-3-nitroindole (167). 4-Methoxy-3-nitroindole (167) was reduced 
with Pd/C-H2 in ethanol. The reaction mixture was treated with a mixture of formic acid 
and acetic anhydride along with Et3N at -10 °C to yield 4ꞌ-methoxyindole-3ꞌ-formamide 
(168) in moderate yield. Another approach to prepare this compound was through 
reduction of 4-methoxy-3-nitroindole (167) in the presence of a mixture of formic 
acid/acetic anhydride and ethanol at -10 °C. Finally, a one pot, one step reaction yielded 
4ꞌ-methoxyindolyl-3ꞌ-formamide (168) and 4ꞌ-methoxyindolyl-3ꞌ-acetamide (206) in a 
10:1 ratio, respectively. This procedure was shorter and more efficient than the first 
approach (66% 168 and 7% 207). 4ꞌ-Methoxyindolyl-3ꞌ-isonitrile (104) was synthesized 
from 4ꞌ-methoxyindolyl-3ꞌ-formamide (168) after treatment with Et3N and POCl3 at 0 
°C under inert atmosphere in 41% yield (Scheme 2.6). 
 
Indolyl-3ꞌ-isonitrile (170) and indolyl-3ꞌ-formamide (169) 
3-Nitroindole (166) was reduced with Pd/C-H2 in ethanol. The reaction mixture 
was treated with a mixture of formic acid and acetic anhydride along with Et3N at -10 
°C to give indolyl-3ꞌ-formamide (169) in moderate yield. Alternatively, the reduction of 
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3-nitroindole (166) in the presence of a mixture of formic acid/acetic anhydride and 
ethanol at -10 °C yielded indole-3ꞌ-formamide (169) and indolyl-3ꞌ-acetamide (207) in a 
3:1 ratio, respectively. This procedure was shorter and more efficient than the first 
approach (64% 169 and 18% 207). Indolyl-3ꞌ-isonitrile (170) was synthesized from 
indolyl-3ꞌ-formamide (169) after treatment with Et3N and POCl3 at 0 °C under inert 
atmosphere in 54% yield (Scheme 2.6). 
  
Scheme 2.6 Synthesis of 168, 104, 169 and 170. Reagents and conditions: i) 
TTFA/TFA, I2/CuI, NaOCH3, 64%; ii) Pd/C-H2, acetic-formic anhydride, -10 °C, (64%, 
169), (66%, 168); iii) POCl3, THF, EtN3, 0 °C, (54%, 170, 41%, 104).  
Compounds 168 and 104 and their analogues (169 and 170) were assayed 
against the plant pathogenic fungi: A. brassicicola, L. maculans, R. solani and S. 
sclerotiorum. Compound 104 strongly inhibited the fungal mycelial growth of R. solani 
and S. sclerotiorum at the concentration of 5x10
-4
 M, while 4ꞌ-methoxyindolyl-3ꞌ-
formamide (168) inhibitory effect was much lower (Pedras and Yaya, 2012). Non 
methoxylated analogs 169 and 170 were also synthesised and assayed; 170 showed 
higher inhibitory effect than 169. Therefore, it was suggested that the isonitrile side 
chain is contributing towards the inhibition of the fungal mycelial growth (Table 2.12) 
(Pedras and Yaya, 2012). Metabolite 104 was identified as the first isonitrile isolated 
from plant origin (Pedras and Yaya, 2012). Since it is an elicited metabolite and 
antifungal, it is categorized under cruciferous phytoalexin and given the name 
166 167 168 104 
169 170 
88 
 
isocyalexin A. Plants produce biologically active compounds that can protect them from 
pathogen attacks. The effect of rapalexin A (103) on L. maculans is a remarkable 
example (Pedras and Sarma-Mamillapalle, 2012). 
Table 2.12 Antifungal activity of isocyalexin A (104), 4ꞌ-methoxyindolyl-3ꞌ-
formamide (168), indolyl-3ꞌ-isonitrile (170) and indolyl-3ꞌ-formamide (169) against 
mycelia
a
 of Alternaria brassicicola, Leptosphaeria maculans, Rhizoctonia solani and 
Sclerotinia sclerotiorum. 
Compounds
b
 A. brassicicola 
(% inh.) 
L. maculans 
(% inh.) 
R. solani 
(% inh.) 
S. sclerotiorum 
(% inh.) 
isocyalexin A (104) 
5.0 × 10
-4 
M
 
2.0 × 10
-4 
M
 
1.0 × 10
-4 
M 
47 ± 0 
14 ± 2 
0 
29 ± 2 
9 ± 0 
8 ± 2 
100 
51 ± 4 
32 ± 2 
65 ± 2 
40 ± 2 
31 ± 5 
indolyl-3ꞌ-isonitrile (170) 
5.0 × 10
-4 
M
 
2.0 × 10
-4 
M
 
1.0 × 10
-4 
M 
42 ± 4 
27 ± 4 
17 ± 4 
5 ± 0 
0 
0 
100 
51 ± 4 
31 ± 4 
60 ± 2 
31 ± 2 
17 ± 0 
4ꞌ-methoxyindolyl-3ꞌ-formamide (168) 
5.0 × 10-
4
 M 
2.0 × 10-
4
 M 
1.0 × 10-
4
 M 
21 ± 2 
9 ± 4 
0 
27 ± 0 
7 ± 0 
2 ± 2 
29 ± 4 
12 ± 2 
6 ± 2 
32 ± 2 
25 ± 4 
17 ± 0 
indolyl-3ꞌ-formamide (169) 
5.0 × 10-
4
 M 
2.0 × 10-
4
 M 
1.0 × 10-
4
 M 
42 ± 4 
27 ± 4 
17 ± 4 
31 ± 3 
16 ± 2 
5 ± 2 
15 ± 4 
0 
0 
25 ± 0 
19 ± 2 
15 ± 2 
a
Percentage of inhibition = 100 – [(growth on medium containing compound-plug/growth 
on control medium-plug) × 100)] ± standard deviation. Results are the averages ± 
standard deviations of two independent experiments conducted in triplicate. 
b
Compounds 
were dissolved in DMSO and added to potato dextrose agar medium. 
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2.2.2.3 Retro-biosynthetic analysis  
Biosynthetic studies involve proposing possible biosynthetic intermediates, their 
synthesis (labeled), and feeding of labeled compounds to appropriate plant tissues/organs, 
extraction and analysis (HPLC-DAD, HPLC-ESI-MS, NMR etc.). Using this approach, 
the biosynthesis of cruciferous phytoalexins has been studied in different plant species 
(e.g. rutabaga, turnip, kohlrabi, dog mustard, salt cress, etc.) using different tissues (roots, 
leaves, tubers etc.) (Pedras, Yaya et al., 2011). The biosynthetic intermediates of 1-
methoxylated phytoalexins were investigated in dog mustard, salt cress and rutabaga 
(Pedras and Okinyo, 2006b; Pedras, Okinyo et al., 2009; Pedras, Yaya et al., 2010). 
However, the biosynthesis of 4-methoxy cruciferous phytoalexins has not been studied, 
even though they are detected in quite a few species (Pedras and Yaya, 2010). The 
discovery of new 4-methoxylated cruciferous phytoalexins, rapalexin A (103) and 
isocyalexin A (104), has triggered investigation of their biosynthetic intermediates, as 
they contain unusual side chains (isothiocyanate and isocyanide respectively). Because of 
significant differences in their side chain, when compared to other phytoalexins of the 
brassinin series (with a carbon linker connecting indole ring with the side chain nitrogen), 
different biosynthetic routes and intermediates were proposed as shown in the retro-
biosynthetic analysis (Scheme 2.7) (Pedras and Yaya, 2012; 2013; Pedras, Zheng et al., 
2007a; Pedras, Zheng et al., 2007b). For the biosynthetic studies, different labeled 
biosynthetic intermediates were proposed, synthesized and used (Table 2.13). 
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Table 2.13 Perdeuterated compounds used in biosynthetic studies. 
Deuterated compound (#)
a
 Origin  
L-[2',4',5',6',7'-
2
H5]tryptophan (66a) commercial (Cambridge Isotopes) 
L-[U-
13
C11,U-
15
N2]tryptophan (66b) commercial (Cambridge Isotopes) 
[4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) synthetic (Pedras and Yaya, 2013) 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57b)  synthetic (Pedras, Yaya et al., 2010) 
(D,L)-[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-
3'-glycine (107b) 
synthetic (Pedras and Yaya, 2013) 
(D,L)-[
2
H3CO]-4'-methoxyindolyl-3'-glycine 
(107a) 
synthetic (Pedras and Yaya, 2013) 
(D,L)-[4',5',6',7'-
2
H4]indolyl-3'-glycine (185a) synthetic (Pedras and Yaya, 2013) 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-
carboxaldehyde oxime (171b) 
synthetic (Pedras and Yaya, 2013) 
[4',5',6',7'-
2
H4]indole-3'-carboxaldehyde 
oxime (176a) 
synthetic (Pedras and Yaya, 2013) 
[
2
H3CO]-4'-methoxyindole-3'-carboxaldehyde 
(190a) 
synthetic (Pedras and Yaya, 2013) 
[
2
H3CO,5',6',7'-
2
H3]desulfoglucorapacissin 
(172b) 
synthetic (Pedras and Yaya, 2013) 
[
2
H3CO]desulfoglucorapassicin (172a) synthetic (Pedras and Yaya, 2013) 
[4',5',6',7'-
2
H4]indole desulfoglucosinolate 
(186a) 
synthetic (Pedras and Yaya, 2013) 
[5,6,7-
2
H3]-4-methoxyindole (149a) synthetic (Pedras and Yaya, 2013) 
[
2
H3CO]-4'-methoxyindolyl-3'-acetonitrile 
(135a) 
synthetic (Pedras and Yaya, 2013) 
[
2
H3CO]rapalexin A (103a) synthetic (Pedras and Yaya, 2013) 
[
2
H3CO]-4'-methoxybrassinin (108a) synthetic (Pedras and Yaya, 2013) 
[4',5',6',7'-
2
H4]indole (120a) synthetic (Pedras and Yaya, 2013) 
a
 Deuterated compounds are referred to by a number followed by the letter a or b. 
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Scheme 2.7 Retro-biosynthetic analysis of rapalexin A (103) biosynthesis. 
2.2.2.4 Synthesis of deuterated compounds 
[4,5,6,7-
2
H4]Indole (120a), [4',5',6',7'-
2
H4]indole-3ꞌ-carboxaldehyde (175a), 
[4',5',6',7'-
2
H4]indole-3'-carboxaldehyde oxime (176a) 
 
[4,5,6,7-
2
H4]Indole (120a) was synthesized with a slight modification of a 
previously published procedure (Pedras and Okinyo, 2006c), from [3,4,5,6-
2
H4]-2-
nitrophenyl acetonitrile (174a) via reductive cyclization with 10% palladium on activated 
carbon in the presence of a catalytic amount of AcOH in 69% yield. [3,4,5,6-
2
H4]-2-
Nitrophenylacetonitrile (174) was prepared from [2,3,4,5,6-
2
H5]nitrobenzene (173) as 
previously published (Makosza and Winiarski, 1984). Indole was converted to [4',5',6',7'-
2
H4]indole-3'-carboxaldehyde (175a) via a Vilsmeier-Haack reaction in 95% yield, which 
on treatment with NH2OH.HCl and Na2CO3 yielded the corresponding oxime (176a) in 
quantitative yield (Scheme 2.8). 
103 
118 172 171 107 
70 57 80 122 
66 
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[4',5',6',7'-
2
H4]Indole desulfoglucosinolate (186a) 
 
[4',5',6',7'-
2
H4]Indole desulfoglucosinolate (186a) was synthesized as previously 
published for the nondeuterated compound (186) (Brochard, Joseph et al., 1994). In a one 
pot reaction, the chlorination of [4',5',6',7'-
2
H4]indolyl-3'-carboxaldehyde oxime (176a) 
with NCS was followed by coupling with 1-thio--D-glucopyranose-2,3,4,6-tetraacetate 
to afford [4',5',6',7'-
2
H4]indolyl-3'-tetraacetyl glucocarboxythiohydroxamate (183a) in 
22% yield which was hydrolyzed in KOCH3 to afford [4',5',6',7'-
2
H4]indole 
desulfoglucosinolate (186a) in quantitative yield (Scheme 2.8).  
 
[4',5',6',7'-
2
H4]indolyl-3'-glycine (185a) 
 
[4',5',6',7'-
2
H4]indolyl-3'-glycine (185a) was prepared from [4,5,6,7-
2
H4]indole 
(120a) analogous to a previously published for the non-deuterated compound (185) 
(Droste and Wileland, 1987). Indole 120a was allowed to react with oxalylchloride in 
anhydrous diethyl ether at 0 °C to yield [4',5',6',7'-
2
H4]indolyl-3'-oxalylchloride (177a), 
which was hydrolyzed by NaOH to yield [4',5',6',7'-
2
H4]indolyl-3'-oxo acid (181a) 
quantitatively. Oximation of 181a was accomplished following a standard procedure 
using NH2OH.HCl and Na2CO3. [4',5',6',7'-
2
H4]Indolyl-3'-oximino acid (184a) was 
reduced with NaBH4 and NiCl2.6H2O to yield the amino acid [4',5',6',7'-
2
H4]-4'-
methoxyindolyl-3'-glycine (185a) (Scheme 2.8). 
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Scheme 2.8 Syntheses of 120a, 175a, 176a, 186a, 80a and 185a. Reagents and 
conditions: i) ClCH2CN, NaOH, 49%; ii) Pd/C, EtOAc, AcOH, 68%; iii) POCl3, DMF, 
95%; iv) Na2CO3, NH2OH.HCl, 70 °C; v) pyridine, NCS, CH2Cl2; vi) 1-thio-β-D-
glucopyranose-2,3,4,6-tetraacetate, Et3N, 22%; vii) KOCH3, MeOH; viii) CH3NO2, 
NaOAc; NaBH4, THF, MeOH; ix) NaOCH3, MeOH; SOCl2, DME,-40 °C, 38%; 1-thio-
β-D-glucopyranose-2,3,4,6-tetraacetate, Et3N, CH2Cl2, Et2O, 33%; x) C2O2Cl2, Et2O; xi) 
NaOH; xii) NaBH4, NiCl2.6H2O. 
  
173a  174a  
120a  175a  176a  
180a  179a  
186a  
183a  
177a  
181a  
184a  
185a  
178a  
182a  
80a  
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[4',5',6',7'-
2
H4]Desulfoglucobrassicin (80a) 
 
Synthesis of [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) was achieved as 
previously published for the nondeuterated compound (80) (Viaud and Rollin, 1990). 
[4,5,6,7-
2
H4]indole (120a) was subjected to a Vilsmeier-Haack formylation reaction to 
afford [4',5',6',7'-
2
H4]indole-3'-carboxaldehyde (175a), which was condensed with 
nitromethane to afford [4,5,6,7-
2
H4]-3-nitrovinylindole (208a) that led to the formation of 
[4,5,6,7-
2
H4]-3-(2'-nitroethyl)indole (178a) after reduction with NaBH4 in 38% yield. 
[4,5,6,7-
2
H4]-3-(2'-Nitroethyl)indole (178a) was reacted with NaOCH3 and 
thionylchloride to afford an oximoyl chloride that coupled with thioglucosetetraacetate 
and led to the formation of [4',5',6',7'-
2
H4]tetraacetyl desulfoglucobrassicin (182a) in 33% 
yield. Finally, methanolysis of 182a afforded [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) 
in quantitative yield (Scheme 2.8). 
 
[
2
H3CO]-4-Methoxyindole (149a) 
 
[
2
H3CO]-4-Methoxyindole (149a) was synthesized from 3-nitrophenol (187) as 
previously published (Mąkosza, Danikiewicz et al., 1988; Robertson and Botting, 1999). 
A solution of 3-nitrophenol (187) was treated with 
2
H3CI in the presence of NaH at 65 ºC 
to yield crude [
2
H3CO]-3-methoxy nitrobenzene (188a) in quantitative yield, which on 
treatment with 4-chlorophenoxyacetonitrile and t-BuOK at -20 ºC yielded ([
2
H3CO]-6-
methoxy-2-nitrophenyl)acetonitrile (189a) in 26%. Reductive cyclization of 189a was 
catalyzed by palladium on activated carbon to yield [
2
H3CO]-4-methoxyindole (149a) in 
81% (Scheme 2.9).  
 
Scheme 2.9 Synthesis of 4-methoxyindole (149a). Reagents and conditions: i) NaH, 
2
H3CI, THF, 65°C; ii) 4-chlorophenoxyacetonitrile, t-BuOK, DMF,-20°C, 26%; (iii) 10% 
Pd/C, H2, MeOH, AcOH 81%.  
187a  188a  189a  149a  
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[
2
H3CO]-4'-Methoxyindole-3'-carboxaldehyde (190a) 
 
[
2
H3CO]-4'-Methoxyindole-3'-carboxaldehyde (190a) was prepared via two 
different routes: the first route that involved formylation of 4-methoxyindole (149a) 
afforded 190a in very good yield. However, the step involving vicarious nucleophilic 
substitution reaction (188a to 189a, Scheme 2.9) gave poor yield (overall yield ca. 25%). 
The second route involved methoxylation of indole-3ꞌ-carboxaldehyde (175) that on 
successive treatment with TTFA, I2/CuI and NaOCD3 afforded 190a in 78% yield 
(Somei, Yamada et al., 1984) (Scheme 2.10). Therefore, the second route was followed 
for the synthesis of deuterated 190 as it is relatively short and provides good yield. 
 
[
2
H3CO]-4'-Methoxyindolyl-3ꞌ-acetonitrile (135a) 
 
[
2
H3CO]-4'-Methoxyindolyl-3'-acetonitrile (135a) was prepared from [
2
H3CO]-4-
methoxy-3-(2'-nitroethyl)indole (195a), synthesized from condensation of 190a with 
nitromethane in the presence of NH4OAc, followed by NaBH4 reduction of the 
intermediate [
2
H3CO]-4-methoxy-3-nitrovinylindole (192a) (Robertson and Botting, 
1999). Finally, treatment of 195a with CS2 and Et3N yielded [
2
H3CO]-4'-methoxyindolyl-
3'-acetonitrile (135a) in 62% yield (Scheme 2.10). Another reported route for the 
synthesis of 4'-methoxyindolyl-3'-acetonitrile (135) involves the reaction between 
Grignard reagent (prepared from 4-methoxyindole) and bromo acetonitrile (Pedras, 
Chumala et al., 2003).  
 
[
2
H3CO]-4'-Methoxybrassinin (108a) 
 
[
2
H3CO]-4'-Methoxybrassinin (108a) was prepared as previously published 
(Yamada, Kobayashi et al., 1993). Compound 190a was transformed to the 
corresponding oxime 171a using NH2OH.HCl and Na2CO3 in very good yield. 
Compound 171a was reduced with NaBH4 in the presence of NiCl2.6H2O to yield the 
corresponding amine, ([
2
H3CO]-4'-methoxy-3'-indolyl)methanamine (193a) in 54% yield 
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that reacted with CS2 and Et3N at 0 ºC to yield a dithiocarbamate salt intermediate that 
afforded [
2
H3CO]-4'-methoxybrassinin (108a) on treatment with MeI in 77% yield 
(Scheme 2.10).  
 
Scheme 2.10 Syntheses of 108a, 190a, 107a and 135a. Reagents and conditions: i) 
POCl3, DMF, 95%; ii) NH2OH.HCl, Na2CO3, 70 ºC; iii) C2O2Cl2, Et2O; iv) aq. NaOH; 
aq. HCl quantitative; v) NaBH4, NiCl2.6H2O, 47%; vi) CH3NO2, NH4OAc; vii) NaBH4, 
THF, 38%; viii) CS2, Et3N, 62%; ix) CS2, Et3N, MeI, 77%. 
[
2
H3CO]-4'-Methoxyindolyl-3'-glycine (107a) 
 
[
2
H3CO]-4'-Methoxyindolyl-3'-glycine (107a) was prepared from [
2
H3CO]-4-
methoxyindole (149a). Compound 149a was allowed to react with oxalylchloride in 
anhydrous diethyl ether at 0 °C to yield [
2
H3CO]-4'-methoxyindolyl-3'-oxalylchloride 
(191a) which hydrolyzed with NaOH solution and worked up with aq. HCl to yield the 
191a  
194a  
192a  
149a  
196a  
107a  
195a  
190a  
135a  
171a  
193a  
108a  
97 
 
corresponding oxo acid (194a). Oximation of 194a was accomplished using NH2OH.HCl 
and Na2CO3 to yield [
2
H3CO]-4'-methoxyindolyl-3'-oximino acid (196a) in 84% that was 
reduced with NaBH4 in the presence of NiCl2.6H2O to yield [
2
H3CO]-4'-methoxyindolyl-
3'-glycine (107a) in 47% (Scheme 2.10). Attempts to reduce 196 with Pd/C or PtO2 
under hydrogen balloon pressure resulted in mixtures of products which were 
inseparable. 
 
[
2
H3CO 5',6',7'-
2
H3]-4'-methoxyindole-3'-carboxaldehyde oxime (171b) 
 
[
2
H3CO,5',6',7'-
2
H3]-4'-Methoxyindole-3'-carboxaldehyde oxime (171b) was 
prepared as previously published for the non-deuterated compound (Yamada, Kobayashi 
et al., 1993). [4',5',6',7'-
2
H4]Indole-3'-carboxaldehyde (175a) in TFA was successively 
treated with TTFA, I2/CuI and NaOCD3 to afford [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-
3'-carboxaldehyde (190b) in 45% yield. Then, [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-
carboxaldehyde (190b) was treated with NH2OH.HCl and Na2CO3 to afford 171b in 82% 
(Scheme 2.11). 
 
[
2
H3CO, 5',6',7'-
2
H3]Desulfoglucorapacissin (172b) 
 
[
2
H3CO,5',6',7'-
2
H3]Desulfoglucorapacissin (172b) was prepared from N-
protected [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carboxaldehyde (190b). N-t-
Boc[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carboxaldehyde, N-t-Boc(190b), was 
treated with NH2OH.HCl and Na2CO3 to yield the corresponding oxime (198b), which on 
treatment with NCS yielded an oximoyl chloride intermediate that was coupled with 1-
thio--D-glucopyranose-2,3,4,6-tetraacetate to yield N-t-Boc[2H3CO,5',6',7'-
2
H3]desulfoglucorapassicin tetraacetate (199b) in 52%. The t-Boc group was hydrolyzed 
with deuterated TFA 20% in CH2Cl2 to yield deprotected intermediate in 92% that 
hydrolyzed in KOMe to afford [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b) 
(Scheme 2.11). The t-Boc deprotection step was carried out using deuterated TFA 
because, 4'-methoxy group caused exchange of indole deuterons 
2
H-5' and 
2
H-7' with 
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protons of TFA. The two affected positions were ortho and para to the methoxy group, 
suggesting the methoxy group has facilitated the exchange.  
 
Scheme 2.11 Synthesis of 171b, 172b and 107b. Reagents and conditions: i) POCl3, 
DMF, 95%; ii) TTFA, TFA; I2, CuI; NaOCD3, 45%; iii) (t-Boc)2O, DMAP, THF; iv) 
NH2OH.HCl, Na2CO3, 70 ºC; v) pyridine, NCS, CH2Cl2, 1-thio-β-D-glucopyranose 
tetraacetate, Et3N, 52%; vi) D-TFA, CH2Cl2, 92%; vii) KOCH3, MeOH, quant; viii) 
C2O2Cl2, Et2O; MeOH; ix) NaBH4, NiCl2.6H2O, 47%. 
(D,L)-[
2
H3CO,5',6',7'-
2
H3]-4'-Methoxyindolyl-3'-glycine (107b) 
 
(D,L)-[
2
H3CO,5',6',7'-
2
H3]-4'-Methoxyindolyl-3'-glycine (107b) was prepared 
from [4',5',6',7'-
2
H4]indole (120a), which on treatment with oxalylchloride yielded 
[4',5',6',7'-
2
H4]indole-3'-oxalylchloride (177a). [4',5',6',7'-
2
H4]Indole-3'-oxalylchloride 
120a 
197a 
194b 
196b 
107b 
190b 
171b 
198b 
199b 
172b 
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(177a) was treated with methanol to afford the corresponding oxoacetate (197a), which 
on successive treatment with TTFA, I2/CuI, and NaOCD3 afforded [
2
H3CO,5',6',7'-
2
H3]-
4ꞌ-methoxyindolyl-3'-oxo acid (194b). Compound 194b was treated with NH2OH.HCl 
and Na2CO3 to afford the corresponding oximino acid (196b), which reduced with 
NaBH4 in the presence of NiCl2.6H2O afforded the desired product (D,L)-[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107b) in 37% over all yield (Scheme 2.11). 
Surprisingly when oxoacid (181) was used instead of the oxoacetate (197) the 
methoxylation reaction did not go to completion which could be due to involvement of 
carbonyl oxygen in intra-molecular hydrogen bonding that lowers the possibility of 
chelating and then directing the metal to C-4 position. 
 
[
2
H3CO]Rapalexin A (103a) 
 
[
2
H3CO]Rapalexin A (103a) was prepared from nitroindole (166) by a slight 
modification of previously a published procedure (Pedras, Zheng et al., 2007a). 
Considering nitrophenol as a staring material this route is found to be lengthy as well as 
low yielded. Therefore, methoxylation of nitrobenzene was proposed as an alternative 
and tested for the synthesis of 167 (Pedras and Yaya, 2012). Methoxylation at position 
four of nitroindole was successfully accomplished using the nitro group as a director. 
First, [
2
H3O]-4-methoxy-3-nitroindole (167a) was prepared from nitroindole (166) 
following a standard procedure for methoxylation of indole-3ꞌ-carboxaldehyde (175) 
(Somei, Yamada et al., 1984). Reduction of 167a with palladium on activated carbon was 
followed by treatment with Et3N and CSCl2 at -10 °C to yield [
2
H3CO]rapalexin A (103a) 
in 28% overall yield (Pedras and Yaya, 2012) (Scheme 2.12).  
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Scheme 2.12 Synthesis of [
2
H3CO]rapalexin A (103a). Reagents and conditions: i) 
TTFA, TFA; I2, CuI; NaOCD3, 54%; ii) Pd/C, H2, THF, EtOH; CSCl2, Et3N, -10 °C, 51% 
over two steps. 
Synthesis of N-t-Bocindole-3-glucosinolate (204) 
 
N-t-Bocindolyl-3-carboxaldehyde (200) was treated with NH2OH.HCl and 
Na2CO3 to give the corresponding oxime (201) in a good yield. Chlorination of 201 was 
followed by coupling with 1-thio-β-D-glucopyranose tetraacetate to yield compound 202. 
Sulfonation of compound 202 with HSO3Cl yielded compound 203, which on treatment 
with KOCH3 yielded the target product N-t-Bocindole-3-glucosinolate (204) (Scheme 
2.13). The compound was found to be unstable in both water and organic solvents, 
decomposes over a period of 12-24 hours.  
 
Scheme 2.13 Synthesis of 204. Reagents and conditions: i) Na2CO3, NH2OH.HCl, 
EtOH, 60 °C, quant; ii) pyridine, NCS, CH2Cl2; 1-thio-β-D-glucopyranose tetraacetate, 
NEt3, 37%; iii) ClSO3H, pyridine, CH2Cl2/ether, 66%; iv) KOCH3, MeOH, quantitative. 
166 167a 103a 
200 201 202 203 
204 
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2.2.2.5 Incorporation experiments using perdeuterated compounds 
For biosynthetic studies rutabaga roots were cut horizontally in 10-15 mm thick 
discs and cylindrical holes (16 mm in diameter) were made on one surface of the discs 
with a cork-borer (Pedras, Montaut et al., 2004). The discs were kept in tightly sealed 
plastic boxes and kept at 21 °C in darkness. After 24 h, the discs were UV-irradiated on 
the surface with holes for 1.5 h, and were kept in dark further for 24 h. Labeled 
compound solution (5×10
-4
 M) dissolved in H2O, H2O-CH3OH (90/10 v/v) or H2O-
CH3OH-T80 (90/10/0.1 v/v) was pipetted into each hole (500 μL per hole) and the discs 
were further incubated at 21 °C in dark. Following adsorption of precursor solution, holes 
were filled with water (Figure 2.15). The aqueous solution in the holes was withdrawn 
after 48 h and was extracted (EtOAc 20 ml × 2). The combined organic extract was dried 
over Na2SO4 and solvent was removed under reduced pressure. The residue obtained was 
dissolved in CH3CN (200 μl) and was analyzed by HPLC-DAD and HPLC-ESI-MS to 
determine the level of incorporation into phytoalexins. Control experiments were 
similarly prepared by incubating rutabaga root slices with non-labeled precursors or with 
carrier solution only. Tissue around the holes was cut, was ground (pestle and mortar) 
and extracted with CH3OH, filtered and the filtrate was concentrated under reduced 
pressure. The residue was dissolved in H2O-CH3OH (50:50) and was analyzed by HPLC-
DAD and HPLC-ESI-MS to determine the level of incorporation of labeled precursors 
into indole glucosinolates (Pedras, Montaut et al., 2004) (Figure 2.15). 
The percentage of 
2
H, 
13
C and 
15
N incorporation was established using peak 
intensities in positive or negative modes ESI-MS according to the equation: % of 
incorporation = [M ± 1 + n]
±
/([M ± 1]
±
 + [M ± 1 + n]
±
) × 100 (n = 3, …) n is the number 
of isotopic elements and M is the peak intensity of each ion [M – 1]- or [M + 1]+. The 
biosynthesis of the phytoalexin rapalexin (103), isocyalexin (104) and isalexin (102) was 
investigated using the labeled biosynthesis precursors/intermediates shown in Table 2.13. 
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Figure 2.15 Flow-chart of elicitation, extraction and analysis of phytoalexins and 
indole glucosinolates produced in rutabaga root 
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2.2.2.5.1 Incorporation of L-[2',4',5',6',7'-2H5]tryptophan (66a) 
Biosynthetic origin of the phytoalexins rapalexin A (103), isocyalexin A (104) 
and isalexin (102) were investigated using commercially available L-[2',4',5',6',7'-
2
H5]tryptophan (66a). Rutabaga tissue was prepared and an aqueous solution of L-
[2',4',5',6',7'-
2
H5]tryptophan (66a) (500µL/hole, 5×10
-4
 M) was added as described in 
Figure 2.15. Control experiments were similarly prepared by incubating rutabaga roots 
with natural abundance L-tryptophan (66) or with carrier solution only. Nonpolar 
fractions that contained phytoalexins (rapalexin A (103), isalexin (102), isocyalexin A 
(104), spirobrassinin (101), rutalexin (116), cyclobrassinin (78) etc.), were analyzed by 
HPLC-DAD and HPLC-ESI-MS. The HPLC-ESI-MS analysis of deuterated and control 
samples revealed that the peak corresponding to rapalexin A (103) (tR = 22.3 min) 
contained two ions: [M - 1]
-
 at m/z 203 (natural abundance) and [M - 1 + 4]
-
 at m/z 207 
that resulted from incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a). The ion with m/z 
207 was not detected in the control sample that was fed with natural abundance L-
tryptophan (66). Peak intensities of the natural abundance [M - 1]
-
 ion (m/z 203) and that 
of deuterated ions (m/z 207) were used to determine the deuterium incorporation (% of 
2
H 
incorporation = {[M - 1 + 4]
-
/([M - 1]
-
 + [M - 1 + 4]
-
)} × 100 ± standard deviation). 
Accordingly, the percentage of deuterium incorporation was calculated to be 26.8 ± 1.2% 
(Table 2.14). The percentage of deuterium incorporation into isocyalexin A (104) was 
calculated similarly (13.6 ± 0.1) (Table 2.14). The HPLC-ESI-MS analysis of isalexin 
(102) peak at tR = 2.0 min showed two ions: [M + 1]
+
 at m/z 178 and [M + 1 + 3]
+
 at m/z 
181 that resulted from incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) (not detected 
in the control samples). Using the same equation, the percentage of deuterium 
incorporation was calculated to be 11.2 ± 1.7%. Similarly, the rutalexin (116) peak at tR = 
13.5 min (negative mode) indicated two ions: [M - 1]
-
 at m/z 231 and [M - 1 + 4]
-
 at m/z 
235 (the latter not detected in the control samples). The percentage of deuterium 
incorporation was determined to be 26.3 ± 3.8%. The HPLC-ESI-MS analysis of 
spirobrassinin (101) peak at tR = 11.8 min showed two ions as well: [M + 1]
+
 at m/z 251 
and [M + 1 + 4]
+
 at m/z 255, not detected in the control samples. Using the equation 
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shown above, the percentage of deuterium incorporation was calculated to be 29.9 ± 
7.9%. Similarly, the percentage of deuterium incorporation into cyclobrassinin (78) and 
4ꞌ-methoxycyclobrassinin (110) were calculated to be 20.1 ± 7.9% and 13.0 ± 5.4% 
respectively (Table 2.14; Figure 2.16). 
The number of deuteria detected in 102 and 110 were three, which is consistent 
with structure. In compound 102, C-2 was oxidized to carbonyl, while in 110 C-4 was 
oxidized to methoxy group. Variation in the standard deviation is due to variation in the 
production of each phytoalexin. The incorporation of L-tryptophan (66) into phytoalexins 
was reported by Pedras and coworkers (Pedras, Okinyo et al., 2009), and the same trend 
was also observed in this work. However, from the previous or current data, it was not 
possible to establish whether the deuterium resulted from tryptophan (66) incorporations 
intact or degradation to indole (120) and reincorporation of 120 back into the 
phytoalexins. To answer this question, use of tryptophan (66) labeled on both the indole 
ring and the side chain was necessary. 
Table 2.14  Metabolites of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) in UV-irradiated  
rutabaga roots.  
Metabolites isolated 
a
  % Incorporation of 
deuterium ± Std 
[2',5',6',7'-
2
H4]rapalexin A (103a)  26.8 ± 1.2%
c
 
[2',5',6',7'-
2
H4]isocyalexin A (104a)  13.6 ± 0.1%
c
 
[5,6,7-
2
H3]isalexin (102a)  11.2 ± 1.7%
b
 
[4',5',6',7'-
2
H4]rutalexin (116a)  26.3 ± 3.8%
c
 
[4',5',6',7'-
2
H4]spirobrassinin (101a)  29.9 ± 7.9%
b
 
[4',5',6',7'-
2
H4]cyclobrassinin (78a)  20.1 ± 7.9%
b
 
[5',6',7'-
2
H3]-4'-methoxycyclobrassinin (110a)  13.0 ± 5.4%
b
 
[2',4',5',6',7'-
2
H5]glucobrassicin (57a)  22.8 ± 2.6%
c
 
[2',4',5',6',7'-
2
H5]-1'-methoxyglucobrassicin (69a)  2.7 ± 1.4%
c
  
[2',5',6',7'-
2
H4]-4'-methoxyglucobrassicin (70a)  9.5 ± 1.6%
c
 
a
 Deuterated compounds are referred to by a number followed by the letter a;  
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b
 Positive ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); % 
of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n =3-5) ± Std 
(standard deviation), where n = number of deuterium atoms. 
c
 Negative ion mode. % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 
(n = 3-5) ± Std (standard deviation), where n = number of deuterium atoms. 
 
Figure 2.16 Deuterated phytoalexins obtained from feeding of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) to UV-irradiated rutabaga root: [2',5',6',7'-
2
H4]rapalexin A (103a) 
(26.8 ± 1.2%), [2',5',6',7'-
2
H4]isocyalexin A (104a) (13.6 ± 0.1%), [4',5',6',7'-
2
H4]rutalexin (116a) (26.3 ± 3.8%), [5,6,7-
2
H3]isalexin (102a) (11.2 ± 1.7%), [4',5',6',7'-
2
H4]spirobrassinin (101a) (29.9 ± 7.9%), [4',5',6',7'-
2
H4]cyclobrassinin (78a) (20.1 ± 
7.9%), [5',6',7'-
2
H3]-4'-methoxycyclobrassinin (110a) (13.0 ± 5.4%).  
The incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) into indole 
glucosinolates (glucobrassicin (57), 4ꞌ-methoxyglucobrassicin (70) and 1ꞌ-
methoxyglucobrassicin (69)) was determined as well. Methanolic extracts of tissues were 
dissolved in water-methanol (50:50) and analyzed by HPLC-DAD and HPLC-ESI-MS as 
described above (Figure 2.15). The HPLC-ESI-MS analyses of the polar extracts showed 
the glucobrassicin (57) peak at tR = 5.3 min containing two ions (negative mode): [M]
-
 at 
m/z 447 and [M + 5]
-
 at m/z 452 that was not detected in the control samples. The 
percentage of deuterium incorporation was calculated to be 22.8 ± 2.6% (Table 2.14). In 
66a 101a 78a 
102a 104a 103a 
116a 110a 
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a similar fashion, the percentages of deuterium incorporation into 70 and 69 were 
calculated to be 9.5 ± 1.6% and 2.7 ± 1.4% respectively (Table 2.14; Figure 2.17).  
 
Figure 2.17 Deuterated indole glucosinolates obtained from feeding of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) to UV-irradiated rutabaga root: [2',4',5',6',7'-
2
H5]glucobrassicin 
(57a) (22.8 ± 2.6%), [2',5',6',7'-
2
H4]-4'-methoxyglucobrassicin (70a) (9.5 ± 1.6%), 
[2',4',5',6',7'-
2
H5]-1'-methoxyglucobrassicin (69a) (2.7 ± 1.4%). 
2.2.2.5.2 Incorporation of [4,5,6,7-2H4]indole (120a) 
An aqueous solution of [4,5,6,7-
2
H4]Indole (120a) (500µL/hole, 5×10
-4
 M) was 
added to UV-irradiated slices of rutabaga roots and analyzed as described in Figure 2.15. 
The HPLC-ESI-MS analysis showed the rapalexin A (103) peak at tR = 22.2 min 
containing two ions (negative mode): [M - 1]
-
 at m/z 203 and [M - 1 + 3]
-
 at m/z 206 
(resulting from incorporation of [4,5,6,7-
2
H4] indole (120a)) that was not detected in the 
control samples. Peak intensities of the natural abundance and those of deuterated ions 
were used to determine the level of deuterium incorporation, using the equation shown in 
Table 2.15; the percentage of deuterium incorporation was calculated to be 11.2 ± 4.4%. 
Similarly, the percentages of deuterium incorporation into isocyalexin A (104) and 
isalexin (102) (positive mode) were calculated to be 7.2 ± 2.9% and 6.5 ± 3.8%, 
respectively (Table 2.15). The HPLC-ESI-MS analysis of rutalexin (116) peak at tR = 
13.5 min (negative mode) indicated two ions as well: [M- 1]
-
 at m/z 231 and [M - 1 + 4]
-
 
at m/z 235, not detected in the control samples. Using the equation shown in Table 2.15, 
66a 57a 70a 
69a 
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the percentage of deuterium incorporation was calculated to be 11.3 ± 1.5%. The HPLC-
ESI-MS analysis of spirobrassinin (101) peak at tR = 11.8 min (positive mode) showed 
two ions: [M + 1]
+
 at m/z 251 and the corresponding [M + 1 + 4]
+
 at m/z 255, not detected 
in the control samples. Accordingly, the percentage of deuterium incorporation was 
calculated to be 10.0 ± 4.7%. In similar fashion, the percentage of deuterium 
incorporations into 78 and 110 were calculated to be 6.0 ± 1.6% and 6.0 ± 0.6% 
respectively (Table 2.15; Figure 2.18).  
Table 2.15 Metabolites of [4,5,6,7-
2
H4]indole (120a) in UV-irradiated  rutabaga roots  
Metabolites isolated 
a
  % Incorporation ± Std 
[5',6',7'-
2
H3]rapalexin A (103a)  11.2 ± 4.4% 
c
 
[5',6',7'-
2
H3]isocyalexin A (104a)  7.2 ± 2.9%
c
 
[5,6,7-
2
H3]isalexin (102a)  6.5 ± 3.8%
b
 
[4',5',6',7'-
2
H4]rutalexin (116a)  11.3 ± 1.5%
c
 
[4',5',6',7'-
2
H4]spirobrassinin (101a) 10.0 ± 4.7%
b
 
[4',5',6',7'-
2
H4]cyclobrassinin (78a)  6.0 ± 1.6%
b
 
[5',6',7'-
2
H3]-4'-methoxycyclobrassinin (110a)  6.0 ± 0.6%
b
 
[4',5',6',7'-
2
H4]glucobrassicin (57a)  12.7 ± 3.6%
c
 
[4',5',6',7'-
2
H4]-1'-methoxyglucobrassicin (69a)  11.2 ± 2.1%
c
  
[5',6',7'-
2
H3]-4'-methoxyglucobrassicin (70a)  10.3 ± 2.0%
c
 
a
 Deuterated compounds are referred to by a number followed by the letter a;  
b
 Positive ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); % 
of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 3 or 4) ± Std 
(standard deviation), where n = number of deuterium atoms. 
c
 Negative ion mode. % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 
(n = 3 or 4) ± Std (standard deviation), where n = number of deuterium atoms. 
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Figure 2.18 Deuterated phytoalexins obtained from feeding of [4,5,6,7-
2
H4]indole 
(120a) to UV-irradiated rutabaga root: [5',6',7'-
2
H3]rapalexin A (103a) (11.2 ± 4.4%), 
[5',6',7'-
2
H3]isocyalexin A (104a) (7.2 ± 2.9%), [4',5',6',7'-
2
H4]rutalexin (116a) (11.3 ± 
1.5%), [5,6,7-
2
H3]isalexin (102a) (6.5 ± 3.8%), [4',5',6',7'-
2
H4]spirobrassinin (101a) (10.0 
± 4.7%), [4',5',6',7'-
2
H4]cyclobrassinin (78a) (6.0 ± 1.6%), [5',6',7'-
2
H3]-4'-
methoxycyclobrassinin (110a) (6.0 ± 0.6%). 
The incorporation of [4,5,6,7-
2
H5]indole (120a) into indole glucosinolates 
(glucobrassicin (57), 4ꞌ-methoxyglucobrassicin (70) and 1ꞌ-methoxyglucobrassicin (69)) 
was investigated as described in Figure 2.15. The HPLC-ESI-MS analyses of the polar 
extracts showed the glucobrassicin (57) peak at tR = 5.3 min containing two ions in a 
negative mode: [M]
-
 at m/z 447 and [M + 4]
-
 m/z 451 that was not detected in the control 
samples. Peak intensities of the natural abundance and those of deuterated ions were used 
to determine the level of deuterium incorporation. Accordingly, the percentage of 
deuterium incorporation into glucobrassicin (57) was calculated to be 12.7 ± 3.6%. 
Similarly, using the equation shown in Table 2.15, the percentages of deuterium 
incorporation into 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-methoxyglucobrassicin (70) were 
calculated to be 11.2 ± 2.1% and 10.3 ± 2.0%, respectively (Table 2.15; Figure 2.19).  
120a 
101a 78a 
102a 104a 103a 
116a 110a 
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Figure 2.19 Deuterated indole glucosinolates obtained from feeding of [4,5,6,7-
2
H4]indole (120a) to UV-irradiated rutabaga root: [4',5',6',7'-
2
H4]glucobrassicin (57a) 
(12.7 ± 3.6%), [5',6',7'-
2
H3]-4'-methoxyglucobrassicin (70a) (10.3 ± 2.0%), [4',5',6',7'-
2
H4]-1'-methoxyglucobrassicin (69a) (11.2 ± 2.1%). 
Incorporation of [4,5,6,7-
2
H4]indole (120a) into rutabaga phytoalexins and indole 
glucosinolates was previously reported (Pedras, Okinyo et al., 2009). It showed 
incorporation levels ranging from 6% to 19%. Compared to the current data, these earlier 
studies show similar trend and level of incorporations. The minor differences observed 
are likely due to variations in the amount of metabolites produced.  
2.2.2.5.3 Incorporation of L-[U-13C11,U-
15
N2]tryptophan (66b) 
To establish unambiguously the origin of the carbon and nitrogen atoms of both 
rapalexin A (103) and isocyalexin A (104), fully labeled L-[
13
C11,
15
N2]tryptophan (66b) 
was used. An aqueous solution of L-[U-
13
C11,U-
15
N2]tryptophan (500 µL/hole, 5×10
-4
 M) 
(66b) was added to UV-irradiated slices of rutabaga roots and analyzed as described in 
Figure 2.15. The HPLC-ESI-MS analysis of the nonpolar fractions revealed the rapalexin 
A (103) peak at tR = 22.3 min containing two ions: [M - 1]
-
 at m/z 203 and [M - 1 + 11]
-
 at 
m/z 214 (resulting from incorporation of L-[U-
13
C11,U-
15
N2]tryptophan (66b)) that was 
not detected in the control samples. Peak intensities of the natural abundance and those of 
labeled ions were used to determine the 
13
C and 
15
N incorporation (% of incorporation = 
120a 57a 70a 
69a 
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{[M - 1 + n]
-
/([M - 1]
-
 + [M - 1 + n]
-
)} × 100 ± standard deviation, where n = number of 
13
C & 
15
N atoms). Accordingly, the percentage of 
13
C and 
15
N incorporation was 
determined to be 25.9 ± 1.4%. Similarly, using equation shown above, the percentage of 
13
C and 
15
N incorporation into isocyalexin A (104) was calculated to be 17.0 ± 6.4%. The 
HPLC-ESI-MS analysis of isalexin (102) peak at tR = 2.0 min (positive mode) indicated 
two ions: [M + 1]
+
 at m/z 178 and [M + 1 + 9]
+
 at m/z 187, not detected in the control 
samples. The percentage of 
13
C and 
15
N incorporation was calculated as indicated above, 
12.1 ± 1.1%. The rutalexin peak (116) at tR = 13.5 min (negative mode) showed two ions: 
molecular ion [M- 1]
-
 at m/z 231 and [M - 1 + 12]
-
 m/z 243, not detected in the control 
samples. The percentage of 
13
C and 
15
N incorporation was calculated as shown above to 
be 13.0 ± 0.3%. The spirobrassinin (101) peak at tR = 11.8 min (positive mode) indicated 
two ions: [M + 1]
+
 at m/z 251 and [M + 1 + 12]
+
 m/z 263, not detected in the control 
samples. Using the equation shown in Table 2.16, the percentage of 
13
C and 
15
N 
incorporation was calculated to be 11.2 ± 0.1%. Using the same equation shown in Table 
2.16, the percentage of 
13
C and 
15
N incorporation into 78 was determined as, 15.5 ± 
4.7%.  The HPLC-ESI-MS analysis of 4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190) peak at 
tR = 7.5 min (positive mode) indicated two ions: [M + 1]
+
 at m/z 176 and the 
corresponding [M + 1 + 10]
+
 m/z 186 that was not detected in the control samples. As 
indicated above, the percentage of 
13
C and 
15
N incorporation was calculated, 16.2 ± 0.7%. 
Likewise, using the equation shown in Table 2.16, the percentage of 
13
C and 
15
N 
incorporation into 4ꞌ-methoxyindolyl-3ꞌ-formamide (168) was determined to be 12.2 ± 
8.1% (Table 2.16; Figure 2.20).  
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Figure 2.20 
13
C and 
15
N labeled phytoalexins obtained from feeding of L-[U-
13
C11,U-
15
N2]tryptophan (66b) to UV-irradiated rutabaga root: [1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N2]rapalexin A (103a) (25.9 ± 1.4%), [1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N2]isocyalexin 
A (104a) (17.0 ± 6.4%), [1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]]rutalexin (116a) (13.0 ± 
0.3%), [2,3,3a,4,5,6,7,7a-
13
C8,
15
N]isalexin (102a) (12.1 ± 1.1%), 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]spirobrassinin (101a) (11.2 ± 0.1%), 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]cyclobrassinin (78a) (15.5 ± 4.7%), 
[1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N]-4'-methoxyindole-3'-carboxaldehyde (190a) (16.2 ± 
0.7%), [1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N2]-4'-methoxyindolyl-3'-formamide (168a) 12.2 ± 
8.1%.  
66b 
101a 78a 
102a 104a 103a 
116a 190a 168a *N = 
15
N 
   C = 
13
C 
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Table 2.16 Metabolites of L-[U-
13
C11,U-
15
N2]tryptophan (66b) in UV-irradiated  
rutabaga roots.  
Metabolites isolated 
a
  % Incorporation ± 
Std 
[1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N2]rapalexin A (103a)  25.9 ± 1.4% 
c
 
[1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N2]isocyalexin A (104a)  17.0 ± 6.4%
c
 
[2,3,3a,4,5,6,7,7a-
13
C8,
15
N]isalexin (102a)  12.1 ± 1.1%
b
 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]]rutalexin (116a)  13.0 ± 0.3%
c
 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]spirobrassinin (101a)  11.2 ± 0.1%
b
 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]cyclobrassinin (78a)  15.5 ± 4.7%
b
 
[1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N]-4ꞌ-methoxyindole-3ꞌ-
carboxaldehyde (190a)  
16.2 ± 0.7%
b
 
[1,2',3',3a',4',5',6',7',7'a-
13
C9,
15
N2]-4ꞌ-methoxyindolyl-3ꞌ-
formamide (168a)  
12.2 ± 8.1%
b
 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]glucobrassicin (57a)  31.3 ± 0.7%
c
 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]-1'-methoxyglucobrassicin 
(69a)  
10.0 ± 2.0%
c
 
[1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]-4'-methoxyglucobrassicin 
(70a)  
10.3 ± 1.5%
c
 
L-[U-
13
C11,U-
15
N2]tryptophan (66b) 74.0 ± 3.0%
b
 
a
 
13
C and 
15
N labeled compounds are referred to by a number followed by the letter a or 
b; 
b
 Positive ion mode. Incorporations calculated from HPLC-ESI-MS (peak intensities); 
% of 
13
C
15
N incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n =9-12) ± 
Std (standard deviation), where n = number of 
13
C & 
15
N  atoms. 
c
 Negative ion mode. % of 
13
C
15
N incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 
100 (n = 9-12) ± Std (standard deviation), where n = number of 
13
C & 
15
N atoms. 
The incorporation of L-[U-
13
C11,U-
15
N2]tryptophan (66b) into indole 
glucosinolates (glucobrassicin (57), 4ꞌ-methoxyglucobrassicin (70) and 1ꞌ-
methoxyglucobrassicin (69)) was investigated as described in Figure 2.15. The HPLC-
ESI-MS analyses of the polar extracts showed glucobrassicin (57) peak at tR = 5.3 min 
containing two ions (negative mode): [M]
-
 at m/z 447 and [M + 12]
-
 at m/z 459 (resulting 
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from incorporation of L-[U-
13
C11,U-
15
N2]tryptophan (66b)) that was not detected in the 
control samples. Peak intensities of the natural abundance and those of labeled ions were 
used to determine the level of 
13
C and 
15
N incorporation. Using the equation shown in 
Table 2.16, the percentage of 
13
C and 
15
N incorporation was calculated to be 31.3 ± 
0.7%. Similarly, the percentage of 
13
C and 
15
N incorporation into 70 and 69 was 
calculated to be 10.3 ± 1.5%, and 10.0 ± 2.0% respectively (Table 2.16; Figure 2.21). 
 
Figure 2.21 
13
C and 
15
N labeled indole glucosinolates obtained from feeding of L-[U-
13
C11,U-
15
N2]tryptophan (66b) to UV-irradiated rutabaga root: [1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]glucobrassicin (57a) (31.3 ± 0.7),  [1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]-4'-
methoxyglucobrassicin (70a) (10.3 ± 1.5%), [1,2,2',3',3a',4',5',6',7',7'a-
13
C10,
15
N2]-1'-
methoxyglucobrassicin (69a) (10.0 ± 2.0%). 
The incorporation of L-[U-
13
C11,U-
15
N2]tryptophan (66b) into indole 
glucosinolates (57, 70 and 69 Figure 2.21) was viewed as intact incorporation of the side 
chain without any rearrangement. The side chain carbon atoms, C2 and C3 of the 
tryptophan (66) appeared to be C1 and C2 of the indole glucosinolates. In the case of 
phytoalexins from the brassinin (45) series (101, 116 and 78), there is exchange of 
positions of a carbon and nitrogen on the side chain, which was due to rearrangement of 
the aglycone (138) derived from hydrolysis of indole glucosinolates. Intermediate 138 is 
transformed to an unstable indolyl-3-methyisothiocyanate (144) which can give brassinin 
(45) in the presence of thiomethyl donor (Pedras, Okinyo et al., 2009; Pedras, Yaya et al., 
66b 57a 
69a 
70a 
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2011) (Figure 2.20). Rapalexin A (103) and isocyalexin A (104) incorporated a carbon 
and nitrogen atom of the side chain of tryptophan (66), which suggested the 
rearrangement of the side chain of 66 (Figure 2.20). To investigate biosynthetic 
pathways of metabolites 103, 104 and 102 and plausible rearrangement sequences, 
potential biosynthetic intermediates were proposed as per the retro-biosynthetic analysis 
shown in Scheme 2.7. 
2.2.2.5.4 Incorporation of [4',5',6',7'-2H4]desulfoglucobrassicin (80a) 
Desulfoglucobrassicin (80) is the last biosynthetic precursor of glucobrassicin 
(57) (Piotrowski, Schemenewitz et al., 2004). A biosynthetic precursor of 
desulfoglucobrassicin (80), indolyl-3-thiohydroxamic acid (79), was proven to be 
common biosynthetic precursor to both indole glucosinolates and cruciferous 
phytoalexins (Pedras and Okinyo, 2008). Nevertheless, biosynthetic relationships of 
desulfoglucobrassicin (80) and indole glucosinolates with cruciferous phytoalexins such 
as rapalexin A (103) and isocyalexin A (104) have not been established. Therefore, the 
relationships were investigated using perdeuterated desulfoglucobrassicin (80a) and 
glucobrassicin (57b).  
An aqueous solution of [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) (500 µL/hole, 
5×10
-4
 M) was added to UV-irradiated slices of rutabaga and analyzed as described in 
Figure 2.15. The nonpolar fractions that contained the rapalexin A (103) peak at tR = 22.3 
min revealed two ions (negative mode): [M - 1]
-
 at m/z 203 and [M - 1 + 3]
-
 at m/z 206, 
not detected in the control samples. Using the equation shown in Table 2.17, the 
percentage of deuterium incorporation was determined to be 4.0 ± 1.7%. Likewise, the 
percentage of deuterium incorporations into isocyalexin A (104) and rutalexin (116) were 
calculated to be 3.0 ± 0.3% and 1.8 ± 0.3%, respectively. The HPLC-ESI-MS analysis of 
spirobrassinin (101) peak at tR = 11.8 min showed two ions: [M + 1]
+
 at m/z 251 and [M + 
1 + 4]
+
 at m/z 255, not detected in the control samples. Using the equation shown in 
Table 2.17, the percentage of deuterium incorporation was measured, 2.0 ± 0.6%. In a 
similar fashion, the percentage of deuterium incorporation into 78 and 110 were 
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calculated to be 2.4 ± 0.3% and 3.8 ± 0.8%, respectively. The 4ꞌ-methoxyindole-3ꞌ-
carboxaldehyde (190) peak at tR = 7.5 min (positive mode) indicated two ions as well:  
[M + 1]
+
 at m/z 176 and [M + 1 + 3]
+
 m/z 179 that was not detected in the control 
samples. The percentage of deuterium incorporation was calculated to be 2.8 ± 0.8%. 
Similarly, the percentage of deuterium incorporation into 4ꞌ-methoxyindolyl-3ꞌ-
formamide (168) was measured, 2.3 ± 0.9% (Table 2.17; Figure 2.22). 
Table 2.17 Metabolites of [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) in UV-irradiated 
rutabaga roots.  
a
 Deuterated compounds are referred to by a number followed by the letter a;  
b
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
3 or 4) ± Std (standard deviation), where n = number of deuterium atoms. 
c
Negative ion mode. % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 
(n = 3 or 4) ± Std (standard deviation), where n = number of deuterium atoms. 
d 
NI=no incorporation implies ≤0.1% deuterium.  
Metabolites isolated 
a 
 % Incorporation
 
± Std 
[5',6',7'-
2
H3]rapalexin A (103a)  4.0 ± 1.7%
c
 
[5',6',7'-
2
H3]isocyalexin A (104a)  3.0 ± 0.3%
c
 
[4',5',6',7'-
2
H4]spirobrassinin (101a)  2.0 ± 0.6%
b
 
[4',5',6',7'-
2
H4]rutalexin (116a)  1.8 ± 0.3%
c
 
[4',5',6',7'-
2
H4]cyclobrassinin (78a)  2.4 ± 0.3%
b
 
[5',6',7'-
2
H3]-4ꞌ-methoxycyclobrassinin (110a)  3.8 ± 0.8%
b
 
[5',6',7'-
2
H3]isalexin (102a) NI
d
 
[5',6',7'-
2
H3]-4ꞌ-methoxyindolyl-3ꞌ-formamide (168a)  2.3 ± 0.9%
b
 
[5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190a) 2.8 ± 0.8%
b
 
[4',5',6',7'-
2
H4]glucobrassicin (57a)  10.1 ± 2.0%
c
 
[5',6',7'-
2
H3]-4'-methoxyglucobrassicin (70a)  3.8 ± 2.0%
c
 
[4',5',6',7'-
2
H4]-1'-methoxyglucobrassicin (69a)  2.8 ± 0.5%
c
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Figure 2.22 Deuterated metabolites obtained from feeding of [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) to UV-irradiated rutabaga root: [5',6',7'-
2
H3]rapalexin A 
(103a) (4.0 ± 1.7%), [5',6',7'-
2
H3]isocyalexin A (104a) (3.0 ± 0.3%), [4',5',6',7'-
2
H4]rutalexin (116a) (1.8 ± 0.3%), [4',5',6',7'-
2
H4]spirobrassinin (101a) (2.0 ± 0.6%), 
[4',5',6',7'-
2
H4]cyclobrassinin (78a) (2.4 ± 0.3%), [5',6',7'-
2
H3]-4'-methoxyindole-3'-
carboxaldehyde (190a) (2.8 ± 0.8%), [5',6',7'-
2
H3]-4'-methoxyindolyl-3'-formamide 
(168a) (2.3 ± 0.9%), [5',6',7'-
2
H3]-4'-methoxycyclobrassinin (110a) (3.8 ± 0.8%). 
Similarly, the HPLC-ESI-MS analyses of the polar extracts showed the 
glucobrassicin (57) peak at tR = 5.3 min containing two ions (negative mode): [M]
-
 at m/z 
447 and [M + 4]
-
 m/z 451, the latter of which was not detected in the control samples. 
Peak intensities of the natural abundance and those of deuterated ions were used to 
determine the level of incorporation. Thus, the percentage of deuterium incorporation 
into glucobrassicin (57) was calculated, 10.1 ± 2.0%. Likewise, using the equation shown 
in Table 2.17, the percentage of deuterium incorporation into 70 and 69 was calculated to 
be 3.8 ± 2.0% and 2.8 ± 0.5% respectively (Table 2.17; Figure 2.23). 
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Figure 2.23 Deuterated indole glucosinolates obtained from feeding of [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) to UV-irradiated rutabaga root: [4',5',6',7'-
2
H4]glucobrassicin (57a) (10.1 ± 2.0%), [5',6',7'-
2
H3]-4′-methoxyglucobrassicin (70a) 
(3.8 ± 2.0%), [4',5',6',7'-
2
H4]-1'-methoxyglucobrassicin (69a) (2.8 ± 0.5%). 
2.2.2.5.5 Incorporation of [2,2,4',5',6',7'-2H6]glucobrassicin (57b) 
The biosynthetic relationship between indole glucosinolates and cruciferous 
phytoalexins such as rapalexin A (103) and isocyalexin A (104) was investigated using 
perdeuterated glucobrassicin (57b). An aqueous solution of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) (500 µL/hole, 5×10
-4
 M) was added to UV-irradiated slices of 
rutabaga and analyzed as described in Figure 2.15. The HPLC-ESI-MS analyses of the 
nonpolar fractions revealed the rapalexin A (103) peak at tR = 22.3 min containing two 
ions: [M - 1]
-
 at m/z 203 and [M - 1 + 3]
-
 at m/z 206, not detected in the control samples. 
Peak intensities of the natural abundance and those of deuterated ions were used to 
determine the level of incorporation. Using the equation shown in Table 2.18, the 
percentage of deuterium incorporation was calculated to be 3.9 ± 1.1%. Similarly, the 
percentages of deuterium incorporation into isocyalexin A (104) and isalexin (102, 
positive mode) were determined to be 2.4 ± 0.8% and 3.2 ± 1.1%, respectively. The 
percentage of deuterium incorporation into 168 was also established in a similar fashion, 
1.3 ± 0.6% Table 2.18. The spirobrassinin (101) peak at tR = 11.8 min (positive mode) 
80a 57a 
69a 
70a 
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indicated two ions:  [M + 1]
+
 at m/z 251 and [M + 1 + 6]
+
 at m/z 257. As indicated in 
Table 2.18, the percentage of deuterium incorporation was calculated, 2.6 ± 0.6%. 
Similarly, the percentages of deuterium incorporations into 78 and 110 were calculated to 
be 1.9 ± 0.7% and 3.0 ± 1.2%, respectively (Table 2.18; Figure 2.24).  
Table 2.18  Metabolites of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) in UV-irradiated 
rutabaga roots.  
Metabolites isolated 
a
  % Incorporation ± 
Std 
[5',6',7'-
2
H3]rapalexin A (103a)  3.9 ± 1.1%
c
 
[5',6',7'-
2
H3]isocyalexin A (104a)  2.4 ± 0.8%
c
 
[5,6,7-
2
H3]isalexin (102a)  3.2 ± 1.1%
b
 
[5',6',7'-
2
H3]-4ꞌ-methoxyindolyl-3ꞌ-formamide (168a)  1.3 ± 0.6%
b
 
[2,2,4',5',6',7'-
2
H6]spirobrassinin (101a)  2.6 ± 0.6%
b
 
[2,2,4',5',6',7'-
2
H6]cyclobrassinin (78a)  1.9 ± 0.7%
b
 
[2,2,5',6',7'-
2
H5]-4'-methoxycyclobrassinin (110a)  3.0 ± 1.2%
b
 
[2,2,4',5',6',7'-
2
H6]glucobrassicin (57a)  18.8 ± 5.1%
c
 
[2,2,5',6',7'-
2
H5]-4'-methoxyglucobrassicin (70a)  5.0 ± 0.4%
c
 
[2,2,4',5',6',7'-
2
H6]-1'-methoxyglucobrassicin (69a)  1.1 ± 0.2%
c
 
a
 Deuterated compounds are referred to by a number followed by the letter a and b;  
b
 Negative ion mode. % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 
(n = 3-6) ± Std (standard deviation), where n = number of deuterium atoms. 
c
 Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
3-6) ± Std (standard deviation), where n = number of deuterium atoms. 
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Figure 2.24 Deuterated phytoalexins obtained from feeding of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57a) to UV-irradiated rutabaga root: [5',6',7'-
2
H3]rapalexin A (103a) 
(3.9 ± 1.1%), [5',6',7'-
2
H3]isocyalexin A (104a) (2.4 ± 0.8%), [2,2,4',5',6',7'-
2
H6]spirobrassinin (101a) (2.6 ± 0.6%), [2,2,4',5',6',7'-
2
H6]cyclobrassinin (78a) (1.9 ± 
0.7%), [5',6',7'-
2
H3]-4ꞌ-methoxyindolyl-3ꞌ-formamide (168a) (1.3 ± 0.6%), [2,2,5',6',7'-
2
H5]-4ꞌ-methoxycyclobrassinin (110a) (3.0 ± 1.2%), [5,6,7-
2
H3]isalexin (102a) (3.2 ± 
1.1%). 
Similarly, the HPLC-ESI-MS analyses of the polar extracts showed 4ꞌ-methoxy 
glucobrassicin (70) peak at tR = 6.9 min containing two ions in (negative mode): [M]
-
 at 
m/z 477 and [M + 5]
-
 at m/z 482, the latter of which was not detected in the control 
sample. Based on peak intensities, the percentage of deuterium incorporation into 70 was 
calculated to be 5.0 ± 0.4%. Similarly, the percentage of deuterium incorporation into 69 
was determined using the equation shown in Table 2.18 to be 1.1 ± 0.2% (Table 2.18; 
Figure 2.25). 
The incorporation of glucobrassicin (57) into phytoalexins and indole 
glucosinolates is consistent with previous results obtained in T. salsuginea (Pedras, Yaya 
et al., 2010). Incorporation into non-methoxylated phytoalexins was proposed to be via 
brassinin (45) while incorporation into 4-methoxylated phytoalexins was via 4ꞌ-
methoxyglucobrassicin (70) (Pedras and Yaya, 2013).  
57b 
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Figure 2.25 Deuterated indole glucosinolates obtained from feeding of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) to UV-irradiated rutabaga root: [2,2,5',6',7'-
2
H5]-4'-
methoxyglucobrassicin (70a) (5.0 ± 0.4%) and [2,2,4',5',6',7'-
2
H6]-1'-
methoxyglucobrassicin (69a) (1.1 ± 0.2%). 
2.2.2.5.6 Incorporation of [2H3CO]-4ꞌ-methoxybrassinin (108a) 
The biosynthetic relationship between indole glucosinolates and cruciferous 
phytoalexins investigated in T. salsuginea suggested that T. salsuginea phytoalexins 
(wasalexins A (43) and B (109) and biswasalexins A1 (131) and A2 (132)) are 
biosynthesized via 1ꞌ-methoxyglucobrassicin (Pedras, Yaya et al., 2010). Based on that 
finding, investigations of the biosynthetic pathways of 4-methoxyphytoalexins were 
conducted using 4-methoxylated biosynthetic precursors. First, an aqueous solution of 
[
2
H3CO]-4ꞌ-methoxybrassinin (108a) (500 µL/hole, 5×10
-4
 M) was added to UV-
irradiated slices of rutabaga and analyzed as described in Figure 2.15. HPLC-ESI-MS 
analyses of the nonpolar fractions that contained phytoalexins revealed the 4ꞌ-
methoxycyclobrassinin (110) peak at tR = 23.4 min (positive mode) containing two ions:  
[M + 1]
+
 at m/z 265 and [M + 1 + 3]
+
 at m/z 268, not detected in the control samples. 
Using the equation shown in Table 2.19, the percentage of deuterium incorporation was 
calculated to be 77.0 ± 4.2%. Similarly, the percentage of deuterium incorporation into 
4ꞌ-methoxydehydrocyclobrassicin (113) was calculated to be 72.0 ± 3.5% (Table 2.19; 
Figure 2.26). 
  
57b 69a 70a 
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Table 2.19 Metabolites of [
2
H3CO]-4ꞌ-methoxybrassinin (108a) in UV-irradiated 
rutabaga roots 
Metabolites isolated 
a 
 % Incorporation 
± Std 
[
2
H3CO]rapalexin A (103a)  NI
d
 
[
2
H3CO]isocyalexin A (104a)  NI
d
 
[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-formamide (168a)  NI
d
 
[
n
Hn]spirobrassinin (101a)  NI
d
 
[
n
Hn]rutalexin (116a)  NI
d
 
[
n
Hn]cyclobrassinin (78a)  NI
d
 
[
2
H3CO]-4ꞌ-methoxycyclobrassinin (110a)  77.0 ± 4.2%
c
 
[
2
H3CO]-4ꞌ-methoxydehydrocyclobrassinin (113a)  72.0 ± 3.5%
c
 
[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190a)  NI
d
 
[
n
Hn]glucobrassicin (57a)  NI
d
 
[
n
Hn]-4ꞌ-methoxyglucobrassicin (70a)  NI
d
 
[
n
Hn]-1ꞌ-methoxyglucobrassicin (69a)  NI
d
 
a
 Deuterated compounds are referred to by a number followed by the letter a. 
b
 Negative ion mode. % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 
(n = 3) ± Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
3) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium 
 
Figure 2.26 Deuterated phytoalexins obtained from feeding of [
2
H3CO]-4ꞌ-
methoxybrassinin (108a) to UV-irradiated rutabaga root: [
2
H3CO]-4ꞌ-
methoxycyclobrassinin (110a) (77.0 ± 4.2%), [
2
H3CO]-4ꞌ-methoxydehydrocyclobrassinin 
(113a) (72.0 ± 3.5%). 
110a 113a 108a 
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The HPLC-ESI-MS analysis of the fractions containing 4-methoxy phytoalexins 
such as rapalexin A (103) and isocyalexin A (104) did not show incorporation of 4ꞌ-
methoxybrassinin. Similarly, analysis of polar extracts showed lack of incorporation of 
4ꞌ-methoxybrassinin (108) into indole glucosinolates 57, 70 and 69 as proposed (Table 
2.19). High level incorporation into 110 and 113 suggests 4ꞌ-methoxybrassinin (108) is a 
close precursor of the metabolites. Lack of incorporation into 103 and 104 suggests 
biosynthesis of these metabolites may follow a different route downstream of 4ꞌ-
methoxyglucobrassicin (70).  
2.2.2.5.7 Incorporation of (R,S)-[2H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-
glycine (107b) 
An aqueous solution of (R,S)-[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine 
(107b) (500 µL/hole, 5×10
-4
 M) was added to UV-irradiated slices of rutabaga and 
analyzed as described above (Figure 2.15). The HPLC-ESI-MS analyses of the nonpolar 
fractions showed the rapalexin A (103) peak at tR = 22.3 min containing two ions: [M - 
1]
-
 at m/z 203 and [M - 1 + 6]
-
 at m/z 209 (resulting from incorporation of (R,S)-
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107b)) that was not detected in the 
control samples. Peak intensities of the natural abundance and those of deuterated ions 
were used to determine the level of deuterium incorporation. Using the equation shown in 
Table 2.20, the percentage of deuterium incorporation was determined to be 4.2 ± 0.7%. 
In similar fashion, the percentage of deuterium incorporation into isocyalexin A (104) 
and isalexin (102, positive mode) were calculated to be 12.8 ± 3.4% and 5.0 ± 2.6%, 
respectively. Similarly, the percentage of deuterium incorporation into 4'-methoxyindole-
3'-carboxaldehyde (190a) was calculated to be 66.0 ± 2.0%. Similar results were obtained 
from feeding of tri-deuterated amino acid (R,S)-[
2
H3CO]-4'-methoxyindolyl-3'-glycine 
(107a) (Table 2.21). No deuterium incorporation was detected into indole glucosinolates 
57, 70 and 69 (Table 2.20 and 2.21; Figure 2.27).  
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Table 2.20 Metabolites of (R,S)-[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine 
(107b) in UV-irradiated rutabaga roots. 
Metabolites detected (#a)
a 
 % Incorporation ± 
Std 
[
2
H3CO,5',6',7'-
2
H3]rapalexin A (103a)  4.2 ± 0.7%
b
 
[
2
H3CO,5',6',7'-
2
H3]isocyalexin A (104a)  12.8 ± 3.4%
b
 
[
2
H3CO,5,6,7-
2
H3]isalexin (102a)  5.0 ± 2.6%
c
 
[
2
Hn]cyclobrassinin (78a)  NI
d
 
[
2
Hn]spirobrassinin (101a)  NI
d
 
[
2
Hn]rutalexin (116a)  NI
d
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107b)  100
c
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carboxaldehyde oxime 
(171a)  
ND
d
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carbonitrile (205a) ND
d
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carboxaldehyde (190a)  66.0 ± 2.0%
c
 
[
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172a)  ND
d
 
[
2
Hn]glucobrassicin (57a)  NI
d
 
[
2
Hn]-4'-methoxyglucobrassicin (70a)  NI
d
 
[
2
Hn]-1'-methoxyglucobrassicin (69a)  NI
d
 
a
 Deuterated compounds are referred to by a number followed by the letter a or b. 
b
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 6) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
6) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium; ND=not detected. 
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Table 2.21 Metabolites of (R,S)-[
2
H3CO]-4'-methoxyindolyl-3'-glycine (107a) in UV–
irradiated rutabaga roots.  
a
 Deuterated compounds are referred to by a number followed by the letter a. 
b
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 3) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
3) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium; ND=not detected. 
 
Figure 2.27 Deuterated phytoalexins obtained from feeding of (R,S)-[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107b) to UV-irradiated rutabaga root: [
2
H3CO,5',6',7'-
2
H3]rapalexin A (103a) (4.2 ± 0.7%), [
2
H3CO,5',6',7'-
2
H3]isocyalexin A (104a) (12.8 ± 
3.4%), [
2
H3CO,5,6,7-
2
H3]isalexin (102a) (5.0 ± 2.6%), [
2
H3CO,5',6',7'-
2
H3]-4'-
methoxyindole-3'-carboxaldehyde (190a) (66.0 ± 2.0%). 
Metabolites detected (#a)
a 
 % Incorporation ± 
Std 
[
2
H3CO]rapalexin A (103a)  6.1 ± 2.4
b
 
[
2
H3CO]isocyalexin A (104a)  2.3 ± 0.7
b
 
[
2
H3CO]isalexin (102a)  17.3 ± 8.3
c
 
[
2
H3CO]-4'-methoxyindolyl-3'-glycine (107b)  100
c
 
[
2
H3CO]-4'-methoxyindole-3'-carboxaldehyde (190a)  83.7 ± 5.0
c
 
107b 
102a 
104a 103a 
190a 
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The incorporation 4'-methoxyindolyl-3'-glycine (107) into 4-methoxy 
phytoalexins 104, 103 and 102 suggested that 107 is likely a biosynthetic intermediate 
between 4ꞌ-methoxyglucobrassicin (70) and the phytoalexins 104, 103 and 102. 4'-
Methoxyindolyl-3'-glycine (107) is likely derived from 4ꞌ-methoxyglucobrassicin (70) via 
a Neber type rearrangement via azirine intermediate  similar to the base-catalyzed 
chemical hydrolysis of benzylglucosinolate to phenyl glycine (Pedras and Yaya, 2013). 
The next proposed intermediate was 171 (Scheme 2.7), which can be obtained from 107 
via N-oxidative decarboxylation of 107. This transformation was proposed to be similar 
to the transformation of tryptophan (66) to indolyl-3ꞌ-acetaldoxime (122).  
2.2.2.5.8 [2H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-carboxaldehyde oxime 
(171b) 
An aqueous solution of [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-carboxaldehyde 
oxime (171b) (500 µL/hole, 5×10
-4
 M) was added to UV-irradiated slices of rutabaga and 
analyzed as described above (Figure 2.15). The HPLC-ESI-MS analyses of the nonpolar 
fractions that contained phytoalexins showed the rapalexin A (103) peak at tR = 22.3 min 
containing two ions: [M - 1]
-
 at m/z 203 and [M - 1 + 6]
-
 at m/z 209, the latter of which 
was not detected in the control samples.  Peak intensities of the natural abundance and 
those of deuterated ions were used to determine the level of deuterium incorporation. 
Accordingly, the percentage of deuterium incorporation was calculated to be 3.4 ± 2.5%. 
Similarly, using the equation in Table 2.22, the percentage of deuterium incorporation 
into isocyalexin A (104) and isalexin (102) were determined to be 9.0 ± 6.0% and 2.5 ± 
0.6%, respectively. Likewise, the percentage of deuterium incorporation into 4'-
methoxyindole-3'-carboxaldehyde (190a) was calculated to be 52.0 ± 1.0% (Tables 
2.22). The HPLC-ESI-MS analyses of the nonpolar fractions also showed [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carbonitrile (205a) peak at tR = 9.7 min containing two ions: [M 
- 1]
+
 at m/z 171 and [M - 1 + 6]
-
 at m/z 177. The percentage of deuterium incorporation 
was calculated to be 69.0 ± 2.7%. Identical results were obtained from feeding of 
[
2
H3CO]-4'-methoxyindolyl-3'-carboxaldehyde oxime (171a) (Table 2.23). No deuterium 
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incorporations were detected into indole glucosinolates 57, 70 and 69 (Tables 2.22 and 
2.23; Figure 2.28). 
Table 2.22 Metabolites of [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-carboxaldehyde 
oxime (171b) in UV-irradiated rutabaga roots.  
Metabolites detected (#a)
a 
 % Incorporation ± 
Std 
[
2
H3CO,5',6',7'-
2
H3]rapalexin A (103a)  3.4 ± 2.5%
b
 
[
2
H3CO,5',6',7'-
2
H3]isocyalexin A (104a)  9.0 ± 6.0%
b
  
[
2
H3CO,5,6,7-
2
H3]isalexin (102a)  2.5 ± 0.6%
c
 
[
2
Hn]cyclobrassinin (78a)  NI
d
 
[
2
Hn]spirobrassinin (101a)  NI
d
 
[
2
Hn]rutalexin (116a)  NI
d
 
[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde 
oxime (171b)  
100 
[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carbonitrile (205a) 69.0 ± 2.7%
b
 
[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde 
(190a)  
52.0 ± 1.0%
 c
 
[
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172a)  ND
d
  
[
2
Hn]glucobrassicin (57a)  NI
d
 
[
2
Hn]-4'-methoxyglucobrassicin (70a)  NI
d
 
[
2
Hn]-1'-methoxyglucobrassicin (69a)  NI
d
 
a
 Deuterated compounds are referred to by a number followed by the letter a or b. 
b
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 6) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
6) ± Std (standard deviation), where n = number of deuterium atoms. 
d 
NI=no incorporation implies ≤0.1% deuterium; ND=not detected. 
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Table 2.23 Metabolites of [
2
H3CO]-4'-methoxyindolyl-3'-carboxaldehyde oxime 
(171a) in UV-irradiated rutabaga roots.  
Metabolites detected (#a)
a 
 % Incorporation ± 
Std 
[
2
H3CO]rapalexin A (103a)  5.8 ± 2.7
b
 
[
2
H3CO]isocyalexin A (104a)  3.0 ± 0.2
b
  
[
2
H3CO]isalexin (102a)  3.1 ± 1.0
c
 
[
2
H3CO]-4'-methoxyindole-3'-carboxaldehyde oxime (171a)  100 
[
2
H3CO]-4'-methoxyindole-3'-carbonitrile (205a) 69.0 ± 2.7
b
 
[
2
H3CO]-4'-methoxyindole-3'-carboxaldehyde (190a)  73.3 ± 2.5
 c
 
a
 Deuterated compounds are referred to by a number followed by the letter a. 
b
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 3) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
3) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium; ND=not detected. 
 
Figure 2.28 Deuterated phytoalexins obtained from feeding of [
2
H3CO,5',6',7'-
2
H3]-4'-
methoxyindolyl-3'-carboxaldehyde oxime (171b) to UV-irradiated rutabaga root: 
[
2
H3CO,5',6',7'-
2
H3]rapalexin A (103a) (3.4 ± 2.5%), [
2
H3CO,5',6',7'-
2
H3]isocyalexin A 
(104a) (9.0 ± 6.0%), [
2
H3CO,5,6,7-
2
H3]isalexin (102a) (2.5 ± 0.6%), [
2
H3CO,5',6',7'-
2
H3]-
4'-methoxyindole-3'-carboxaldehyde (190a) (52.0 ± 1.0%), [
2
H3CO,5',6',7'-
2
H3]-4'-
methoxyindole-3'-carbonitrile (205a) (69.0 ± 2.7%). 
171b 
205a 
104a 103a 
190a 
102a 
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4'-Methoxyindolyl-3'-carboxaldehyde oxime (171) was proposed to be 
biosynthesized from 4ꞌ-methoxyindolyl-3ꞌ-glycine (107) via oxidative decarboxylation 
(Scheme 2.7) similar to the biosynthesis of indolyl-3ꞌ-acetaldoxime (122) from 
tryptophan (66). Incorporation of 171 into 102, 103 and 104 is in agreement with the 
proposed pathway (Scheme 2.7). Transformation of 171 to rapalexin A (103) isocyalexin 
A (104) and isalexin (102) is likely through the glucosinolate 118 intermediate that can 
give rapalexin A (103) via hydrolysis, followed by Lossen type rearrangement (Pedras 
and Yaya, 2013). Isocyalexin A (104) is likely formed through desulfurization of 
rapalexin A (103) (Pedras and Yaya, 2013). Another possibility is likely via sulfation of 
compound 171 followed by Beckmann type rearrangement. Isalexin (102) is possibly 
derived from rapalexin A (103) through oxidation reaction. 
2.2.2.5.9 Incorporation of [2H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b) 
An aqueous solution of [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b) (500 
µL/hole, 5×10
-4
 M) was added to UV-irradiated slices of rutabaga and analyzed as 
described above (Figure 2.15). The HPLC-ESI-MS analyses of the nonpolar fractions 
that contained phytoalexins showed the rapalexin A (103) peak at tR = 22.3 min 
containing two ions: [M - 1]
-
 at m/z 203 and [M - 1 + 6]
-
 at m/z 209 (resulting from 
incorporation of [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b)) that was not detected 
in the control samples. Peak intensities of the natural abundance and those of deuterated 
ions were used to determine the level of deuterium incorporation as described above. 
Accordingly, the percentage of deuterium incorporation was calculated to be 6.2 ± 4.2%. 
Similarly, the percentages of deuterium incorporation into isalexin (102) and 4ꞌ-
methoxyindole-3'-carbonitrile (205) were calculated to be 7.1 ± 2.9% and 93.0 ± 1.0% 
respectively. Identical results were obtained from feeding of 
[
2
H3CO]desulfoglucorapassicin (172a) (Table 2.25). No deuterium incorporation was 
detected into indole glucosinolates 57, 70 and 69 (Tables 2.24 and 2.25; Figure 2.29).  
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Table 2.24 Metabolites of [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b)   in UV-
irradiated rutabaga roots.  
Metabolites detected (#a)
a 
 % Incorporation 
± Std 
[
2
H3CO,5',6',7'-
2
H3]rapalexin A (103a)  6.2 ± 4.2%
b
 
[
2
H3CO,5',6',7'-
2
H3]isocyalexin A (104a)  NI
d
 
[
2
H3CO,5,6,7-
2
H3]isalexin (102a)  7.1 ± 2.9%
c
 
[
2
Hn]cyclobrassinin (78a)  NI
d
 
[
2
Hn]spirobrassinin (101a)  NI
d
 
[
2
Hn]rutalexin (116a)  NI
d
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107a)  ND
d
 
[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime 
(171a)  
ND
d
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3ꞌ-carbonitrile (205a) 93.0 ± 1.0%
b 
 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3ꞌ-carboxaldehyde (190a)  ND
d
 
[
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b)  100 
[
2
Hn]glucobrassicin (57a)  NI
d
 
[
2
Hn]-4'-methoxyglucobrassicin (70a)  NI
d
 
[
2
Hn]-1'-methoxyglucobrassicin (69a)  NI
d
 
a
 Deuterated compounds are referred to by a number followed by the letter a or b. 
b
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 6) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
6) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium; ND=not detected. 
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Table 2.25 Metabolites of [
2
H3CO]desulfoglucorapassicin (172a)   in UV-irradiated 
rutabaga roots.  
Metabolites detected (#a)
a 
 % Incorporation ± Std 
[
2
H3CO]rapalexin A (103a)  25.3 ± 8.4
b
 
[
2
H3CO]isalexin (102a)  6.7 ± 0.4
c
 
[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carbonitrile (205a) 87.7.0 ± 1.5
b 
 
[
2
H3CO]desulfoglucorapassicin (172b)  100 
a
 Deuterated compounds are referred to by a number followed by the letter a. 
b
 Negative ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M-1 + n]
−
/([M-1]
−
 + [M-1 + n]
−
)} × 100 (n = 3) ± 
Std (standard deviation), where n = number of deuterium atoms. 
c 
Positive ion mode. Incorporations calculated from HPLC-ESI-MS (normalized peak 
intensities); % of 
2
H incorporation = {[M + 1 + n]
+
/([M + 1]
+
 + [M + 1 + n]
+
)} × 100 (n = 
3) ± Std (standard deviation), where n = number of deuterium atoms. 
d NI=no incorporation implies ≤0.1% deuterium; ND=not detected. 
 
Figure 2.29 Deuterated metabolites obtained from feeding of [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b) to UV-irradiated rutabaga root: [
2
H3CO,5',6',7'-
2
H3]rapalexin A (103a) (6.2 ± 4.2%), [
2
H3CO,5,6,7-
2
H3]isalexin (102a) (7.1 ± 2.9%), 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindole-3'-carbonitrile (205a) (93.0 ± 1.0%). 
Transformation of 172 to 103 was proposed to occur through enzymatic 
hydrolysis followed by Lossen type rearrangement, similar to proposed transformation of 
69 to 165 (Pedras, Okinyo et al., 2009; Pedras, Yaya et al., 2010) (Scheme 2.5). The lack 
of incorporation of 172 into isocyalexin A (104) suggested that the biosynthetic pathways 
towards 103 and 104 split at the oxime (171) stage (both 171 and 107 were incorporated 
into 104). Biosynthesis of 103 requires additional intermediate 118 that may be 
biosynthesized from 172 (Pedras and Yaya, 2013) (Scheme 2.7).  
172b 102a 103a 205a 
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2.2.2.5.10 Incorporation of [2H3CO]rapalexin A (103a) 
The structural closeness between rapalexin A (103) and isocyalexin A (104) 
suggested rapalexin A was a biosynthetic precursor of 104. It was assumed that 
desulfurization on the side chain of 103 would give isocyalexin A 104. In order to prove 
this hypothesis, a feeding experiment was conducted using labeled 103. An aqueous 
solution of [
2
H3CO]rapalexin A (103a) (500 µL/hole, 5×10
-4
 M) was added to UV-
irradiated slices of rutabaga and analyzed as described in Figure 2.15. The HPLC-ESI-
MS analyses of the nonpolar extracts that contained phytoalexins revealed the isocyalexin 
A (104) peak at tR = 12.3 min containing [M - 1]
-
 at m/z 171. However, no ion [M - 1 + 
3]
-
 at m/z 174 was detected. This suggests that biosynthetic route of 104 is not through 
rapalexin A (103). In contrast, the isalexin (102) peak at tR = 2.0 min showed two ions: 
[M + 1]
+
 at m/z 178 and [M + 1 + 3]
-
 at m/z 181, the latter of which was not detected in 
the control sample. Peak intensities were measured and the percentage of deuterium 
incorporation was calculated as described above to be 60.0 ± 8.0% (Figure 2.30). This 
transformation is due to oxidation of rapalexin A (103) at C-2 and C-3. 
 
Figure 2.30 Deuterated phytoalexin obtained from feeding of [
2
H3CO]rapalexin A 
(103a) to UV-irradiated rutabaga root: [
2
H3CO]isalexin (102a) (60.0 ± 8.0%). 
2.2.2.5.11 Feeding of [4',5',6',7'-2H4]indole desulfoglucosinolate (186a), 
[4',5',6',7'-
2
H4]indolyl-3'-glycine (185a), [
2
H3CO]-4'-methoxyindolyl-3ꞌ-acetonitrile 
(135a), [
2
H3CO]-4'-methoxyindole-3'-carboxaldehyde (190a), [4',5',6',7'-
2
H4]indole-
3'-carboxaldehyde oxime (176a), [
2
H3CO]-4-methoxyindole (149a)  
Biosynthetic intermediates of rapalexin A (103), isocyalexin A (104) and isalexin 
(102) were confirmed using the labeled compounds [4',5',6',7'-
2
H4]indole 
desulfoglucosinolate (186a), [4',5',6',7'-
2
H4]indolyl-3'-glycine (185a), [
2
H3CO]-4'-
methoxyindolyl-3ꞌ-acetonitrile (135a), [2H3CO]-4'-methoxyindole-3'-carboxaldehyde 
102a 103a 104a 
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(190a), [4',5',6',7'-
2
H4]indole-3'-carboxaldehyde oxime (176a) and [
2
H3CO]-4-
methoxyindole (149a) (Figure 2.31). As it has been described in Figure 2.15, an aqueous 
solution of each precursor (500 µL/hole, 5×10
-4
 M) was added to UV-irradiated slices of 
rutabagas and analyzed. HPLC-ESI-MS analyses of the non-polar and polar extracts 
revealed no deuterium incorporation into the phytoalexins. These results suggest that 
biosynthetic enzymes downstream of 4ꞌ-methoxyglucobrassicin (70) are selective. 
 
Figure 2.31 Labeled compounds for biosynthetic study. 
2.2.2.6 Conclusion 
Biosynthetic intermediates of novel cruciferous phytoalexins isolated from 
rutabaga were established using labeled (
2
H, 
13
C, 
15
N) synthetic and commercially 
available precursors. The incorporation of L-[2',4',5',6',7'-
2
H5]tryptophan (66a) into 
rutabaga phytoalexins (spirobrassinin (101), cyclobrassinin (78), rutalexin (116), 
rapalexin A (103), isocyalexin A (104) and isalexin (102) as well as indole 
glucosinolates, glucobrassicin (57), 4ꞌ-methoxyglucobrassicin (70) and 1ꞌ-methoxy 
glucobrassicin (69) show that the indolyl moiety of these metabolites derives from L-
tryptophan (66) (Pedras, Yaya et al., 2011) (Scheme 2.14). 
Intact incorporation of [2,2,4',5',6',7'-
2
H6]glucobrassicin (57b) into spirobrassinin 
(101), cyclobrassinin (78), rutalexin (116) shows the biosynthetic relationship between 
indole glucosinolates and cruciferous phytoalexins (Pedras and Yaya, 2013; Pedras, Yaya 
149a 190a 
185a 186a 176a 
135a 
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et al., 2010). The same transformation was confirmed using salt cress leaves, in which 
phytoalexins and indole glucosinolates incorporated glucobrassicin (57). The first step is 
oxidations and subsequent methylations of glucobrassicin (57) into 1ꞌ- and 4ꞌ 
methoxyglucobrassicins (69 and 70), which are precursors for 1 and 4-methoxy 
phytoalexins respectively (Pedras and Yaya, 2013; Pedras, Yaya et al., 2010). 
Glucobrassicins (57, 70, 69) are hydrolyzed by myrosinase to give unstable intermediates 
aglycones, which rearrange into the corresponding indolyl-3ꞌ-methylisothiocyanates via 
Lossen type rearrangement and then can be thiomethylated in the presence of thiomethyl 
donor (S-adenosyl methionine) to give the corresponding brassinins (45, 108 and 105) 
(Pedras and Yaya, 2013; Pedras, Yaya et al., 2010).  
The origin of side chain carbon and nitrogen atoms of cruciferous phytoalexins 
rapalexin A (103) and isocyalexin A (103) was established by administering 
[
13
C11,
15
N2]tryptophan (66b) to rutabaga roots. Side chain carbon and nitrogen atoms 
were proven to be derived from 66b. 4-Methoxylated phytoalexins were shown to be 
derived from 57 via 70. 4ꞌ-Methoxybrassinin (108) was incorporated into 110 and 113 but 
not into 103 or 104 suggesting the presence of two distinct pathways for the biosynthesis 
of 4-methoxyphytoalexins (Pedras and Yaya, 2013). The novel amino acid 107, oxime 
171 and desulfoglucosinolate 172 were identified as biosynthetic precursors for rapalexin 
A (103) and isalexin (102) while isocyalexin A incorporated only 107 and 171 (Pedras 
and Yaya, 2013) (Scheme 2.14). 
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Scheme 2.14 Biosynthetic pathways of metabolites of rutabaga (Pedras and Yaya, 
2013). 
2.3 General conclusion and future direction 
Considering the number of cruciferous species (ca. 3700), it is surprising that only a 
limited number have been investigated for the production of phytoalexins. Since most 
wild species have not been investigated, B. tournefortii, C. abyssinica, D. tenuifolia and 
D. tenuisiliqua were screened for the production of elicited metabolites. Arvelexin (135) 
was detected in all species and was the only phytoalexin detected in D. tenuifolia. In D. 
tenuisiliqua, arvelexin (135) was produced together with another elicited metabolite, 
1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (tenualexin) (148). 148 is reported here for the first 
time as a phytoalexin. It showed antifungal activity against A. brassicicola, L. maculans, 
R. solani and S. sclerotiorum, strongly inhibiting their mycelial growth. The inhibition 
effect was stronger compared to 1ꞌ-methoxyindolyl-3ꞌ-acetonitrile (67) and 4ꞌ-
methoxyindolyl-3ꞌ-acetonitrile (135), suggesting that dimethoxysubstitution is important 
102 
172 
171 
107 
104 
66 57 70 108 110 
113 
103 
135 
 
for antifungal inhibition. Indolyl-3ꞌ-acetonitrile (67) is derived from glucobrassicin (57), 
while 4ꞌ-methoxyglucobrassicin (70) is a precursor of 4ꞌ-methoxyindolyl-3ꞌ-acetonitrile 
(135). By analogy, 1ꞌ,4ꞌ-dimethoxyglucobrassicin is proposed to be the biosynthetic 
precursor of (148). The similarity in the metabolic profiles of wild crucifers (C. 
abyssinica and B. tournefortii) and cultivated species indicates that they may share 
common biosynthetic intermediates. As crucifers produce a mixture of phytoalexins, 
whose composition and amounts depend on the type of stress (Pedras and Yaya, 2010; 
Pedras, Yaya et al., 2011; Pedras, Zheng et al., 2007b), it is worthy to investigate 
different plant tissues using different elicitation techniques. Absence of additional 
phytoalexins in, for example, elicited leaves of D. tenuifolia suggests the need to try 
different elicitation strategies, including UV-light and other heavy metal salt solutions. 
Especially wild crucifers are likely to produce new metabolites, as most of them are not 
yet investigated. 
The incorporation of L-tryptophan (66) into phytoalexins wasalexin A (43), 
wasalexin B (109), biswasalexin A1 (131), biswasalexin A2 (132), isalexin (102), 
rapalexin A (103), isocyalexin A (104), 4ꞌ-methoxycyclobrassinin (110), 4ꞌ-
methoxydehydrocyclobrassinin (113) spirobrassinin (101), rutalexin (116), cyclobrassinin 
(78) and indole glucosinolates glucobrassicin (57), 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-
methoxyglucobrassicin (70) is consistent with previous work (Pedras, Yaya et al., 2011; 
Pedras, Zheng et al., 2007b), showing that L-tryptophan is the primary building block. 
Particularly, intact incorporation of fully labelled L-tryptophan (66b) into cruciferous 
phytoalexins and indole glucosinolates confirmed the origin of the side chain carbon and 
nitrogen atoms (Pedras and Yaya, 2013). Two carbon and nitrogen atoms in indole 
glucosinolate functional group are derived from tryptophan (66) (Pedras and Yaya, 
2013). Phytoalexins side chains are likely formed from the rearrangement of the indole 
glucosinolate functional group. Intact incorporation of hexadeuterated glucobrassicin (57) 
into cruciferous phytoalexins indicated that it is are intermediates in the biosynthesis of 
phytoalexins (Pedras and Yaya, 2013; Pedras, Yaya et al., 2010). 
Incorporation of [
2
H3CS,4',5',6',7'-
2
H4]-1'-methoxybrassinin (105a) into 
wasalexins A (43) and B (109), biswasalexins A1 (131) and A2 (132) suggested that 105 
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is a close biosynthetic precursor that upon successive oxidations and thiomethylation 
gives 43 and 109 (Pedras, Yaya et al., 2010). 1ꞌ-Methoxyglucobrassicin (69) was 
proposed to be a biosynthetic intermediate located between glucobrassicin (57) and 1ꞌ-
methoxybrassinin (105). The first step in the metabolism of 1ꞌ-methoxyglucobrassicin 
(69) into 1ꞌ-methoxybrassinin (105) is a deglucosylation likely catalyzed by a hydrolase 
enzyme to give unstable aglycone (138). This intermediate spontaneously rearranges into 
the corresponding 1ꞌ-methoxyindolyl-3ꞌ-methylisothiocyanate (165) which, in the 
presence of thiomethyl donor (S-adenosyl methionine), could give rise to 1ꞌ-
methoxybrassinin (105) (Pedras, Yaya et al., 2010) (Scheme 2.15). Absence of 
incorporation of [4',5',6',7'-
2
H4]brassinin (45a) into 43, 109, 131 and 132 was consistent 
with a methoxylation of glucobrassicin (57) before functional group modifications 
(Pedras, Yaya et al., 2010). Nevertheless, detection of metabolites 157, 158, 159 and 
metabolic products 101, 155, 156 deriving from brassinin (45) suggests enzymes can take 
brassinin (45) and metabolize it similarly to 1ꞌ-methoxybrassinin (105) (Pedras, Yaya et 
al., 2010). Stages at which oxidations could occur were probed by administering 1'-
methoxy-2'-methyl brassinin (160). Interestingly, no metabolic products were detected, 
which suggested the importance of H-2 of indole for oxidation of the ring and the side 
chain (Pedras, Yaya et al., 2010). L-methionine was found to be methyl source for the 
phytoalexins and indole glucosinolates (Pedras, Yaya et al., 2010). 
 
Scheme 2.15 Metabolism of 1ꞌ-methoxyglucobrassicin (69) to 1ꞌ-methoxybrassinin 
(105) 
69  138  165  
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4ꞌ-Methoxybrassinin (108) was incorporated into 4ꞌ-methoxycyclobrassinin (110) 
and 4ꞌ-methoxydehydrocyclobrassinin (113), but not into rapalexin A (103) or 
isocyalexin A (104), suggesting the presence of two distinct pathways in the biosynthesis 
of 4-methoxyphytoalexins (Pedras and Yaya, 2013). Therefore, 4-methoxyphytoalexins 
were categorized into two groups, the brassinin (45) series and rapalexin A (103) series. 
The brassinin series 4-methoxyphytoalexins includes 4ꞌ-methoxycyclobrassinin (110) and 
4ꞌ-methoxydehydrocyclobrassinin (113), in which the side chain nitrogen is connected to 
the indole ring via a carbon linker. The rapalexin A (103) series are those in which side 
chain nitrogen or oxygen is directly connected to the indole ring (rapalexin A (103), 
isocyalexin A (104) and isalexin (102)). Incorporation of 57 into 110 and 113 occurs 
likely via 70. Hydrolysis of 70 is followed by Lossen type rearrangement to give unstable 
4ꞌ-methoxyindolyl-3ꞌ-isothiocyanate (Scheme 2.15), which converts to 4ꞌ-
methoxybrassinin (108) in the presence of the thiomethyl donor (S-adenosyl methionine) 
(Pedras and Yaya, 2013). In the case of the rapalexin A (103) series, compound 70 likely 
follows a different route that gives 4ꞌ-methoxyindolyl-3ꞌ-glycine (107). 4'-
Methoxyindolyl-3'-glycine (107) is possibly derived from 4ꞌ-methoxyglucobrassicin (70) 
through Neber type rearrangement via an azirine intermediate similar to the base-
catalyzed chemical hydrolysis of benzylglucosinolate to phenylglycine (Pedras and Yaya, 
2013). This was confirmed by the incorporation of 107 into 104, 103 and 102. 4ꞌ-
Methoxyindole-3ꞌ-carboxaldehyde oxime (171) was also incorporated into 104, 103 and 
102, which could be another intermediate likely formed from 107 via N-oxidation 
followed by decarboxylation (Pedras and Yaya, 2013). Desulfoglucorapassicin (172) a 
proposed biosynthetic precursor of rapalexin A (103) was incorporated into 103 and 102, 
but not into 104 suggesting splitting of the biosynthetic pathway, probably at the oxime 
(171) stage (Pedras and Yaya, 2013). In vivo, 172 is likely to derive from 171 via sulphur 
transfer from GSH followed by glucosilation (Pedras and Yaya, 2013), similar to 
glucosinolate biosynthetic pathways (Sønderby, Geu-Flores et al., 2010). Incorporation of 
rapalexin A (103) into 102 shows the biosynthetic link between 102 and 103 (Pedras and 
Yaya, 2012).  
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The biosynthetic route established in this thesis is indicated below (Scheme 2.16). 
L-tryptophan (66) is transformed to glucobrassicin (57) which oxidized at N-1 and C-4 to 
give 1ꞌ-methoxyglucobrassicin (69) and 4ꞌ-methoxyglucobrassicin (70), respectively. 
Glucosinolates 57, 69 and 70 are first hydrolyzed to give unstable aglycon intermediates, 
which subjected to rearrangements and thiomethylation to give brassinins (45, 105 and 
108), respectively (Pedras and Yaya, 2013; Pedras, Yaya et al., 2010). 1ꞌ-
methoxybrassinin 105 is further oxidized and methylated to give wasalexin A (43) and 
wasalexin B (109) (Pedras, Yaya et al., 2010). Metabolite 43 is transformed to 
biswasalexins A1 (131) and A2 (132) via dimerization (Pedras, Yaya et al., 2010; Pedras, 
Zheng et al., 2009). 4ꞌ-Methoxybrassinin (108) is a biosynthetic precursor for 4ꞌ-
methoxycyclobrassinin (110) and 4ꞌ-methoxydehydrocyclobrassinin (113) (Pedras and 
Yaya, 2013). Rapalexin A (103), isocyalexin A (104) and isalexin (102) are derived from 
4ꞌ-methoxyindolyl-3-glycine (107) (Pedras and Yaya, 2013). Compound 107 gives 4ꞌ-
methoxyindole-3ꞌ-carboxaldehyde oxime (171) that metabolized to give isocyalexin A 
(104) via sulfation followed by Beckmann-type rearrangement (Pedras and Yaya, 2012; 
2013). Compound 171 can also be metabolized to give desulfoglucorapassicin (172) 
which is a likely precursor of glucorapassicin (118), whose synthesis was not 
accomplished (Pedras and Yaya, 2013). In vivo hydrolysis of 118 followed by Lossen 
type rearrangement would give rapalexin A (103) that can be oxidized to isalexin A (102) 
(Pedras and Yaya, 2013).  
Even though the major part of the biosynthetic route of cruciferous phytoalexins 
has been established, there are still a few questions that need to be addressed;  
1. In the biosynthesis of rapalexin A (103), one of the proposed biosynthetic 
precursors is glucorapassicin (118), whose synthesis was not accomplished. A 
synthetic methodology needs to be devised so that its stability under different 
experimental conditions can be studied and it can then be used as a substrate 
for enzyme isolation.  
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2. Otherwise, major questions are related to the biosynthetic enzymes involved 
in biosynthesis of most cruciferous phytoalexins (except camalexin), and the 
enzymes need to be characterized and genes need to be cloned. 
 
Scheme 2.16 Biosynthetic pathways of metabolites of salt cress and rutabaga (Pedras 
and Yaya, 2013; Pedras, Yaya et al., 2011; Pedras, Yaya et al., 2010). 
  
102 
172 
171 
107 
104 
66 57 70 108 110 
45 78 
113 
103 
105 
69 
43/109 
140 
 
3 EXPERIMENTAL 
3.1 General 
All chemicals were purchased from Sigma-Aldrich Canada Ltd., Oakville, ON, or 
Alfa Aesar 26 Parkridge Rd, Ward Hill, USA, except for isotope-labeled compounds that 
were purchased from Cambridge Isotope Laboratories Inc., Andover, MA, and C/D/N 
Isotopes Inc., Pointe-Claire, Quebec. All solvents were HPLC grade and used as such, 
except for THF and Et2O (dried over sodium), CH2Cl2 (dried over CaH2), MeOH (dried 
over CaO) and DMF (dried over molecular sieves).  
Flash column chromatography (FCC) was carried out using silica gel, grade 60, 
230-400 µm. Organic extracts were dried over Na2SO4 and the solvents were removed 
using a rotary evaporator.  
Analytical TLC was performed on pre-coated silica gel TLC plates (Merck, 
Kieselgel 60 F254, 5 2 cm 0.2 mm layer thickness) aluminum sheets. The compounds 
were eluted with suitable solvent systems, then visualized under UV light (254/366 nm), 
and by dipping the plates in a 5% (w/v) aqueous phosphomolybdic acid solution 
containing 1% (w/v) cerium(IV) sulfate and 4% (v/v) H2SO4, followed by heating at 260 
ºC. 
PTLC was performed on pre-coated silica gel, (Merck, Kieselgel 60 F254, 20 20 
cm 0.25 mm thickness). The compounds were eluted with suitable solvent systems, 
then visualized under UV light (254/366 nm).  
NMR spectra were recorded on Bruker Avance 500 MHz spectrometers. For 
1
H 
NMR (500 MHz) and 
13
C NMR (125.8 MHz) spectra, the chemical shifts () are reported 
in parts per million (ppm) relative to TMS.  The δ values are referenced to CHCl3 in 
CDCl3 at 7.27 ppm CH3CN in CD3CN at 1.94 ppm, CH3OH in CD3OD at 3.31 or CH2Cl2 
in CD2Cl2 at 5.31. Multiplicities are indicated by the following symbols: s = singlet, d = 
doublet, dd = doublet of doublets, m = multiplet and br = broad. Spin coupling constants 
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(J values) are reported to the nearest 0.5 Hz. For 
13
C NMR (125.8 MHz) the δ values 
are referenced to CDCl3 (77.23 ppm), CD3CN (118.69 ppm), CD3OD (49.15 ppm) or 
CD2Cl2 (53.80). 
Fourier transform infrared (FT-IR) data were acquired on a Bio-Rad FTS-40 
spectrometer and spectra were measured by the diffuse reflectance method on samples 
dispersed in KBr.  
HPLC analysis was carried out with either Agilent 1100 series or Hewlett Packard 
HPLC systems equipped with quaternary pump, auto sampler, diode array detector 
(DAD, wavelength range 190-600 nm), and degasser. Method A  (phytoalexins and non-
polar metabolites) used a Zorbax Eclipse XDB-C18 column (5 µm particle size silica, 
150  4.6 mm I.D.), equipped with an in-line filter, with the mobile phase H2O-CH3OH 
from 50:50 to 0:100, linear gradient for 25 min, and a flow rate of 0.75 ml/min or H2O-
CH3CN (75:25 to 25:75 in 35 min, to 0:100 in 5 min) and a flow rate of 1 mL/min; 
Method B (indolyl glucosinolates and other polar metabolites) used a Zorbax SB-C18 
column (3.5 µm particle size silica, 100  3.0 mm I.D.), equipped with an in-line filter, 
with the mobile phase H2O (with 0.1% TFA) - CH3OH (with 0.1% TFA) from 85:15 to 
70:30 in 25 min, to 50:50 in 5 min, to 40:60 in 5 min and a flow rate of 0.40 ml/min or 
H2O-CH3CN (100:0 to 25:75 in 35 min, to 0:100 in 5 min) and a flow rate of 1 mL/min. 
Samples were dissolved in CH3OH or CH3CN for Method A, and in H2O-CH3OH (1:1) 
for Method B.  
 HPLC-ESI-MS analysis was carried out with an Agilent 1100 series HPLC 
system equipped with an auto sampler, binary pump, degasser, and a diode array detector 
connected directly to a mass detector (Agilent G2440A MSD-Trap-XCT ion trap mass 
spectrometer) with an electrospray ionization (ESI) source. Chromatographic separations 
were carried out at room temperature using an Eclipse XDB-C-18 column (5 m particle 
size silica, 150  4.6 mm I.D.). The mobile phase consisted of a linear gradient of: 
Method A, in H2O (with 0.2% HCO2H) - CH3CN (with 0.2% HCO2H) from 75:25 to 
25:75 in 35 min, to 0:100 in 5 min and a flow rate of 1.0 ml/min; Method B, H2O (with 
0.2% HCO2H) - CH3CN (with 0.2% HCO2H) from 90:10 to 50:50 in 25 min and a flow 
rate of 1.0 ml/min. Data acquisition was carried out in positive and negative polarity 
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modes in a single LC run, and data processing carried out with Agilent Chemstation 
Software. Samples were dissolved in CH3CN for Method A, and in methanol-water 
(50:50) for Method B.  
HPLC-ESI-HRMS was performed on an Agilent HPLC 1100 series directly 
connected to QSTAR XL Systems Mass Spectrometer (Hybrid Quadrupole-TOF 
LC/MS/MS) with turbo spray ESI source. Chromatographic separation was carried out at 
room temperature using a Hypersil ODS C-18 column (5 m particle size silica, 200 
2.1 mm I.D.) or a Hypersil ODS C-18 column (5 m particle size silica, 100 2.1 mm 
I.D.). The mobile phase consisted of a linear gradient of; Method A: 0.1% formic acid in 
water and 0.1% formic acid in acetonitrile (75:25 to 25:75 in 35 min, to 0:100 in 5 min) 
and a flow rate of 0.25 mL/min; Method B: 0.1% formic acid in water and 0.1% formic 
acid in acetonitrile (97:3 to 50:50 in 25 min, to 97:3 in 10 min) and a flow rate of 0.25 
mL/min. Data acquisition was carried out in either positive or negative polarity mode per 
LC run. Data processing was carried out by Analyst QS Software. Samples were 
dissolved in acetonitrile for Method A and in methanol-water (50:50) for Method B. Data 
were presented as measured and calculated values.  
MS [high resolution (HR), electron ionization (EI)] were obtained on a VG 70 SE 
mass spectrometer employing a solids probe. Data were presented as measured and 
calculated values. 
Specific rotation ([α]D was determined at ambient temperature on a DigiPol 781 
automatic polarimeter by using a 1 mL, 10 cm cell at the concentration of c = g/100 mL. 
The unit of [α]D is deg dm
-1
 cm
3
 g
-1
. 
3.1.1 Plant materials and growth conditions 
 Thellungiella salsuginea ecotype Shandong was obtained from TAIR (envelope 
labeled as Thellungiella halophila). Seeds were sown in a perlite and nutrient free LG-3 
soil (Sun Gro Horticulture Canada) in a Petri dish and incubated at 4 °C. After 10 days, 
the Petri dishes containing seeds were transferred to a growth chamber at 16 h of light/8 h 
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of dark, 23 °C day/ 16 °C night, light intensity of 150 μEm-2s-1, and with ambient 
humidity. After seven days, the seedlings were transferred into soil in small pots (50 
pots/tray), and kept under the same conditions. Seeds of sand rocket (Brassica 
tournefortii), Abyssinian mustard (Crambe abyssinica), Diplotaxis tenuisiliqua and 
Diplotaxis tenuifolia were obtained from Plant Gene Resources, AAFC, Saskatoon, 
Canada. The seeds were sown in a commercial potting soil mixture, and plants were 
grown in a growth chamber under controlled environmental conditions for 3-4 weeks. 
Rutabaga roots were purchased from Sobeys or Safeway Saskatoon, Sk.  
3.2 Analysis of antifungal secondary metabolites from wild crucifers 
3.2.1 Time-course analysis 
Plants (B. tournefortii, C. abyssinica, D. tenuisiliqua and D. tenuifolia) 2 to 4 
weeks old were sprayed with CuCl2 (2-10 mM) solution  to the point of run-off and 
incubated in a growth chamber. Leaves from elicited and control plants were harvested at 
24, 72 and 120 h, separately frozen in liquid nitrogen, crushed and extracted with 
methanol (2 x 20 ml) on a shaker for 1 h. Methanol extracts were filtered and 
concentrated under reduced pressure. The residue was washed with dichloromethane (6 
ml) and concentrated. The dichloromethane extract was dissolved in acetonitrile (200 µl) 
and analyzed by HPLC-DAD and HPLC-ESI-MS. The residue was dissolved in 
methanol-water (1:1, 1 mL) and analyzed by HPLC-DAD and HPLC-ESI-MS. Known 
induced compounds were identified by comparing their UV spectra and retention times 
with that of authentic samples. 
3.2.2 TLC biodetection 
A solution of potato dextrose broth (PDB) with double strength was prepared by 
autoclaving a suspension of PDB (4.8 g) in H2O (100 mL), and spores of Cladosporium 
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cucumerinum were added to make a concentration of 1 × 10
6
 spores/mL. Bioassays were 
conducted following previously established method (Pedras and Sorensen, 1998). 
Samples were spotted on 2 × 20 cm TLC plates which were developed using solvent 
system, EtOAc-hexane (60:40). The developed plates were air dried (60 min), were 
sprayed with the spore suspension, and incubated under high humidity in the dark for 36 
h. Control plates were also prepared similarly but without spotting leaf extracts. From 
these experiments, the antifungal areas appeared white (due to inhibition of spore 
germination) against a dark gray background due to fungal growth. The white spots were 
not observed in control plates.   
3.2.3  Isolation of secondary metabolites from Diplotaxis tenuisiliqua 
A large scale experiment was conducted in order to isolate and characterize 
antifungal metabolites from 3 week old plants of D. tenuisiliqua. Plants were elicited 
with CuCl2 (10 mM) solution, leaves were harvested, weighed (300 g) and crushed in 
liquid nitrogen. The crushed leaves were divided into two parts and extracted with 
methanol for overnight. The plant tissue was filtered and the filtrate was concentrated. 
The crude methanol extract was washed with dichloromethane and concentrated. The 
polar residue and the dichloromethane extracts were assayed (TLC biodetection) against 
a fungus, Cladosporium cucumerinum, for the analysis of the antifungal activity. Based 
on the inhibition effect on the fungus, dichloromethane extract was subjected to 
chromatographic purification using FCC (hexane:EtOAc 80:20 to 0:100 and 
CH2Cl2:MeOH 95:5 v/v). The fractions were analyzed by HPLC-DAD and TLC 
biodetection. A fraction containing a peak at tR = 19.7 min and that had shown antifungal 
activity was further purified by FCC (hexane:EtOAc 90:20 to 70:30). Final purification 
of the fraction containing the peak at tR = 19.7 min was carried out using PTLC 
(hexane:EtOAc 85:15) to yield 1ꞌ,4ꞌ-dimethoxyindolyl-3ꞌ-acetonitrile (148) 0.8 mg.  
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3.2.4 Chemical characterization of a metabolite from Diplotaxis tenuisiliqua 
3.2.4.1 1ꞌ,4ꞌ-Dimethoxyindolyl-3ꞌ-acetonitrile (148) 
 
HPLC tR = 19.7 min, method A. 
UV (HPLC, H2O-CH3CN) max (nm): 220, 265, 295. 
FTIR (KBr, cm
-1
) max: 2935, 2359, 1502, 1456, 1303, 1260, 1060, 1033.  
1
H NMR (500 MHz, CDCl3): 1H,  s), 7.18 (1H, dd, J = 8, 8 Hz),7.03 (1H, d, J = 
8 Hz), 6.51 (1H, d, J = 8 Hz), 4.06 (3H, s), 4.02 (2H, s), 3.92 (3H, s). 
13
C NMR (125 MHz, CDCl3) 154.6, 134.0, 124.3, 120.3, 118.9, 112.8, 101.9, 101.1, 
100.2, 66.1, 55.4, 16.1.l. 
HREI-MS m/z calc. for C12H12N2O2: 216.0897 [M]
+
; found 216.0897 (87%), 185.0 
(100%), 170.0 (34%).  
MS-ESI m/z [M+1]
+
 217.0 (100%), 186.0 (20%).  
148 
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3.3 Syntheses of metabolites 
3.3.1 Metabolite of Diplotaxis tenuisiliqua 
3.3.1.1 1ꞌ,4ꞌ-Dimethoxyindolyl-3ꞌ-acetonitrile(148) 
 
Scheme 3.1 Synthesis of 148. Reagents and conditions: i) NaCNBH3, AcOH; ii) 
Na2WO4, H2O2, K2CO3, (CH3)2SO4 41%; iii) POCl3, DMF; iv) CH3NO2, NH4OAc, 105 
ºC; v) NaBH4, THF, MeOH; vi) CS2, Et3N , 40 ºC 77%. 
NaCNBH3 (382 mg, 6.06 mmol) was added portion wise over a period of 10 min 
to a solution of 4-methoxyindole (149) (300 mg, 2.04 mmol) in acetic acid (6 mL) and 
the reaction mixture was stirred at room temperature for 1 hour, diluted with water and 
basified with NaOH, extracted with ether, and the organic phase was dried and 
concentrated to yield crude 4-methoxyindoline (150) 303 mg in 97% yield (Wang, Gao et 
al., 2009). Na2WO4.2H2O (126 mg, 0.38 mmol) in water (1 mL) was added to the stirred 
solution of 4-methoxyindoline (150) (333 mg, 2.25 mmol) in MeOH (8 mL) and cooled 
to -20 

C. A solution of H2O2 (1.5 mL, 19.6 mmol) in MeOH (2 mL) was added drop 
wise to the cooled suspension. The reaction mixture was stirred at room temperature for 
10 min, K2CO3 (2.5 g, 18.11 mmol) and (CH3O)2SO2 (341 L, 3.60 mmol) were added 
under vigorous stirring (Somei and Kawasaki, 1989). After being stirred for 10 min, the 
reaction mixture was diluted with water and extracted with ether (40 mL × 3). The 
148 
149 151  150  152  
153  154  
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organic extract was dried, concentrated and subjected to FCC (CH2Cl2, 100%) to yield 
1,4-dimethoxyindole (151)  (163 mg, 0.92 mmol) in 41% yield. 
 POCl3 (127 L, 1.36 mmol) was added drop wise to a solution of 1,4-
dimethoxyindole (151) (160 mg, 0.91 mmol) in DMF (2 mL) at 0 

C. The reaction 
mixture was stirred for 1 h at room temperature, basified with ammonium hydroxide (28 
%), diluted with water and extracted with ether (30 mL × 3). The organic layer was dried, 
concentrated and subjected to FCC (CH2Cl2-MeOH 98:2) to yield 1ꞌ,4ꞌ-dimethoxyindole-
3ꞌ-carboxaldehyde (152) (149 mg, 0.73 mmol) in 81% yield. 
NH4OAc (26 mg, 0.34 mmol) was added to a solution of 1,4-dimethoxyindolyl-3-
carboxaldehyde (152) (139 mg, 0.68 mmol) in nitromethane (1.5 mL) and refluxed 
(Canoira, Rodriguez et al., 1989; Somei, Sato et al., 1985) at 105 °C for 90 min. The 
reaction mixture was allowed to cool, diluted with water, extracted by CH2Cl2 and 
concentrated to yield crude 1,4-dimethoxy-3-nitrovinyl indole (153), which was taken to 
the next step without further purification. NaBH4 (78 mg, 2.04 mmol) was added to a 
solution of crude 1,4-dimethoxy-3-nitrovinyl indole (153) (169 mg, 0.68 mmol) in THF 
(4 mL) and methanol (500 µL). The reaction mixture was stirred for 3 h at room 
temperature and excess NaBH4 was destroyed by adding water to the reaction mixture. 
The reaction mixture was extracted by CH2Cl2, concentrated and subjected to FCC 
(CH2Cl2, 100%) to yield 1,4-dimethoxy-3-(2ꞌ-nitroethyl) indole (154)  65 mg, 0.38 mmol) 
in 26%.  
Et3N (500 µL, 3.60 mmol) and CS2 (217 µL, 3.60 mmol) were added to a solution 
of 1,4-dimethoxy-3-(2ꞌ-nitroethyl) indole (154) (45 mg, 0.18 mmol) in ACN (4 mL) 
(Somei, Sato et al., 1985). The reaction mixture was stirred at 40 ºC for 20 h in a sealed 
reaction vial, excess solvent was evaporated and the residue was diluted with water and 
extracted by CH2Cl2 (3 × 20 mL). The organic layer was dried, concentrated, the crude 
reaction mixture was purified by FCC (CH2Cl2, 100 %) to yield 1ꞌ,4ꞌ-dimethoxyindolyl-
3ꞌ-acetonitrile (148) (30 mg, 0.14 mmol) as a brown oil in 77% (Scheme 3.1). 
HPLC tR = 19.7 min, method A. 
UV (HPLC, H2O-CH3CN) max (nm): 220, 265, 295. 
FTIR (KBr, cm
-1
) max: 2935, 2359, 1502, 1456, 1303, 1260, 1060, 1033.  
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1
H NMR (500 MHz, CDCl3): 1H,  s), 7.18 (1H, dd, J = 8, 8 Hz),7.03 (1H, d, J = 
8 Hz), 6.51 (1H, d, J = 8 Hz), 4.06 (3H, s), 4.02 (2H, s), 3.92 (3H, s). 
13
C NMR (125 MHz, CDCl3) 154.6, 134.0, 124.3, 120.3, 118.9, 112.8, 101.9, 101.1, 
100.2, 66.1, 55.4, 16.1.l. 
HREI-MS m/z calc. for C12H12N2O2: 216.0897 [M]
+
; found 216.0897 (87%), 185.0 
(100%), 170.0 (34%).  
MS-ESI m/z [M+1]
+
 217.0 (100%), 186.0 (20%).  
3.3.2 Metabolic products of Thellungiella salsuginea (salt cress) 
Administration of perdeuterated brassinin to leaves of salt cress resulted in 
metabolism of brassinin into known as well as new metabolic products. In this section; 
synthesis of the new metabolic products will be described. 
3.3.2.1 Demethoxywasalexins A (157) and B (158) 
 
Scheme 3.2 Synthesis of 157 and 158. Reagents and conditions: i) DMF, POCl3, 45 ºC, 
(aq. NH3, 28%) 67%; ii) NaH, CS2, MeI, THF, 0 ºC; iii) pyridine, NEt3, MeI, CH2Cl2 
53%. 
161  162  163  
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A solution of 2-oxindole (161) (500 mg, 3.80 mmol) in DMF (5 mL) was added 
to a solution of POCl3 (420 µL, 4.50 mmol) in DMF (1 mL) at 45 ºC (Pedras and Suchy, 
2006; Pedras, Yaya et al., 2010; Pedras and Zaharia, 2001). The reaction mixture was 
stirred at 45 ºC for 30 min and cooled down to 0 °C. Cold aq. NH3 (28%) was slowly 
added to the reaction mixture at 0 

C and allowed to warm up to room temperature and 
stirred for 1 h. The mixture was filtered and the filtrate was extracted with EtOAc; the 
organic layer was dried, concentrated and subjected to FCC (EtOAc/Hexane 1:1) to yield 
3-aminomethylene-2-oxindole (162) (400 mg, 2.48 mmol) in 67% . 
NaH (60% suspension in mineral oil, 10 mg, 0.25 mmol) and CS2 (30 L, 0.50 
mmol), were added to a stirred solution of 3-aminomethylene-2-oxindole (162) (80 mg, 
0.50 mmol) in dry THF (1 ml, cooled to 0 °C), and after 10 minutes CH3I (15 L, 0.23 
mmol) was added (Pedras and Suchy, 2006; Pedras, Yaya et al., 2010). The mixture was 
stirred for 30 min at 0 °C, diluted with brine (10 ml), extracted (EtOAc) and the 
combined organic extract was dried and concentrated to yield crude (E,Z)-methyl ((2-
oxoindolin-3-ylidene)methyl)carbamodithioate (163). Pyridine (30 l, 0.37 mmol) and 
Et3N  (50 l, 0.36 mmol) were added to the solution of (E,Z)-methyl ((2-oxoindolin-3-
ylidene)methyl)carbamodithioate (163)  (10 mg, 0.04 mmol) in CH2Cl2 (3 ml) and the 
reaction mixture was stirred at 30 °C for 10 min. MeI (8 l, 0.13 mmol) was added to the 
reaction mixture and the solution was stirred for 14 h at 30 °C. The reaction mixture was 
diluted with brine, extracted with EtOAc, and the organic extract was concentrated. After 
separation of the extract by prep TLC, demethoxywasalexins A (157) and B (158) 
(yellow solid, mixture of E and Z isomers 4:1) was obtained in 53% yield (5 mg, 0.02 
mmol) (Pedras, Yaya et al., 2010) (Scheme 3.2). 
M.P. 207-209 ºC 
HPLC tR = 15.3; 16.2 min, method A.  
UV (CH3CN) max (nm): 254, 286, 362.  
FTIR (KBr, cm
-1
) max: 3167, 2918, 1695, 1624, 1613, 1466, 1176, 935, 781. 
1
H NMR (500 MHz, CD2Cl2) 8.00 (1 H, s), 7.88 (1H, s, D2O exchangeable), 7.86 (1H, d, 
J = 7.5 Hz), 7.18 (1H, dd, J = 7.5, 7.5 Hz), 6.99 (1H, dd, J = 7.5, 7.5 Hz), 6.86 (1H, d, J = 
8 Hz), 2.69 (6H, s).  
150 
 
13
C NMR (125.8 MHz, CD2Cl2) 176.6, 170.8, 140.4, 138.7, 128.7, 125.1, 123.6, 122.3, 
119.5, 109.7, 16.2 (2C).  
HREI-MS m/z calc. for C12H12N2OS2: 264.0391 [M]
+
; found 264.0396 (57%), 271.0 
(100%), 202.0 (43%), 144.0 (24%).  
MS-ESI m/z [M+1]
+
 265.0 (100%), 217.0 (64%).  
3.3.2.2 Demethoxydihydrowasalexin (159) 
 
Scheme 3.3 Synthesis of 159. Reagents and conditions: i) DMF, POCl3, 45 ºC, (aq. 
NH3, 28%); ii) NaH, CS2, MeI, THF, 0 ºC; iii) NaCNBH3, AcOH, 60 ºC, 55%; (iv) 
K2CO3, (CH3O)2SO2, acetone, 30 ºC, 58%. 
NaBH3CN (90 mg, 1.42 mmol) was added to a solution of methyl ((2-oxoindolin-
3-ylidene)methyl)carbamodithioate (163) (18 mg, 0.07 mmol) in AcOH (1.0 ml). The 
mixture was stirred at 60 °C for 18 h, was diluted with water (3 ml) and the pH of the 
solution was adjusted to 6 with Na2CO3 (sat. solution) and the solution was extracted 
(EtOAc). The combined organic extract was concentrated and the residue was subjected 
to FCC (EtOAc-hexane, 3:7) to yield methyl ((2-oxoindolin-3-
yl)methyl)carbamodithioate (164) (10 mg, 0.04 mmol) in 55%. Dimethylsulfate (4 l, 
0.04 mmol) and K2CO3 (6 mg, 0.04 mmol) were added to a solution of methyl ((2-
oxoindolin-3-yl)methyl)carbamodithioate (164) (8 mg, 0.03 mmol) in acetone (200 l) 
and the mixture was stirred at 30 ºC for 20 h. The reaction mixture was concentrated, 
161  162  163  
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then diluted with water (3 ml) and extracted with EtOAc. The combined organic extract 
was dried, was concentrated and the residue was subjected to FCC (EtO2) to afford 
demethoxydihydrowasalexin (159) (yellow solid, 5 mg, 0.02 mmol) in 58% (Pedras, 
Yaya et al., 2010) (Scheme 3.3). 
M.P. 172-174 ºC 
HPLC tR = 14.8 min, method A.  
UV (CH3CN) max (nm): 242.  
FTIR (KBr, cm
-1
) max: 3180, 2922, 2851, 1703, 1621, 1574, 1468, 747.  
1
H NMR (500 MHz, CD2Cl2) 7.95 (1 H, s), 7.29 (1H, d, J = 7.5 Hz), 7.20 (1H, dd, J = 
7.5, 7.5 Hz), 6.99 (1H, dd, J = 7.5, 7.5 Hz), 6.86 (1H, d, J = 7.5 Hz), 3.98 (1H, dd, J = 14, 
3 Hz), 3.81-3.74 (2H, m), 2.51 (3H, s), 2.19 (3H, s).  
13
C NMR (125.8 MHz, CD2Cl2) 178.7, 142.6, 129.9, 128.4, 125.2, 122.6, 118.5, 109.6, 
53.6, 47.9, 15.2, 14.9.  
HREI-MS m/z calc. for C12H14N2OS2: 266.0548; found 266.0542 (6%), 146.0 (100%).  
MS-ESI m/z [M+1]
+
 267 (100%), 219 (47%), 146 (50%).  
3.3.3 Metabolites of rutabaga and analogous 
In this section synthesis of two new metabolites that were isolated from rutabaga, 
and their analogues will be described.   
3.3.3.1 4ꞌ-Methoxyindolyl-3ꞌ-formamide (168) 
 
Scheme 3.4 Synthesis of 4ꞌ-Methoxyindolyl-3ꞌ-formamide 168. Reagents and 
conditions: i) TTFA/TFA, I2/CuI, NaOCH3, 64%; ii) Pd/C-H2, acetic-formic anhydride, -
10 °C, 66% 
166 167 168 206 
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TTFA (503 mg, 0.93 mmol) was added to a solution of 3-nitroindole (166) (100 
mg, 0.62 mmol) in TFA (3 mL) and the reaction mixture was stirred for 4 h at 30 °C. The 
solvent was evaporated under reduced pressure, I2 (472 mg, 1.86 mmol) and CuI (472 
mg, 2.48 mmol) in DMF (4 mL) were added to the reaction mixture and the mixture was 
stirred for 1 h at 25 °C. NaOCH3 (prepared from Na, 800 mg, 34.80 mmol, in anhydrous 
MeOH, 5 mL) was added to the reaction mixture and the mixture was refluxed at 110 °C 
for 1 h. The reaction mixture was neutralized (pH 7, HCl, 1 M), filtered through celite 
and the solvent was evaporated. The residue was taken in water, extracted with EtOAc, 
dried, concentrated and the crude product was subjected to FCC (EtOAc-hex, 1:1) to 
yield 4-methoxy-3-nitroindole (167) (77 mg, 0.40 mmol) in 64% yield. 
Procedure A: Pd/C (52 mg) was added to a solution of 4-methoxy-3-nitroindole 
(167) (52 mg, 0.27 mmol) in EtOH (1 mL) and reaction mixture was stirred under H2 at 
balloon pressure for 5 h. The reaction mixture was cooled to -10 °C, Et3N (112 µL, 0.81 
mmol) and a solution of HCO2H/Ac2O (1:0.8, 2 mL) were added and the mixture was 
further stirred for 1 h, while allowing the temperature to rise to 0 °C. The reaction 
mixture was diluted with water, extracted with CH2Cl2, the organic phase was dried, 
concentrated and the crude product was subjected to FCC (CH2Cl2:MeOH, 98:2) to yield 
4ꞌ-methoxyindolyl-3ꞌ-formamide (168) (24 mg, 0.13 mmol) in 47% yield(Pedras and 
Yaya, 2012). 
Procedure B: Pd/C (20 mg) was added to a solution of 4-methoxy-3-nitroindole 
(167) (20 mg, 0.10 mmol) in MeOH (1 mL) and solution of HCO2H/Ac2O (1.5:1) (55 µL, 
0.62 mmol). The reaction mixture was stirred under H2 at balloon pressure for 3 h at -10 
°C and allowed to warm up to 10 °C for an additional 1 h. The reaction mixture was 
diluted with water, extracted with CH2Cl2, the organic phase was dried, concentrated and 
the crude product was subjected to FCC (CH2Cl2:MeOH, 98:2) to yield 4ꞌ-
methoxyindolyl-3ꞌ-formamide (168) (12.6 mg 0.07 mmol) in 66 % yield and 4ꞌ-
methoxyindolyl-3ꞌ-acetamide (206) (1.4 mg, 0.007) in 7% yield (Pedras and Yaya, 2012) 
(Scheme 3.4). 
HPLC tR = 5.6 min, method A.  
UV (CH3OH-H2O, HPLC) λmax (nm): 223, 250, 285.  
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FTIR (KBr, cm
-1) νmax: 3399, 3302, 1661, 1502, 1263, 1085.  
1
H NMR (500 MHz, CD3OD) δ 8.25 (1H, s), 7.68 (1H, s), 7.00 (1H, dd, J = 8, 8 Hz), 
6.91 (1H, d, J = 8 Hz), 6.46 (1H, d, J = 7.5 Hz), 3.93 (3H, s).  
13
C NMR (125.8 MHz, CD3OD) δ 160.5, 155.0, 136.6, 124.1, 115.5, 115.1, 111.3, 106.0, 
99.9, 55.7.  
HRMS-EI m/z 190.0736 [M]
+
, calcd. for C10H10N2O2 190.0742 (100%), 162.08 (20%), 
147.0557 (74%).  
HPLC-MS-ESI m/z [M+H]+ 191.2 (40%), 163.2 (100%). 
3.3.3.2 Isocyalexin A (104) 
 
Scheme 3.5 Synthesis of isocyalexin A 104. Reagents and conditions: i) POCl3, THF, 
EtN3, 0 °C; 10% aq Na2CO3, 41%.  
Freshly distilled POCl3 (22 µL, 0.23 mmol) was added to a stirred solution of 4ꞌ-
methoxyindole-3ꞌ-formamide (168) (22 mg, 0.11 mmol) and Et3N (48 µL, 0.34 mmol) in 
THF (1 mL) at 0 °C under inert atmosphere. The reaction mixture was stirred for 1 h at 0 
°C, was neutralized (10% aq Na2CO3) and stirred for 30 min at room temperature. The 
reaction mixture was diluted with water, extracted with CH2Cl2, the organic layer was 
dried, concentrated, and the crude product was subjected to FCC (CH2Cl2 100%) to yield 
isocyalexin A (104) (8 mg, 0.05 mmol) in 41% yield (Pedras and Yaya, 2012) (Scheme 
3.5). 
HPLC tR= 11.0 min, method A.  
UV (CH3CN-H2O) λmax (nm):  220, 269.  
FTIR (KBr, cm
-1) νmax: 3305, 3129, 2964, 2134, 1592, 1514, 1447, 1366, 1336, 1272, 
1079. 
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1
H NMR (500 MHz, CD3OD) δ 7.45 (1H, s), 7.10 (1H, dd, J = 8, 8 Hz), 6.97 (1H, d, J = 
8.5 Hz), 6.58 (1H, d, J = 8 Hz), 3.91 (3H, s).  
13
C NMR (125.8 MHz, CD3OD) δ 164.1, 154.8, 137.3, 125.5, 124.3, 113.9, 106.4, 103.2 
(JC-3-N = 15 Hz), 102.1, 56.0.  
HREI-MS m/z 172.0633 (M)
+
, calcd for C10H8N2O 172.0632 (100%), 157.04 (69%), 
129.05 (69%).  
HPLC-MS-ESI m/z [M-H]
-
, 171.1 (11%), 156.0 (100%). 
3.3.3.3 Indolyl-3ꞌ-formamide (169) 
 
Scheme 3.6 Synthesis of indolyl-3ꞌ-formamide 169. Reagents and conditions: ii) Pd/C-
H2, acetic-formic anhydride, -10 °C, 64%.  
Procedure A: Pd/C (50 mg) was added to a solution of 3-nitroindole (166) (50 
mg, 0.31 mmol) in EtOH (1 mL) and the reaction mixture was stirred under H2 at balloon 
pressure for 5 h. The reaction mixture was cooled to -10 °C, Et3N (129 µL, 0.93 mmol) 
and HCO2H/Ac2O (1:0.8, 2 mL) were added and the reaction mixture was further stirred 
for 1 h, while temperature was allowed to warm up to 0 °C. The reaction mixture was 
diluted with water, extracted with CH2Cl2, the organic phase was dried, concentrated and 
the crude product was subjected to FCC (CH2Cl2:EtOAC, 8:2) to yield indolyl-3-
formamide (169) (12.5 mg, 0.08 mmol) in 25% yield and indolyl-3-acetamide (207) (5.2 
mg, 0.03 mmol) in 9% yield (Pedras and Yaya, 2012). 
Procedure B: Pd/C (25 mg) was added to a solution of 3-nitroindole (166) (20 
mg, 0.12 mmol) in MeOH (1 mL) and HCO2H/Ac2O (1.5:1) (100 µL, 1.12 mmol). The 
reaction mixture was stirred under H2 balloon pressure for 3 h at -10 °C and allowed to 
warm up to 10 °C for an additional 1 h. The reaction mixture was diluted with water, 
extracted by CH2Cl2, the organic phase was dried over Na2SO4 and concentrated to yield 
169 166 207 
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indolyl-3ꞌ-formamide (169) (13 mg, 0.08 mmol) in 64% yield and indolyl-3ꞌ-acetamide 
(207) 4 mg, (0.02) in 18% yield (Pedras and Yaya, 2012) (Scheme 3.6). 
HPLC tR= 4.2 min, method A. 
UV (CH3OH-H2O, HPLC) λmax (nm): 222, 260.  
FTIR (KBr, cm
-1
) νmax (cm
-1
): 3263, 3057, 2922, 1665, 1565, 1458, 1385, 1237.  
1
H NMR (500 MHz, CD3OD) δ 8.27 (1H, s), 7.69 (1H, s), 7.60 (1H, d, J = 8 Hz), 7.32 
(1H, d, J = 8 Hz), 7.12 (1H, dd, J = 8, 7 Hz), 7.02 (1H, dd, J = 8, 7 Hz).  
13
C NMR (125.8 MHz, CD3OD) δ 160.7, 135.6, 123.2, 122.0, 120.1, 118.1, 117.5, 114.7, 
112.5. 
 HRMS-EI m/z 160.0635 [M]
+
, calcd. for C9H8N2O 160.0637 (100%), 131.06 (59%), 
104.05 (26%).  
HPLC-ESI-MS m/z [M+H]
+
, 161.3 (50%), 134.3 (100%). 
3.3.3.4 Indolyl-3-isonitrile (170) 
 
Scheme 3.7 Synthesis of indolyl-3-isonitrile 170. Reagents and conditions: i) POCl3, 
THF, EtN3, 0 °C; 10% aq Na2CO3, 54%.  
Freshly distilled POCl3 (35 µL, 0.38 mmol) was added to a stirred solution of 
indolyl-3ꞌ-formamide (169) (30 mg, 0.19 mmol) and Et3N (78 µL, 0.56 mmol) in THF (1 
mL) at 0 °C under inert atmosphere. The reaction mixture was stirred for 1 h at 0 °C, 
neutralized (10% aq. Na2CO3) and further stirred for 30 min at room temperature. The 
reaction mixture was diluted with water (5 mL), extracted with CH2Cl2, the organic layer 
was dried, concentrated and the crude product was subjected to FCC (CH2Cl2, 100 %) to 
yield indolyl-3-isonitrile (170) (14 mg, 0.10 mmol) in 53% yield (Pedras and Yaya, 2012) 
(Scheme 3.7).   
HPLC tR= 10.3 min, method A.  
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UV (CH3OH-H2O, HPLC) λmax (nm): 240, 279.  
FTIR (KBr, cm
-1) νmax: 3217, 2144, 1436, 1339, 1241.  
1
H NMR (500 MHz, CD3OD) δ 7.57 (1H, s), 7.55 (1H, d, J = 8 Hz), 7.39 (1H, d, J = 8 
Hz), 7.20 (1H, dd, J = 7, 8,  Hz), 7.15 (1H, dd, J = 7, 8, Hz).  
13
C NMR (125.8 MHz, CD3OD) δ 165.3, 135.7, 124.8, 124.6, 124.2, 122.1, 118.2, 113.4, 
104.3 (t, 16 Hz, C-3).  
HRMS-EI m/z 142.0531 [M]
+
, calcd. for C9H6N2 142.0531 (100%), 115.04 (44%).  
HPLC-MS-ESI m/z [M-H]
-
 141.0 (100%). 
3.4 Syntheses of compounds 
3.4.1 Synthesis of labeled compounds  
3.4.1.1 [4,5,6,7-2H4]Indole (120a) 
 
Scheme 3.8 Syntheses of 120a. Reagents and conditions: i) ClCH2CN, NaOH, 49%; ii) 
Pd/C, AcOH, EtOAc, 68%. 
[4,5,6,7-
2
H4]indole (120a) was synthesized from [2,3,4,5,6,-
2
H5]nitrobenzene 
(173a) by modifying a procedure reported by Pedras and Okinyo (Pedras and Okinyo, 
2006c). A solution of [2,3,4,5,6,-
2
H5]nitrobenzene (173a) (4.0 mL, 39.00 mmol) and 
chloroacetonitrile (246 μL, 3.90 mmol) in DMSO (3.9 mL) was added drop wise over 30 
min to a thoroughly stirred suspension of NaOH (1.56 g, 39.00 mmol) in DMSO (4 mL) 
at room temperature (Makosza and Winiarski, 1984). After 1 hour, the reaction mixture 
was quenched with ice-cold HCl (35 mL, 1 M), was diluted with H2O (20 mL), and was 
extracted with CHCl3 (50 mL  3). The combined organic extract was washed with H2O, 
dried, concentrated and subjected to FCC (hexane-EtOAc, 5:1) to yield a mixture of 
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[3,4,5,6-
2
H4]-2-nitrophenylacetonitrile and [2,3,5,6-
2
H4]-4-nitrophenylacetonitrile (174) 
(in a 10:1 ratio, 49% yield). 
10% Pd/C (40 mg) was added to the solution of [3,4,5,6-
2
H4]-2-
nitrophenylacetonitrile and [2,3,5,6-
2
H4]-4-nitrophenylacetonitrile (174) (106 mg, 0.64 
mmol) in freshly distilled EtOAc (6 mL) and AcOH (177 L) and the resulting reaction 
mixture was stirred under H2 atmosphere (balloon pressure) at rt. After 16 h, the catalyst 
was filtered off, the filtrate was concentrated, the residue was taken in CH2Cl2 (20 mL), 
was washed with HCl (10 mL × 2, 1M). The organic layer was dried, and concentrated 
under reduced pressure to yield [4,5,6,7-
2
H4]indole (120a) (53 mg, 0.44) 69% yield 
(Scheme 3.8). 
HPLC-DAD, tR = 13.9 min, method A.  
UV (CH3CN-H2O) λmax (nm): 215, 275 
1
H NMR (500 MHz CDCl3) 8.14 (brs, NH), 7.23 (brs, 1H), 6.59 (brs, 1H). 
HR-EIMS m/z measured 121.08293 calcd for C8H3
2
H4N 121.008295 (100%), 94.07 (22). 
3.4.1.2 [4',5',6',7'-2H4]Indoledesulfoglucosinolate (186a) 
 
Scheme 3.9 Syntheses of 186a. Reagents and conditions: i) Na2CO3, NH2OH.HCl, 70 
°C; ii) NCS, pyridine, CH2Cl2; iii) 1-thio-β-D-glucopyranose-2,3,4,6-tetraacetate, NEt3, 
22%; iv) KOCH3, MeOH quant. 
175a  176a  180a  183a  
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To a solution of [4',5',6',7'-
2
H4]indole-3ꞌ-carboxaldehyde (175a) (39 mg, 0.26 
mmol) in EtOH (2 mL), a solution of Na2CO3 (28 mg, 0.26 mmol) and NH2OH.HCl (36 
mg, 0.52 mmol) in water (1 mL) was added and stirred at 70 °C for 3 h. EtOH was 
removed, the reaction mixture was diluted with water and extracted with EtOAc. The 
organic layer was dried and concentrated under reduced pressure to yield [4',5',6',7'-
2
H4]indole-3'-carboxaldehyde oxime (176a) quantitatively.  
NCS (27 mg, 0.20 mmol) was added to a solution of [4',5',6',7'-
2
H4]indole-3-
carboxaldoxime (176a) (28 mg, 0.17 mmol) in pyridine (100 µL) and CH2Cl2 (1 mL) at 0 
°C. The reaction mixture was stirred for 30 min at rt, 1-thio--D-glucopyranose-2,3,4,6-
tetraacetate (37 mg, 0.10 mmol) in CH2Cl2 (0.2 mL) was added, and then Et3N (71 µL, 
0.51 mmol) and the reaction mixture was stirred for 3 h at rt. The reaction mixture was 
diluted with water, extracted with CH2Cl2, the organic layer was dried and concentrated. 
The residue was subjected to FCC (EtOAc-Hex, 1:1) to yield [4',5',6',7'-
2
H4]indolyl-3'-
tetraacetyl glucocarboxythiohydroxamate (183a) (20 mg, 0.04 mmol, 22% from oxime).  
KOCH3 (75µL, 1 mM) was added to the solution of compound (183a) (20 mg, 
0.04 mmol) in anhydrous MeOH (1 mL). The reaction mixture was stirred for 30 min and 
neutralized with acetic acid. The solvent was evaporated, the residue was dissolved in 
water and freeze dried to yield [4',5',6',7'-
2
H4]indole desulfoglucosinolate (186a)  in 
quantitative yield (22 mg, 0.06 mmol) (Scheme 3.9).  
HPLC tR=6.1 min, method B.  
UV (CH3CN-H2O) max (nm): 270.  
1
H NMR  (500 MHz, CD3OD) 7.71 (1H, s), 4.54 (1H, d, J = 10 Hz), 3.66 (1H, dd, J = 
12, 2 Hz), 3.56 (1H, dd, J = 12, 5.5 Hz), 3.28-3.15 (2H, m), 3.15 (1H, dd, 9, 9 Hz), 2.77 
(1H, m).  
HR-ESI-MS m/z 397.0769 [M+K]
+
, calcd for C15H14
2
H4N2O6SK 397.0768 (28%), 224.11 
(100%).  
ESI-MS m/z: [M+1]
+
 197.1 (100%), 359.1 (96%).  
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3.4.1.3 Indoledesulfoglucosinolate (186) 
 
Indoledesulfoglucosinolate (186) was first synthesized by Rollin‘s group 
(Brochard, Joseph et al., 1994) as a standard for HPLC analysis of natural glucosinolates. 
A solution of NH2OH.HCl (95 mg. 1.37 mmol) and Na2CO3 (73 mg, 0.69 mmol) in water 
(1 ml) was added to a solution of indole-3ꞌ-carboxaldehyde (175) (100mg, 0.69 mmol) in 
EtOH (3 ml) and stirring at 70 ºC for 3 h. Excess EtOH was removed, the reaction 
mixture was diluted with water, extracted with EtOAc, the organic extract was dried and 
concentrated to yield indole-3ꞌ-carboxaldehyde oxime (176) (110 mg, 0.69 mmol) in 
quantitative yield. 
NCS (20 mg, 0.15 mmol) was added to a solution of indole-3ꞌ-carboxaldehyde 
oxime (176) (20 mg, 0.13 mmol) in pyridine (100µL) and CH2Cl2 (1 mL) at 0 °C. The 
reaction mixture was stirred at rt for 30 min and then 1-thio-β-D-glucopyrasos-2,3,4,6-
tetraacetate (29 mg, 0.08 mmol) in CH2Cl2 (0.2 mL) and Et3N (54 µL) were added and 
stirred for 3 h. The reaction mixture was diluted with water (5 mL), extracted with 
CH2Cl2, dried, and concentrated. The residue was subjected to FCC (EtOAc:Hexane, 1:1) 
to yield indolyl-3ꞌ-tetraacetylgluco carboxythiohydroxamate (183) (32 mg, 0.06 mmol) in 
47% from oxime.  
KOCH3 (75µL, 1mM) was added to a solution of indolyl-3-tetraacetylgluco 
carboxythiohydroxamate (183) (30 mg, 0.06 mmol) in anhydrous methanol (1 mL). The 
reaction mixture was stirred for 30 min and neutralized with acetic acid. The solvent was 
evaporated under reduced pressure to yield indole desulfoglucosinolate (186) (21 mg, 
0.06 mmol) in quantitative yield (Brochard, Joseph et al., 1994). 
HPLC tR=6.1 min, method B.  
UV (CH3CN-H2O) max(nm): 270.  
FTIR (KBr, cm
-1
) max: 3270, 2932, 1565, 1413, 1105, 1048, 747.  
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1
H NMR (500 MHz, CD3OD)  7.83 (1H, d, J= 8 Hz), 7.70 (1H, s), 7.39 (1H, d, J = 8 
Hz), 7.15 (1H, dd, J = 7, 8 Hz), 7.08 (1H, dd, J = 7, 8 Hz), 4.52 (1H, d, J = 10 Hz), 3.66 
(1H, dd, J = 12, 2 Hz), 3.54 (1H, dd, J = 12, 5.5 Hz), 3.29-3.25 (2H, m), 3.13 (1H, dd, J 
= 9, 9 Hz), 2.74 (1H, m).  
13
C NMR  (125.8 MHz, CD3OD). 149.3, 137.9, 128.7, 127.6, 123.4, 121.6, 121.3, 
112.6, 110.4, 86.1, 82.0, 79.6, 74.4, 71.1, 62.5.  
HR-ESI-MS m/z 393.0572 [M+K]
+
, calcd for C15H19N2O6SK 393.0517 (16%).  
HPLC-ESI-MS m/z [M+1]
+
 355.1 (96%), 193.1 (100%).  
3.4.1.4 (R,S)-[4',5',6',7'-2H4]Indolyl-3'-glycine (185a) 
 
Scheme 3.10 Syntheses of 185a. Reagents and conditions: i) C2O2Cl2, Et2O ii) NaOH; 
iii) NaOAc, NH2OH.HCl, 70 °C; iv) NaBH4, NiCl2.6H2O, 75% over all. 
Oxalyl chloride (52 µL, 0.61 mmol) was slowly added to a solution of [4,5,6,7-
2
H4]indole (120a) (60 mg, 0.50 mmol) in anhydrous Et2O (2 mL) at 0 ºC, and the reaction 
mixture stirred for 1 h at 0 ºC. The reaction mixture was filtered and residue was washed 
with ice cold ether and concentrated under reduced pressure to yield crude [4',5',6',7'-
2
H4]indolyl-3'-oxalylchloride (177a) in quantitative yield. NaOH (20%) was slowly 
added to a suspension of [4',5',6',7'-
2
H4]indolyl-3'-oxalylchloride (177a) (105 mg, 0.50 
mmol) in THF to obtain pH 10. The reaction mixture was stirred at room temperature for 
30 min, acidified (HCl, 2 M) and further stirred for 30 min. The reaction mixture was 
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diluted with water, extracted with EtOAc, the organic layer was dried and concentrated to 
yield [4',5',6',7'-
2
H4]indolyl-3'-oxo acid (181a) (72 mg, 0.37 mmol, 75% over two steps). 
A solution of NH2OH.HCl (108 mg, 1.55 mmol) and NaOAc (211 mg, 1.55 mmol) in 
water (1 mL) was added to a solution of [4',5',6',7'-
2
H4]indolyl-3'-oxo acid (181a) (50 mg, 
0.26 mmol) in EtOH (2 mL). The reaction mixture was stirred for 3 hours at 70 ºC, EtOH 
was removed under reduced pressure and the residue was washed with CH2Cl2. The 
residue was diluted with water (10 mL), acidified (HCl, 1 M) and extracted with EtOAc. 
The organic extract was dried and concentrated to yield crude [4',5',6',7'-
2
H4]indolyl-3'-
oximino acid (184a), which was taken to the next step without further purification. A 
solution of NiCl2.6H2O (61 mg, 0.26 mmol) in EtOH (1 mL) was added to a solution of 
[4',5',6',7'-
2
H4]indolyl-3'-oximino acid (184a) (54 mg, 0.26 mmol) in EtOH (3 mL), 
followed by addition of NaBH4 (30 mg, 0.78 mmol) over 20 min period. The reaction 
mixture was stirred at rt for 48 h, was acidified with HCl (1 M), the solvent was removed 
under reduced pressure, the residue was extracted with MeOH and the extract was 
concentrated to yield [4',5',6',7'-
2
H4]indolyl-3'-glycine (185a) (50 mg, 0.26 mmol) 
quantitatively (Scheme 3.10).  
HPLC tR=6.9 min, method B.  
UV (CH3CN-H2O) max (nm): 220, 275. 
1
H NMR (500 MHz, CD3OD)  7.58 (1H, s), 5.50 (1H, s).  
HR-ESI-MS m/z 178.0796 [M-NH2]
+
, calcd for C10H4
2
H4NO2 178.0800 (100%).  
HPLC-ESI-MS m/z: [M-H]
-
 193.1 (100%). 
3.4.1.5 (R,S)-Indolyl-3'-glycine (185) 
 
The first synthesis of indolyl-3ꞌ-glycine was reported by Drost and Wileland, 
(Droste and Wileland, 1987). Oxalylchloride (450 µL, 5.31 mmol) was slowly added to a 
185 
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solution of indole (120) (500 mg, 4.27 mmol) in anhydrous diethyl ether (8 mL) at 0 °C. 
The reaction mixture was stirred for 1 h at 0 °C, solid was filtered off, washed with ice 
cold ether and concentrated under reduced pressure to yield crude indolyl-3ꞌ-
oxalylchloride (177) (730 mg, 3.52 mmol) in 84% yield (Garg, Sarpong et al., 2002). 
NaOH (20 %) was slowly added to the suspension of indolyl-3ꞌ-oxalylchloride (177) (300 
mg, 1.44 mmol) in THF to attain pH 10. The reaction mixture was stirred at room 
temperature for 30 min, was acidified by HCl (2 M) and further stirred for 30 min, diluted 
with water and extracted with EtOAc. The organic layer was dried and concentrated to 
yield indolyl-3ꞌ-oxo acid (181) as yellowish solid in (266 mg, 1.41 mmol) in 98% yield. 
A solution of NH2OH.HCl (221 mg. 3.17 mmol) and NaOAc (430 mg, 3.17 
mmol) in water (2 ml) was added to a solution of indolyl-3-oxo acid (181) (100 mg, 0.53 
mmol) in EtOH (4 ml). The reaction mixture was stirred for 2 hours at 60 ºC, EtOH was 
removed under reduced pressure and the residue was washed with CH2Cl2. The residue 
was diluted in water (10 mL), acidified (HCl, 1 M) and extracted by EtOAc. The organic 
extract was dried, and concentrated to afford oximino acid (184) (99 mg, 0.48 mmol) in 
91 % yield. 
NiCl2.6H2O (24 mg, 0.10 mmol) in EtOH (0.5 mL) was added to a solution of 
indolyl-3'-oximino acid (184) (20 mg, 0.10 mmol) in EtOH (1.5 mL) followed by 
addition of NaBH4 (11 mg, 0.29 mmol) over a 15 min period. The reaction mixture was 
stirred at rt for 48 h, acidified (HCl, 1 M) and the solvent was removed. The residue was 
extracted with MeOH and the extract was concentrated to yield indolyl-3'-glycine (185) 
(23 mg, 0.12 mmol) quantitatively (Droste and Wileland, 1987).  
HPLC tR=6.9 min, method B.  
UV (CH3CN-H2O) max(nm): 220, 275.  
FTIR (KBr, cm
-1
) max: 3389, 3000, 1737, 1488, 1454, 1426, 1193, 1105, 753.  
1
H NMR (500 MHz, D2O)  7.68 (1H, d, J = 8 Hz), 7.59 (1H, s), 7.57 (1H, d, J = 8.5 
Hz), 7.31 (1H, dd, J = 8, 8 Hz), 7.23 (1H, dd, J = 8, 8 Hz), 5.51 (1H, s).  
13
C NMR (125.8 MHz, D2O)  171.7, 136.2, 127.0, 124.4, 122.7, 120.4, 117.9, 112.4, 
105.0, 49.7.  
HR-ESI-MS m/z 174.0556 [M-NH2]
+
, calcd for C10H8NO2 174.0555 (100%).  
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HPLC-ESI-MS m/z [M-H]
-
 189.1 (100%), 146.2 (16%). 
3.4.1.6 [4',5',6',7'-2H4]Desulfoglucobrassicin (80a) 
 
Scheme 3.11 Syntheses of 80a. Reagents and conditions: i) CH3NO2, NH4OAc; ii) 
NaBH4, THF, MeOH 38%; iii) NaOCH3, MeOH; SOCl2, DME,-40 °C; 1-thio-β-D-
glucopyranose-2,3,4,6-tetraacetate, Et3N, CH2Cl2, Et2O, 33%; iv) KOCH3, MeOH. 
NH4OAc (13 mg, 0.16 mmol) was added to a solution of [4',5',6',7'-
2
H4]indole-3'-
carboxaldehyde (175a) (48 mg, 0.32 mmol) in nitromethane (1 mL) and refluxed at 105 
°C for 90 min. The reaction mixture was diluted with water, extracted by CH2Cl2 and 
concentrated to yield crude [4,5,6,7-
2
H4]-3-nitrovinylindole (208a), which was taken to 
the next step without further purification. NaBH4 (38 mg, 0.96 mmol) was added to a 
solution of crude [4,5,6,7-
2
H4]-3-nitrovinylindole (208a) (62 mg, 0.32 mmol) in THF (2 
mL) and MeOH (200 µL). The reaction mixture was stirred for 3 h at rt and excess 
NaBH4 was destroyed by adding ice-cold water to the reaction mixture. The reaction 
mixture was extracted with CH2Cl2, the solvent was removed and the residue was 
subjected to FCC (100% CH2Cl2) to yield [4,5,6,7-
2
H4]-3-(2'-nitroethyl)indole (178a) (23 
mg, 0.12 mmol, 38 % over two steps).  
NaOCH3 (23 mg/mL, 1mL) was added to a solution of [4,5,6,7-
2
H4]-3-(2'-
nitroethyl)indole (178a) (23 mg, 0.12 mmol) in MeOH (1 mL), the reaction mixture was 
175a  208a  182a  
80a  
178a  
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stirred for 30 min at rt and the solvent was removed. The residue was suspended in DME 
(1 mL) at -40 °C, thionyl chloride (35 µL, 0.29 mmol) in DME (0.5 mL) was added drop 
wise and the reaction mixture was stirred for 1 h at -40 °C. The solvent was removed, the 
residue was diluted with water, extracted with CH2Cl2 and concentrated to yield the 
corresponding crude oximoyl chloride, which was taken to the next step without further 
purification. A solution of 1-thio--D-glucopyranose tetraacetate (22 mg, 0.09 mmol) in 
anhydrous CH2Cl2 (1 mL) and Et3N (50 µL, 0.36 mmol) in Et2O (1 mL) were 
successively added with stirring to a solution of crude oximoyl chloride in Et2O-CH2Cl2 
(2:1, 3 mL) at rt. After 3 h, the reaction mixture was diluted with water, extracted with 
CH2Cl2 and concentrated. The residue was subjected to FCC (CH2Cl2-MeOH, 98:2) to 
yield [4',5',6',7'-
2
H4]tetraacetyldesulfoglucobrassicin (182a) (22 mg, 0.04 mmol, 33%).  
Freshly prepared KOCH3 (1 mM, 75 µL) was added to a solution of [4',5',6',7'-
2
H4]tetraacetyldesulfoglucobrassicin (182a) (22 mg, 0.04 mmol) in anhydrous MeOH (1 
mL) at rt under inert atmosphere, and the mixture was stirred for 30 min. The reaction 
mixture was neutralized with acetic acid and concentrated. The residue was dissolved in 
water and freeze-dried to yield [4',5',6',7'-
2
H4]desulfoglucobrassicin (80a) (23 mg, 0.06 
mmol) quantitatively (Scheme 3.11).  
HPLC tR=11.9 min, method B.  
UV (CH3CN-H2O) max (nm): 222, 280.  
1
H NMR  (500 MHz, CD3OD) 7.11 (1H, s), 4.68 (1H, d, J = 10 Hz), 4.23 (1H, d, J = 
16 Hz), 3.92 (1H, dd, J = 16, 1 Hz), 3.78 (1H, dd, J = 12, 2 Hz), 3.59 (1H, dd, J = 12, 6 
Hz), 3.22 (1H, dd, J = 9.5, 9.5 Hz), 3.13 (1H, dd, J = 9.9.5, 9 Hz), 3.06-3.03 (2H, m).  
HR-EI-MS m/z 160.0931 [M-(S-glc)-OH]
+
, calcd for C10H4
2
H4N2 160.0938 (74%), 
134.09 (100%).  
HPLC-ESI-MS m/z [M+1]
+
 373.1 (41%), 211.1 (100%). 
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3.4.1.7 Desulfoglucobrassicin (80) 
 
 Desulfoglucobrassicin was synthesized following previously published procedure 
(Viaud and Rollin, 1990). NH4OAc (266 mg, 3.40 mmol) was added to a solution of 
indole-3-carboxaldehyde (175) (1 g, 6.90 mmol) in nitromethane (6 mL) and refluxed at 
105 °C for 90 min. The reaction mixture was diluted with water, extracted with CH2Cl2 
and concentrated to give crude 3-nitrovinylindole (208), which was taken to the next step 
without further purification. NaBH4 (830 mg, 21.58 mmol) was added portion by portion 
to the solution of 3-nitrovinylindole (208) (1.27 g, 6.90 mmol) in THF (35 mL) and 
methanol (5 mL). The reaction was stirred at rt for 3 h, excess NaBH4 was destroyed by 
adding water, the reaction mixture was extracted with CH2Cl2, concentrated and the crude 
was subjected to FCC (CH2Cl2, 100%) to give 3-(2ꞌ-nitroethyl)indole (178) (540 mg, 2.84 
mmol) in 41 %, over two steps.  
 NaOCH3 (23 mg/mL, 1 mL) was added to the solution of 3-(2ꞌ-nitroethyl)indole 
(178) (50 mg, 0.26 mmol) in anhydrous methanol (1 mL). The reaction mixture was 
stirred at rt for 30 min and solvent was evaporated. The residue was suspended in DME 
(1 mL) at -40 ° C, thionyl chloride (50 µL, 0.65 mmol) in DME (1.5 mL) was added drop 
wise and the reaction mixture was stirred at -40 °C for 1 h. Excess solvent was 
evaporated, residue was diluted with water and extracted with CH2Cl2 and concentrated. 
Crude oximoyl chloride was taken to the next step without further purification. Solution 
of 1-thio-β-D-2,3,4,6-glucopyranose tetraacetate (48 mg, 0.13 mmol) in anhydrous 
CH2Cl2 (1 mL) and Et3N (108 µL, 0.78) in Et2O (1 mL) were added successively to the 
solution of crude oximoyl chloride in anhydrous (Et2O: CH2Cl2 2:1, 3 mL) at rt. After 3 
h, the reaction mixture was diluted with water, extracted with CH2Cl2, concentrated and 
80 
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the crude was subjected FCC (CH2Cl2:MeOH 98:2) to yield tetraacetyl 
desulfoglucobrassicin (182) (60 mg, 0.11 mmol) in 43%.. 
 Freshly prepared KOCH3 (1 mM, 75 µL) was added to a solution of tetraacetyl 
desulfoglucobrassicin (15 mg, 0.03 mmol) in anhydrous MeOH (1 mL) under inert 
atmosphere at rt and stirred for 30 min. The reaction mixture was neutralized by acetic 
acid and concentrated. The residue was diluted with water and freeze dried to give 
desulfoglucobrassicin (80) (15 mg, 0.04 mmol) in quantitative yield (Robertson and 
Botting, 1999; Viaud and Rollin, 1990).  
[α]D = -44.5 (c 0.13, MeOH) 
HPLC tR=11.9 min, method B.  
UV (CH3CN-H2O) max(nm): 222, 280.  
FTIR (KBr, cm-1) max: 3389, 2889, 1456, 1422, 1340, 1048, 745.  
1
H NMR (500 MHz, CD3OD) 7.64 (1H, d, J = 8.0 Hz), 7.33 (1H, d, J = 8 Hz), 7.13 
(1H, s), 7.09 (1H, dd, J = 8, 7.5 Hz), 7.01 (1H, dd, J = 7.5, 7.5 Hz), 4.68 (1H, d, J = 10 
Hz), 4.25 (1H, d, J = 16 Hz), 3.94 (1H, d, J = 16 Hz), 3.80 (1H, d, J = 12 Hz), 3.59 (1H, 
m), 3.23 (1H, dd, J = 9.5, 9 Hz), 3.14 (1H, dd, J = 9, 9 Hz), 3.09-3.03 (2H, m).  
13
C NMR (125.8 MHz, CD3OD)  154,3, 138.2, 128.3, 124.1, 122.7, 120.0, 119.7, 112.4, 
111.7, 83.0, 82.1, 79.5, 74.6, 71.3, 62.8, 30.4.  
HR-EI-MS m/z 156.0685 [M-(S-glc)-OH]
+
, calcd for C10H8N2 156.0687 (72%), 130.06 
(100%). HPLC-ESI-MS m/z [M+1]
+
 368.9 (42%). 207.0 (100%), 174.0 (27%), 130.0 
(40%)  
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3.4.1.8 [2H3CO]-4-Methoxyindole (149a) 
 
Scheme 3.12 Synthesis of 4-methoxyindole (149a). Reagents and conditions: i) NaH, 
2
H3CI, THF, 65°C; ii) 4-chlorophenoxyacetonitrile, t-BuOK, DMF,-20°C, 26%; (iii) 10% 
Pd/C, H2, MeOH, AcOH 81%. 
A solution of 3-nitrophenol (187) (100 mg, 0.72 mmol) in THF (1 mL) was added 
to a suspension of NaH (24 mg, 1.00 mmol) in THF (2 mL). The reaction mixture was 
stirred at room temperature for 10 min, 
2
H3CI (90 L, 1.42 mmol) was added and the 
reaction mixture was stirred at 65 ºC for 5 hours. The reaction mixture was diluted with 
water, extracted with CH2Cl2, the organic layer was dried and concentrated to yield crude 
[
2
H3CO]-3-methoxynitrobenzene (188a) (112 mg, 0.73 mmol) in quantitative yield. A 
solution of [
2
H3CO]-3-methoxynitrobenzene (188a) (110 mg, 0.70 mmol) and 4-
chlorophenyl acetonitrile (127 mg, 0.75 mmol) in DMF (2 mL) was slowly added to a 
suspension of t-BuOK (300 mg, 2.67 mmol) in DMF (1.5 mL) at -20 ºC. The reaction 
mixture was stirred at -20 ºC for 2 h, quenched with ice cold HCl (1 M) and extracted 
with EtOAc. The organic extract was washed with NaOH (2 M), dried and concentrated. 
The crude reaction mixture was subjected to FCC (EtOAc-Hex 1:3) to yield ([
2
H3CO]-6-
methoxy-2-nitrophenyl) acetonitrile (189a) ( 37 mg, 0.19 mmol, 26%).  
Palladium on carbon (10% Pd/C, 10 mg) was added to the solution of ([
2
H3CO]-6-
methoxy-2-nitrophenyl) acetonitrile (50 mg, 0.25 mmol) in MeOH (2.5 mL) and AcOH 
(244 L) and the resulting reaction mixture was stirred under H2 atmosphere (balloon 
pressure) at rt. After 12 h, the catalyst was filtered off, and the filtrate was concentrated 
under reduced pressure. The residue was suspended in sat. NaHCO3 (5 mL) and extracted 
with CH2Cl2. The organic layer was washed with water, dried and concentrated under 
reduced pressure to yield [
2
H3CO]-4-methoxyindole (149a) (30 mg, 0.20 mmol, 81%) 
(Mąkosza, Danikiewicz et al., 1988; Robertson and Botting, 1999) (Scheme 3.12).  
187a  188a  189a  149a  
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HPLC tR=12.5 min, method A.  
UV (CH3CN-H2O) max (nm): 220, 263.  
1
H NMR (500 MHz, CD3Cl)  8.16 (1H, brs), 7.13 (1H, dd, J = 7.5, 8 Hz), 7.13 (1H, s), 
7.03 (1H, d, J = 8 Hz) 6.67 (1H, brs), 6.53 (1H, d, J = 7.5 Hz).  
HR-EI-MS m/z 150.0872 (M
+
), calcd for C9H6
2
H3NO 150.0872 (100%), 132.04 (73%) 
104.04 (36%).  
HPLC-ESI-MS m/z: [M+H]
+
 151.1 (100%), 133.0 (44%). 
3.4.1.9 [2H3CO]-4'-Methoxyindole-3'-carboxaldehyde (190a) 
 
Scheme 3.13 Syntheses of 190a. Reagents and conditions: i) TTFA, TFA; I2, CuI; 
NaOCD3, 78% 
[
2
H3CO]-4ꞌ-Methoxyindole-3ꞌ-carboxaldehyde was synthesized from indole-3ꞌ-
carboxaldehyde through a reaction route that involves thalliation and iodination (Somei, 
Yamada et al., 1984). A solution of TTFA (280 mg, 0.51 mmol) in TFA (2 mL) was 
added to indole-3'-carboxaldehyde (175) (50 mg, 0.34 mmol). The mixture was stirred for 
3 h at 30 ºC and the solvent was removed under reduced pressure. Iodine (260 mg, 1.02 
mmol), CuI (260 mg, 1.36 mmol) and DMF (2 mL) were added to the reaction mixture 
and the mixture was stirred for 1 h at 25 ºC. NaOCD3 (prepared from Na 400 mg, 17.40 
mmol in CD3OD, 3 mL) was added and the reaction mixture was further stirred at 110 ºC 
for 1 h. The reaction mixture was cooled, neutralized (HCl, 1 M), filtered through celite, 
the filtrate was diluted with water and extracted with EtOAc. The organic layer was 
dried, concentrated and the crude product was subjected to FCC (EtOAc-Hex, 3:7) to 
yield [
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190a) (47 mg, 0.26 mmol, 78%). 
The corresponding non-deuterated compound 190 was prepared similarly but using non-
deuterated materials (Somei, Iwasa et al., 1986; Somei, Yamada et al., 1984) (Scheme 
3.13). 
175 190a  
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Compound 26. M.P. 146-148 ºC 
HPLC tR=7.3 min, method A.  
UV (CH3CN-H2O) max(nm): 210, 250, 325.  
FTIR (KBr, cm
-1
) max: 3194, 1718, 1644, 1624, 1512, 1383, 1271, 1100, 781.  
1
H NMR (500 MHz, CD3CN) 10.41 (1H, s), 10.2 (1H, brs), 7.90 (1H, s), 7.19 (1H, dd, 
J = 8, 8 Hz), 7.14 (1H, d, J = 8 Hz), 6.75 (1H, d, J = 7.5 Hz), 3.95 (3H, s).  
13
C NMR (125.8 MHz, CD3CN)  188.2, 155.4, 139.1, 129.8, 125.0, 119.9, 116.9, 106.6, 
103.4, 56.1  
HR-EI-MS m/z 175.0629 (M
+
), calcd for C10H9NO2 175.0633 (100%), 160.04 (28%), 
144.04 (26%) 129.06 (43%).  
HPLC-ESI-MS m/z [M-H]
-
 173.9 (100%), 158.9 (98%). 
Compound 26a. HPLC tR=7.3 min, method A.  
UV (CH3CN-H2O) max (nm): 210, 250, 325.  
1
H NMR (500 MHz, CD3Cl)  10.51 (1H, s), 8.95 (1H, brs), 7.93 (1H, d, J = 3 Hz), 7.22 
(1H, dd, J = 8, 8 Hz), 7.09 (1H, d, J = 8 Hz), 6.72 (1H, d, J = 7.5 Hz).  
HR-EI-MS m/z 178.0819 (M
+
), calcd for C10H6
2
H3NO2 178.0821 (100%), 145.05 (21%) 
131.07 (32%).  
HPLC-ESI-MS m/z: [M-H]
-
 176.9 (92%), 158.9 (100%). 
3.4.1.10 [2H3CO]-4'-Methoxyindolyl-3'-acetonitrile (135a) (arvelexin) 
 
Scheme 3.14 Syntheses of 135a. Reagents and conditions: i) CH3NO2, NH4OAc; ii) 
NaBH4, THF, 38%; iii) CS2, Et3N, 62% 
Synthesis of arvelexin was first reported by Pedras and co-workers, (Pedras, 
Chumala et al., 2003). A solution of TTFA (280 mg, 0.51 mmol) in TFA (2 mL) was 
135a  190a  171a  195a  
170 
 
added to indole-3ꞌ-carboxaldehyde (175a) (50 mg, 0.34 mmol). The mixture was stirred 
for 3 h at 30 ºC. Solvent was removed under reduced pressure. Iodine (260 mg, 1.02 
mmol), CuI (260 mg, 1.36 mmol) and DMF (2 mL) were added and stirred for 1 h at 25 
°C. NaOCD3 (prepared from Na 400 mg, 17.40 mmol in CD3OD 3 mL) was added and 
the reaction mixture was further stirred at 110 ºC for 1 h. The reaction mixture was 
cooled, neutralized (HCl, 1 M), filtered through celite and the filtrate was diluted with 
water and extracted with EtOAc. The organic layer was dried, concentrated and the crude 
product was subjected to FCC (EtOAc-Hex, 3:7) to afford [
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-
carboxaldehyde (190a) (47 mg, 0.26 mmol, 79%) (Somei, Iwasa et al., 1986; Somei, 
Yamada et al., 1984). 
NH4OAc (14 mg, 0.18 mmol) was added to a solution of [
2
H3CO]-4ꞌ-
methoxyindole-3ꞌ-carboxaldehyde (190a) (65 mg, 0.36 mmol) in nitromethane (1 mL) 
and refluxed at 105 °C for 90 min. The reaction mixture was allowed to cool, diluted with 
water, extracted with CH2Cl2 and concentrated to yield crude [
2
H3CO]-4-methoxy-3-
nitrovinylindole (192a), which was taken to the next step without further purification. 
NaBH4 (42 mg, 1.11 mmol) was added to a solution of crude [
2
H3CO]-4-methoxy-3-
nitrovinylindole (192a) (79 mg, 0.36 mmol) in THF (3 mL) and MeOH (300 µL). The 
reaction mixture was stirred for 3 h at rt, after which excess NaBH4 was destroyed by 
adding ice-cold water to the reaction mixture. The reaction mixture was extracted with 
CH2Cl2, concentrated and subjected to FCC (CH2Cl2, 100%) to yield [
2
H3CO]-4-
methoxy-3-(2'-nitroethyl)indole (195a) (27 mg, 0.12 mmol, 34%) (Robertson and 
Botting, 1999).  
Et3N (324 µL, 2.34 mmol) and CS2 (72 µL, 1.20 mmol) were added to a solution 
of [
2
H3CO]-4-methoxy-3-(2'-nitroethyl)indole (195a) (26 mg, 0.12 mmol) in acetonitrile 
(1.5 mL) and the reaction mixture was stirred at 40 ºC for 20 h. The solvent was 
removed, the residue was diluted with water (10 mL) and extracted with CH2Cl2. The 
organic layer was dried, concentrated and the residue was subjected to FCC (CH2Cl2, 
100%) to yield [
2
H3CO]-4'-methoxyindolyl-3'-acetonitrile (135a) (14 mg, 0.07 mmol, 62 
%) (Scheme 3.14).  
HPLC tR=13.7 min, method A.  
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UV (CH3CN-H2O) max (nm): 220, 260.  
1
H NMR (500 MHz, CD3Cl)  8.16 (1H, brs), 7.13 (1H, dd, J = 8, 8 Hz), 7.10 (1H, s), 
6.98 (1H, d, J = 8 Hz), 6.51 (1H, d, J = 8 Hz), 4.06 (2H, s).  
HR-EI-MS m/z 189.0977 [M]
+
, calcd for C11H7
2
H3N2O 189.0981 (100%), 171.05 (92%).  
HPLC-ESI-MS m/z: [M+H]
+
 190.2 (100%), 163.2 (48%), 150.3 (89%). 
3.4.1.11 [2H3CO]-4ꞌ-Methoxybrassinin (108a) 
 
Scheme 3.15 Syntheses of 108a. Reagents and conditions: i) NH2OH.HCl, Na2CO3, 70 
ºC; iii) NaBH4, NiCl2.6H2O, 54%; iv) CS2, Et3N, MeI, 77%. 
A solution of NH2OH.HCl (78 mg. 1.12 mmol) and Na2CO3 (60 mg, 0.56 mmol) 
in water (1 ml) was added to a solution of [
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde 
(190a) (100 mg, 0.56 mmol) in EtOH (2 mL). The reaction mixture was stirred at 70 ºC 
for 3 h, EtOH was removed under reduced pressure and the residue was diluted in water 
and extracted with EtOAc. The organic extract was dried and concentrated to yield 
[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (171a) (107 mg, 0.56 mmol) in a 
quantitative yield. 
NaBH4 (65 mg, 1.65 mmol) was added, portion by portion, to a solution of 
[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (171a) (107 mg, 0.56 mmol) and 
NiCl2.6H2O (132 mg, 0.55 mmol) in EtOH (10 mL) at 0 °C. The reaction mixture was 
stirred for 1 h at room temperature, was concentrated to 1/3 of its original volume, was 
basified with aq. NH3 (28%) (10 mL) and then extracted with EtOAc. The organic phase 
was dried, concentrated and subjected to FCC (CH2Cl2:MeOH:NH4OH (80:20:1)) to 
afford ([
2
H3CO]-4ꞌ-methoxy-3ꞌ-indolyl) methanamine (193a) (53 mg, 0.29 mmol) in 54% 
yield. 
190a  171a  193a  108a  
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CS2 (22 µL, 0.35 mmol) was added to a solution of ([
2
H3CO]-4ꞌ-methoxy-3ꞌ-
indolyl) methanamine (193a) (53 mg, 0.29 mmol) and Et3N (82 µL, 0.59 mmol) in 
pyridine (0.5 ml) and CH2Cl2 (1 mL) and stirred for 20 min at 0 ºC. MeI (22 µL, 0.35 
mmol) was added to the reaction mixture, stirred further for 1 h at rt, the reaction mixture 
was diluted with H2O, extracted with CH2Cl2 and the organic extract was dried and 
concentrated. The residue was subjected to FCC (CH2Cl2 100 %) to afford [
2
H3CO]-4ꞌ-
methoxybrassinin (108a) (60 mg, 0.22 mmol) in 77 % (Yamada, Kobayashi et al., 1993) 
(Scheme 3.15). 
HPLC tR = 20.3 min, method A. 
UV (CH3CN-H2O) λmax (nm):  220, 265.  
FTIR (KBr, cm
-1) νmax: 3395, 2935, 2834, 1505, 1359, 1255, 1079, 920, 732.  
1H NMR δ (500 MHz, CDCCl3) 8.15 (1H, s), 7.96 (1H, s), 7.14 (1H, dd, J = 8, 8 Hz), 
7.10 (1H, s), 7.01 (1H, d, J = 8 Hz), 6.57 (1H, d, J = 8 Hz) 5.13 (2H, d, J = 5.5 Hz), 2.63 
(3H, s).  
13C NMR δ (125.8 MHz, CDCCl3). 179.3, 153.4, 138.0, 123.3, 122.7, 116.7, 110.6, 
105.1, 99.9, 43.6, 17.8.  
HREI-MS m/z 269.0738 (M
+
), calcd. for C10H11
2
H3N2OS2 269.0738 (89), 254.05 (27), 
195.0686 (28), 163.09 (100), 130.06 (31)  
MS-ESI m/z [M+1]
+
 325 (100%), 163 (51%)  
3.4.1.12 4ꞌ-Methoxybrassinin (108) 
 
Synthesis of 4ꞌ-methoxybrassinin was first reported by Somei and co-workers 
(Yamada, Kobayashi et al., 1993). A solution of NH2OH.HCl (79 mg. 1.14 mmol) and 
Na2CO3 (60 mg, 0.57 mmol) in water (1 mL) was added to a solution of 4ꞌ-
methoxyindole-3ꞌ-carboxaldehyde (190) (100 mg, 0.57 mmol) in EtOH (2 mL). The 
reaction mixture was stirred for 3 h at 70 ºC, EtOH was removed under reduced pressure 
108 
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and residue was diluted in water (10 mL) and extracted with EtOAc. The organic extract 
was dried and concentrated to yield 4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (171) in 
quantitative yield. NaBH4 (65 mg, 1.71 mmol) was added, portion by portion, to a 
solution of 171 (108 mg, 0.57 mmol) and NiCl2.6H2O (136 mg, 0.57 mmol) in EtOH (10 
mL) at 0 °C. The reaction mixture was stirred for 1 h at room temperature, was 
concentrated to 1/3 of its original volume, was basified with aq. NH3 28% (10 mL) and 
then extracted with EtOAc. The organic phase was dried, concentrated and subjected to 
FCC (CH2Cl2:MeOH:NH4OH (80:20:1)) to afford (4ꞌ-methoxy-3ꞌ-indolyl)methanamine 
(193) (66 mg, 0.38 mmol) in 66% yield. 
CS2 (13 µL, 0.23 mmol) was added to a solution of (4ꞌ-methoxy-3ꞌ-indolyl) 
methanamine (193) (35 mg, 0.20 mmol) and Et3N (53 µL, 0.38 mmol) in pyridine (0.5 
mL) and CH2Cl2 (1 mL) and stirred for 20 min at 0 ºC. MeI (14 µL, 0.23 mmol) was 
added and stirred further for 1 h at rt. The reaction mixture was diluted with H2O, 
extracted with CH2Cl2 and the organic extract was dried and concentrated. The residue 
was subjected to FCC (CH2Cl2, 100%) to afford 4ꞌ-methoxybrassinin (108) (51 mg, 0.20 
mmol) in quantitative yield (Yamada, Kobayashi et al., 1993). 
HPLC tR = 20.3 min, method A. 
UV (CH3CN-H2O) λmax (nm):  220, 265.  
FTIR (KBr, cm-1) νmax: 3395, 2935, 2834, 1505, 1359, 1255, 1079, 920, 732.  
1H NMR δ (500 MHz, CDCCl3) 8.15 (1H, s), 7.96 (1H, s), 7.14 (1H, dd, J = 8, 8 Hz), 
7.10 (1H, s), 7.01 (1H, d, J = 8 Hz), 6.57 (1H, d, J = 8 Hz) 5.13 (2H, d, J = 5.5 Hz), 4.01 
(3H, s),  2.63 (3H, s).  
HREI-MS m/z 266.05492 (M
+
), calcd for C12H14N2OS2 266.05475 (83%), 251.03 (23%), 
192.05 (24%), 160.07 (100%), 130.06 (45%)  
HPLC-ESI-MS m/z [M+1]
+
 319 (100%), 160 (51%)  
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3.4.1.13  (R,S)-[2H3CO]-4ꞌ-Methoxyindolyl-3ꞌ-glycine (107a) 
 
Scheme 3.16 Reagents and conditions: i) C2O2Cl2, Et2O ii) NaOH; iii) Na2CO3, 
NH2OH.HCl, 70 °C; iv) NaBH4, NiCl2.6H2O, 39% over all. 
 Oxalylchloride (39 µL, 0.44 mmol) was slowly added to a solution of [
2
H3CO]-4-
methoxyindole (149a) (54.6 mg, 0.37 mmol) in anhydrous diethyl ether (2 mL) at 0 °C. 
The reaction mixture was stirred at 0 °C for 1 h, the solvent was removed, the residue 
was washed with ice cold ether and concentrated to yield crude [
2
H3CO]-4ꞌ-
methoxyindolyl-3ꞌ-oxalylchloride (191a) (90 mg, 0.38 mmol). NaOH (20%) was slowly 
added to the suspension of crude [
2
H3CO]-4ꞌ-methoxyindolyl-3ꞌ-oxalylchloride (191a) 
(88 mg, 0.37 mmol) in THF (1 mL) to attain pH 10, the reaction mixture was stirred at 
room temperature for 30 min, acidified (HCl, 1 M) and stirred for 30 more minutes. The 
reaction mixture was diluted with water, extracted with EtOAc, the organic layer was 
dried, and concentrated to yield [
2
H3CO]-4ꞌ-methoxyindolyl-3ꞌ-oxo acid (194a) (83 mg, 
0.37 mmol) quantitatively.  
A solution of NH2OH.HCl (51 mg. 0.73 mmol) and Na2CO3 (39 mg, 0.37 mmol) 
in water (1 mL) was added to a solution of [
2
H3CO]-4ꞌ-methoxyindolyl-3ꞌ-oxo acid 
(194a) (82 mg, 0.37 mmol) in EtOH (3 mL). The reaction mixture was stirred at 70 ºC for 
3 h, EtOH was removed under reduced pressure and the residue was washed with 
CH2Cl2. The residue was diluted with water (10 mL), acidified with HCl and extracted 
149a  191a  194a  
196a  
107a  
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with EtOAc. The organic extract was dried and concentrated to yield crude [
2
H3CO]-4ꞌ-
methoxyindolyl-3ꞌ-oximino acid (196a) (74 mg, 0.31 mmol) in 84% yield over two steps. 
A solution of NiCl2.6H2O (63 mg, 0.27 mmol) in EtOH (1 mL) was added to a 
solution of [
2
H3CO]-4'-methoxyindolyl-3'-oximino acid (196a) (64 mg, 0.27 mmol) in 
ethanol (3 mL) followed by portion wise addition of NaBH4 (30 mg, 0.78 mmol) over a 
period of 20 min. The reaction mixture was stirred at rt for 48 h, was acidified (HCl, 1 M) 
and the solvent was removed. The residue was extracted with methanol, was concentrated 
and subjected to FCC (CH2Cl2:MeOH:AcOH 80:20:1) to yield [
2
H3CO]-4ꞌ-
methoxyindolyl-3ꞌ-glycine (107a) (28 mg, 0.13 mmol) in 47% (Scheme 3.16). 
HPLC tR= 6.8 min, Method B.  
UV (CH3CN-H2O) λmax (nm):  220, 265 
FTIR (KBr, cm
-1) νmax: 3181, 2928, 1624, 1504, 1466, 1362, 1246, 1088, 731.  
1
H NMR (500 MHz, CD3OD) δ 7.22 (1H, s), 7.07 (1H, dd, J = 8, 8 Hz), 7.00 (1H, d, J = 
8 Hz), 6.56 (1H, d, J = 7.5 Hz), 5.12 (1H, s).  
13
C NMR (125.8 MHz, CD3OD) δ 173.9, 154.5, 139.9, 125.7, 124.2, 117.4, 109.9, 106.5, 
100.9, 55.1.  
HPLC-ESI-MS m/z [M-H]
-
 222.3 (34%), 205.3 (27%), 179.3 (41%), 161.3 (100%).  
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3.4.1.14 (R,S)-[2H3CO,5',6',7'-
2
H3]-4'-Methoxyindolyl-3'-glycine (107b) 
 
Scheme 3.17 Synthesis of 107b. Reagents and conditions: i) C2O2Cl2, Et2O; MeOH; ii) 
TTFA, TFA; I2, CuI; NaOCD3; iii) NH2OH.HCl, Na2CO3, 70 ºC; iv) NaBH4, NiCl2.6H2O 
37% over all yield. 
Oxalyl chloride (52 µL, 0.60 mmol) was slowly added to a solution of [4,5,6,7-
2
H4]indole (120a) (60 mg, 0.50 mmol) in anhydrous diethyl ether (2 mL) at 0 ºC. The 
reaction mixture was stirred for 1 h at 0 ºC, was filtered and the residue was washed with 
ice cold ether and concentrated under reduced pressure to yield crude [4',5',6',7'-
2
H4]indolyl-3'-oxalylchloride (177a) quantitatively. [4',5',6',7'-
2
H4]Indolyl-3'-
oxalylchloride (177a) (100 mg, 0.48 mmol) was dissolved in MeOH (2 mL) and stirred at 
rt for 1 h. The solvent was evaporated under reduced pressure to yield methyl[4',5',6',7'-
2
H4]indolyl-3'-oxoacetate (197a) quantitatively. TTFA (209 mg, 0.38 mmol) was added 
to a solution of methyl[4',5',6',7'-
2
H4]indolyl-3'-oxoacetate (197a) (53 mg, 0.26 mmol) in 
TFA (2 mL) and stirred for 15 h at 60 °C. The solvent was evaporated under reduced 
pressure, a solution of I2 (195 mg, 0.77 mmol) and CuI (195 mg, 1.02 mmol) in DMF (2 
mL) was added to the reaction mixture and stirred for 1 h at 25 °C. Fresh NaOCD3 
(prepared from Na, 400 mg, 17.40 mmol, in anhydrous CD3OD, 3 mL) was added to the 
reaction mixture and refluxed at 110 °C for 1 h. The reaction mixture was acidified (HCl, 
1 M), filtered through celite and extracted with EtOAc. The organic layer was dried and 
120a 197a 194b 196b 
107b 
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concentrated. The crude product was subjected to FCC (CH2Cl2-MeOH-AcOH, 80:20:1) 
to yield [
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindolyl-3'-oxo acid (194b) (0.10 mmol, 22 mg, 
37%). A solution of NH2OH.HCl (13 mg, 0.19 mmol) and Na2CO3 (10 mg, 0.09 mmol) 
in water (1 mL) was added to a solution of [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-oxo 
acid (194b) (21 mg, 0.09 mmol) in EtOH (2 mL). The reaction mixture was stirred for 3 h 
at 70 ºC, EtOH was removed under reduced pressure and the residue was washed with 
CH2Cl2. The residue was dissolved in water (10 mL), acidified with HCl (1 M) and 
extracted with EtOAc. The organic extract was dried and concentrated to afford crude 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-oximino acid (196b)quantitatively.  
NiCl2.6H2O (11 mg, 0.05 mmol) in EtOH (0.5 mL) was added to a solution of 
[
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-oximino acid (196b) (11 mg, 0.05 mmol) in 
EtOH (1 mL) followed by addition of NaBH4 (5 mg, 0.13 mmol) over a period of 5 min. 
The reaction mixture was stirred at rt for 48 h, acidified (HCl, 1 M) and the solvent was 
removed. The residue was extracted with MeOH and the extract was concentrated to 
yield [
2
H3CO,5',6',7'-
2
H3]-4'-methoxyindolyl-3'-glycine (107b) quantitatively (Scheme 
3.17).  
HPLC tR=6.8 min, method B.  
UV (CH3CN-H2O) max(nm): 220, 265.  
1
H NMR (500 MHz, CD3OD)  7.43 (1H, s), 5.32 (1H, s).  
HR-ESI-MS m/z: 210.1033 [M-NH2]
+
, calcd. for C11H4
2
H6NO3 210.1031.  
HPLC-ESI-MS m/z: [M-H]
-
 224.9 (34%), 207.9 (47%), 180.9 (38%), 162.9 (100). 
3.4.1.15 (R,S)-4ꞌ-Methoxyindolyl-3ꞌ-glycine (107) 
 
 Oxalylchloride (32 µL, 0.41 mmol) was slowly added to a solution of 4-
methoxyindole (149) (50 mg, 0.34 mmol) in anhydrous diethyl ether (2 mL) at 0 °C. The 
107 
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reaction mixture was stirred for 1 h at 0 °C, solvent was evaporated and the residue was 
washed with ice cold ether and concentrated under reduced pressure to give crude 4ꞌ-
methoxyindolyl-3ꞌ-oxalylchloride (191). NaOH (20 %) was slowly added to a solution of 
crude 4ꞌ-methoxyindolyl-3ꞌ-oxalylchloride (191) in THF (1 mL) to attain pH 10. The 
reaction mixture was stirred at room temperature for 30 min and acidified with HCl (2 M) 
and further stirred for 30 min. The reaction mixture was diluted with water and extracted 
with EtOAc. The organic layer was dried and concentrated to give 4'-methoxyindolyl-3'-
oxo acid (194) (crude, 68 mg, 0.31mmol) in 91 % over two steps. 
A solution of NH2OH.HCl (40 mg, 0.58 mmol) and NaOAc (31 mg, 0.29 mmol) 
in water (1 ml) was added to a solution of 4'-methoxyindolyl-3'-oxo acid (194) (64 mg, 
0.29 mmol) in EtOH (2 ml). The reaction mixture was stirred for 3 h at 70 ºC, EtOH was 
removed under reduced pressure and the residue was washed with CH2Cl2. The residue 
was diluted with water (10 mL), acidified (HCl, 1 M) and extracted with EtOAc. The 
organic extract was dried, and concentrated to afford crude 4ꞌ-methoxy indolyl-3ꞌ-
oximino acid (196) (55 mg, 0.24 mmol) in 81%. 
A solution of NiCl2.6H2O (55 mg, 0.24 mmol) in EtOH (1 mL) was added to a 
solution of 4ꞌ-methoxyindolyl-3ꞌ-oximino acid (196) (55 mg, 0.24 mmol) in Ethanol (3 
mL) followed by portion wise addition of NaBH4 (27 mg, 0.72 mmol) over a period of 20 
min. The reaction mixture was stirred at rt for 48 h, was acidified (HCl, 1 M) and the 
solvent was removed. The residue was washed with CH2Cl2, extracted with methanol and 
concentrated to yield 4ꞌ-methoxyindolyl-3ꞌ-glycine (107) (44 mg, 0.20 mmol) in 83%. 
M.P. 222-224 ºC 
HPLC tR= 6.8 min, method B.  
UV (CH3CN-H2O) max(nm): 220, 265.  
FTIR (KBr, cm
-1
) max 3181, 2928, 1624, 1504, 1466, 1362, 1246, 1088, 731.  
1
H NMR (500 MHz, CD3OD)  7.11 (1H, s), 6.97 (1H, dd, J = 8, 8 Hz), 6.91 (1H, d, J = 
8 Hz), 6.46 (1H, d, J = 7.5 Hz), 5.03 (1H, s), 3.83 (3H, s).  
13
C NMR (125.8 MHz, CD3OD)  173.9, 154.5, 139.9, 125.7, 124.2, 117.4, 109.9, 106.6, 
100.9, 55.9, 53.9.  
HR-ESI-MS m/z: [M+H-NH2]
+
 204.0662, calcd for C11H10NO3 204.0665.  
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HPLC-ESI-MS m/z [M-H]
-
 219.2 (41%), 202.2 (24%), 176.2 (29%), 158 .2 (100%).  
3.4.1.16 [2H3CO,5',6',7'-
2
H3]-4ꞌ-Methoxyindole-3ꞌ-carboxaldehyde oxime (171b) 
 
Scheme 3.18 Synthesis of 171b. Reagents and conditions: i) POCl3, DMF, 95%; ii) 
TTFA, TFA; I2, CuI; NaOCD3, 45%; iii) NH2OH.HCl, Na2CO3, 70 ºC, 82%; 
Freshly distilled POCl3 (96 L, 1.02 mmol) was added drop wise to a solution of 
[4,5,6,7-
2
H4]indole (120a) (83 mg, 0.69 mmol) in anhydrous DMF (1 mL) at 0 ºC. The 
reaction mixture was stirred for 1 h at rt, basified with aq. NH3 (28%), diluted with water 
and extracted with EtOAc. The organic extract was dried and concentrated to yield 
[4',5',6',7'-
2
H4]indole-3ꞌ-carboxaldehyde (175a) (98 mg, 0.66 mmol, 95%). A solution of 
TTFA (260 mg, 0.49 mmol) in TFA (2 mL) was added to [4',5',6',7'-
2
H4]indole-3ꞌ-
carboxaldehyde (175a) (49 mg, 0.33 mmol), the mixture was stirred 12 h at 30 ºC, and 
the solvent was removed under reduced pressure. DMF (2 mL), iodine (260 mg, 1.02 
mmol) and CuI (260 mg, 1.36 mmol) were added (Somei, Iwasa et al., 1986) to the 
residue and the reaction mixture was stirred for 2 h at 25 °C. NaOCD3 (prepared from Na 
400 mg, 17.40 mmol in CD3OD 3 mL) was added to the reaction mixture and the mixture 
was further stirred at 110 °C for 1 h. The reaction mixture was cooled to room 
temperature, neutralized (HCl, 1 M) and filtered through celite. The filtrate was diluted 
with water and extracted with EtOAc. The organic layer was dried, concentrated and the 
crude product was subjected to FCC (EtOAc-Hex, 3:7) to afford [
2
H3CO,5',6',7'-
2
H3]-4ꞌ-
methoxyindole-3ꞌ-carboxaldehyde (190b) (27 mg, 0.15 mmol, 45%).  
A solution of NH2OH.HCl (15 mg, 0.22 mmol) and Na2CO3 (13 mg, 0.12 mmol) 
in water (1 mL) was added to a solution of [
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-
carboxaldehyde (190b) (20 mg, 0.11 mmol) in MeOH (2 mL) at 70 ºC. After 3 h, the 
solvent was removed, the residue was dissolved in water, extracted with EtOAc, the 
120a 190b 171b 
180 
 
organic phase was dried, concentrated and subjected to FCC (CH2Cl2-MeOH, 98:2) to 
yield [
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (171b) (18 mg, 
0.09 mmol, 82%) (Scheme 3.18). The corresponding non-deuterated compound 171 was 
prepared similarly but using non-deuterated materials. 
Compound 171. M.P. 205-207 ºC 
HPLC tR=7.9 min, method A.  
UV (CH3CN-H2O) max(nm): 220, 240, 295.  
FTIR (KBr, cm-1) max: 3260, 2932, 1620, 1379, 1267, 1100, 1026.  
1
H NMR (500 MHz CD3CN) 9.68 (1H, brs), 8.23 (1H, brs), 8.22 (1H, s), 8.21 (1H, d, J 
= 3 Hz), 7.13 (1H, dd, J = 8, 8 Hz), 7.08 (1H, d, J = 8 Hz), 6.64 (1H, d, J = 7.5 Hz), 3.94 
(3H, s).  
13
C NMR (125.8 MHz, CD3CN)  155.5, 146.7, 142.2, 137.7, 131.1, 124.3, 108.0, 106.0, 
102.0, 55.9  
HR-EI-MS m/z 190.0741 (M
+
), calcd for C10H10N2O2 190.0742 (32%), 172.06 (100%), 
157.04 (65%), 129.05 (72%).  
HPLC-ESI-MS m/z [M+H]
+
 191.0 (100%), 174.0 (11%). 
Compound 171b. HPLC-DAD, tR=7.9 min, method A.  
UV (CH3CN-H2O) max (nm): 220, 240, 295.  
1
H NMR (500 MHz CD3CN) 9.68 (1H, br s), 8.23 (1H, s), 8.21 (1H, s).  
HR-EI-MS m/z 196.1124 (M
+
), calcd for C10H4
2
H6N2O2 196.1119 (88%), 178.10 (100%), 
160.05 (62%), 132.06 (44%).  
HPLC-ESI-MS m/z: [M+H]
+
 197.0 (100%), 180.0 (12%).  
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3.4.1.17 [2H3CO,5',6',7'-
2
H3]Desulfoglucorapassicin (172b) 
 
Scheme 3.19 Synthesis of 172b. Reagents and conditions: i) (t-Boc)2O, DMAP, THF; 
ii) NH2OH.HCl, Na2CO3, 60 ºC, 95%; iii) pyridine, NCS, DCM, 1-thio-β-D-
glucopyranose tetraacetate, Et3N, 52%; iv) D-TFA, CH2Cl2, 92%; v) KOCH3, MeOH, 
quant. 
(t-Boc)2O (72 mg, 0.33 mmol) and DMAP (2 mg, 0.02 mmol) were added to a 
solution of [
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190b) (40 mg, 0.22 
mmol) in THF (3 mL) at 0 ºC. The reaction mixture was stirred at rt for 2 h, was 
neutralized (HCl, 1M), diluted with water and extracted with CH2Cl2. The organic phase 
was dried and concentrated to yield crude N-t-Boc[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-
3ꞌ-carboxaldehyde (63 mg, 0.22 mmol). A solution of NH2OH.HCl (31 mg, 0.44 mmol) 
and Na2CO3 (24 mg, 0.22 mmol) in water (1 mL) was added to a solution of N-t-
Boc[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (63 mg, 0.22 mmol) in 
MeOH (4 mL) at 60 ºC. After 3 h the solvent was removed, the residue was dissolved in 
water and extracted with CH2Cl2. The organic phase was dried, and concentrated to yield 
crude N-t-Boc[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (198b) (65 
mg, 0.21 mmol) 95%. NCS (16 mg, 0.12 mmol) was added to a solution of N-t-
Boc[
2
H3CO,5',6',7'-
2
H3]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (198b) (35 mg, 0.12 
mmol) in CH2Cl2 (1 mL) and pyridine (100 µL) at 0 ºC and the reaction mixture was 
stirred for 30 min at rt. 1-Thio--D-glucopyranose-2,3,4,6-tetraacetate (26 mg, 0.06 
mmol) in CH2Cl2 (200 µL) and Et3N (50 µL, 0.36 mmol) were added to the reaction 
mixture and the mixture was stirred for 3 h at rt. The reaction mixture was diluted with 
water, extracted with CH2Cl2, the organic layer was dried, concentrated and the residue 
was subjected to FCC (EtOAc-Hexane, 1:1) to yield N-t-Boc[
2
H3CO,5',6',7'-
190b 198b 199b 172b 
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2
H3]desulfoglucorapassicin tetraacetate (199b) (41 mg, 0.06 mmol, 52%). N-t-
Boc[
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin tetraacetate (199b) (41 mg, 0.06 mmol) 
was dissolved in CH2Cl2 (3.7 mL) and D-TFA (750 µL) and stirred at rt for 3 h. The 
reaction mixture was diluted with water and extracted with CH2Cl2. The organic layer 
was dried, concentrated and subjected to FCC (EtOAc-Hexane, 1:1) to yield 
[
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin tetraacetate (31 mg, 0.06, 92%). Freshly 
prepared KOCH3 (1 mM, 75 µL) was added to the solution of [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin tetraacetate (31 mg, 0.06 mmol) in anhydrous MeOH (1 mL) 
and stirred at rt for 30 min. The reaction mixture was neutralized with acetic acid and the 
solvent was evaporated under reduced pressure to yield [
2
H3CO,5',6',7'-
2
H3]desulfoglucorapassicin (172b) quantitatively (Scheme 3.19).  
HPLC tR=9.3 min, method B.  
UV (CH3CN-H2O) max (nm): 220, 270.  
1
H NMR (500 MHz, CD3OD)  7.28 (1H, s) 4.20 (1H, d, J = 10 Hz), 3.43-3.23 (4H, m) 
2.98 (1H, dd, J = 9, 9 Hz), 2.24-2.21 (1H, m).  
HR-MS-ESI m/z 429.1009 [M+K]
+
, calcd for C16H14
2
H6N2O7SK 429.1004 (100%), 
391.1440 [M+1]
+
 (82%), 229.0 (17%), 201 (36%).  
HPLC-ESI-MS m/z [M+H]
+
 391.0 (100%), 229.0 (38%). 
3.4.1.18 [2H3CO]Desulfoglucorapassicin(172a) 
 
 (t-Boc)2O (23 mg, 0.19 mmol) and DMAP (2 mg, 0.02 mmol) were added to a 
solution of [
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190a) (23 mg, 0.13 mmol) in 
THF (1 mL) at 0 ºC. The reaction mixture was stirred at rt for 2 h, neutralized with HCl 
(1M), diluted with water and extracted with CH2Cl2. The organic phase was dried, and 
172a 
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concentrated to give N-t-Boc[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (37 mg, 0.13 
mmol) quantitatively. 
 NH2OH.HCl (19 mg, 0.27 mmol) and Na2CO3 (14 mg, 0.13 mmol) in water (1 
mL) was added to a solution of N-t-Boc[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (37 
mg, 0.13 mmol) in methanol (3 mL) at 60 ºC and stirred for 3 hr. Excess solvent was 
evaporated, the residue was diluted with water and extracted with CH2Cl2. The organic 
phase was dried, concentrated and subjected to FCC (CH2Cl2:MeOH 98:2) to yield N-t-
Boc[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (198a) (36 mg, 0.12 mmol) in 
95%.  
 NCS (9 mg, 0.07 mmol) was added, portion by portion, to a solution of N-t-
Boc[
2
H3CO]-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde oxime (198a) (19 mg, 0.07 mmol) in 
CH2Cl2 (500 µL) and pyridine (50 µL) at 0 ºC and stirred at rt for 30 min. 1-Thio-β-D-
glucopyrasos-2,3,4,6- tetraacetate (15 mg, 0.04 mmol) in CH2Cl2 (200 µL) and Et3N (29 
µL, 0.21 mmol) were added to the reaction mixture and stirred at rt for 3 h. The reaction 
mixture was diluted with water, extracted with CH2Cl2, the organic layer was dried, 
concentrated and subjected to FCC (EtOAc:Hexane 1:1) to yield N-t-
Boc[
2
H3CO]desulfoglucorapassicin tetraacetate (199a) (24.2 mg, 0.04 mmol) in 52 %. 
 N-t-Boc[
2
H3CO]desulfoglucorapassicin tetraacetate (199a) (45 mg, 0.07 mmol) 
was dissolved in CH2Cl2 (1 mL) and TFA (200 µL) and stirred at rt for 3 h. The reaction 
mixture was diluted with water, extracted with CH2Cl2, the organic layer was dried, 
concentrated and subjected to FCC (EtOAc:Hexane 1:1) to yield 
[
2
H3CO]desulfoglucorapassicin tetraacetate (26 mg, 0.05 mmol) in 67%. Freshly 
prepared KOCH3 (1 mM, 75 µL) was added to the solution of 
[
2
H3CO]desulfoglucorapassicin tetraacetate (26 mg, 0.05 mmol) in anhydrous MeOH (1 
mL) and stirred at rt for 30 min. The reaction mixture was neutralized with acetic acid 
and the solvent was evaporated to yield [
2
H3CO]desulfoglucorapassicin (172a) (20 mg, 
0.05 mmol)  in quantitative yield. 
HPLC tR= 9.3 min, Method B.  
UV (CH3CN-H2O) λmax (nm):  220, 270.  
FTIR (KBr, cm
-1) νmax: 3160, 1687, 2926, 1667, 1405, 1263, 1085.  
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1
H NMR (500 MHz, CD3OD) δ 7.32 (1H, s), 7.08  (1H, dd, J = 8, 8 Hz), 7.01 (1H, d, J = 
8 Hz), 6.55 (1H, d, J = 7.5 Hz), 4.20 (1H, d, J = 10 Hz),  3.45-3.23 (4H, m), 2.98 (1H, dd, 
J = 9, 9 Hz), 2.24-2.21 (1H, m).  
13
C NMR (125.8 MHz, CD3OD) δ 155.7, 151.7, 137.4, 125.4, 122.8, 117.1, 106.2, 104.6, 
100.4, 83.7, 80.0 78.2, 72.2, 69.2, 60.4.  
HPLC-ESI-MS m/z [M+H]
+
 388 (100%), 226 (38%). 
3.4.1.19 Desulfoglucorapassicin(172) 
 
 (t-Boc)2O (95, 0.44 mmol) and DMAP (2 mg, 0.02 mmol) were added to a 
solution of 4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (190) (50 mg, 0.29 mmol) in THF (2 
mL) at 0 ºC. The reaction mixture was stirred for 3 h at rt, neutralized by HCl (1 M), 
diluted with water and extracted with CH2Cl2. The organic phase was dried, and 
concentrated to give N-t-Boc-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (99 mg, 0.35 mmol) in 
quantitative yield. 
 NH2OH.HCl (12 mg, 0.17 mmol) and Na2CO3 (9 mg, 0.08 mmol) in water (1 mL) 
was added to a solution of N-t-Boc-4ꞌ-methoxyindole-3ꞌ-carboxaldehyde (23 mg, 0.08 
mmol) in methanol (2 mL) at 60 ºC and stirred for 3 h. Excess solvent was evaporated, 
the residue was diluted in water and extracted with CH2Cl2. The organic phase was dried, 
concentrated and subjected to FCC (CH2Cl2:MeOH 98:2) to yield N-t-Boc-4ꞌ-
methoxyindole-3ꞌ-carboxaldehyde oxime (198) (22 mg, 0.07 mmol) in 93% yield.  
 NCS (7.2 mg, 0.05 mmol) was added, portion by portion, to a solution of N-t-
Boc-4ꞌ-methoxyindole-3ꞌ-carboxaldoxime (198) (15.8 mg, 0.05 mmol) in CH2Cl2 (400 
µL) at 0 ºC and stirred at rt for 30 min. 1-Thio-β-D-glucopyranos-2,3,4,6-tetraacetate (12 
mg, 0.03 mmol) in CH2Cl2 (200 µL) and Et3N (23 µL, 0.16 mmol) were added to the 
reaction mixture and stirred at rt for 3 h. The reaction mixture was diluted with water, 
172 
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extracted with CH2Cl2, the organic layer was dried, concentrated and subjected to FCC 
(EtOAc:Hexane 1:1) to yield N-t-Bocdesulfoglucorapassicin tetraacetate (199) (19 mg, 
0.03 mmol) in 52 % yield. 
 N-t-Bocdesulfoglucorapassicin tetraacetate (199) (12 mg, 0.02 mmol) was 
dissolved in CH2Cl2 (1 mL) and TFA (200 µL) and stirred at rt for 3 h. The reaction 
mixture was diluted with water and extracted with CH2Cl2. The organic layer was dried, 
concentrated and flash chromatographed (EtOAc:Hexane 1:1) to yield 
desulfoglucorapassicin tetraacetate (7.17 mg, 0.01 mmol) in 71% yield. Freshly prepared 
KOCH3 (1 mM, 75 µL) was added to the solution of desulfoglucorapassicin tetraacetate 
(12.6 mg, 0.02 mmol) in anhydrous MeOH (1 mL) and stirred at rt for 30 min. The 
reaction mixture was neutralized with acetic acid and solvent was evaporated to yield 
desulfoglucorapassicin (172) (10 mg, 0.02 mmol) quantitatively. 
HPLC tR=9.3 min, method B.  
UV (CH3CN-H2O) max(nm): 220, 270.  
FTIR (KBr, cm
-1
) max: 3160, 1667, 1405.  
1
H NMR (500 MHz, CD3OD)  7.32 (1H, s), 7.08 (1H, dd, J = 8, 8 Hz), 7.02 (1H, d, J = 
8 Hz), 6.56 (1H, d, J = 7.5 Hz), 4.19 (1H, d, J = 10 Hz), 3.87 (3H, s), 3.45-3.23 (4H, m) 
2.99 (1H, dd, J = 9, 9 Hz), 2.24-2.21 (1H, m).  
13
C NMR (125.8 MHz, CD3OD)  155.3, 153.2, 139.0, 127.0, 124.3, 118.7, 107.7, 106.2, 
102.1, 85.3, 81.6, 79.8, 73.7, 70.7, 61.9, 56.2.  
HR-EI-MS m/z 423.0632 [M+K]
+
, calcd for C16H20N2O7SK 423.0622 (100%).  
HPLC-ESI-MS m/z [M+H]
+
 385.0 (100%), 223.0 (38%).  
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3.4.1.20  [2H3CO]Rapalexin A (103a) 
 
Scheme 3.20 Synthesis of [
2
H3CO]rapalexin A (103a). Reagents and conditions: i) 
TTFA, TFA; I2, CuI; NaOCD3, 54%; ii) Pd/C, H2, THF, EtOH; CSCl2, Et3N, -10 °C, 51% 
over two steps. 
TTFA (252 mg, 0.46 mmol) was added to a solution of 3-nitroindole (166) (50 
mg, 0.31 mmol) in TFA (3 mL) and the reaction mixture was stirred for 4 h at 30 °C. The 
solvent was evaporated under reduced pressure, I2 (236 mg, 0.93 mmol) and CuI (236 
mg, 1.24 mmol) in DMF (4 mL) were added to the reaction mixture and the mixture was 
stirred for 1 h at 25 °C. NaOCD3 (prepared from Na, 400 mg, 17.40 mmol, in D3COD, 3 
mL) was added to the reaction mixture and the mixture was refluxed at 110 °C for 1 h. 
The reaction mixture was neutralized (pH 7, HCl, 1 M), was filtered through celite and 
the solvent was evaporated. The residue was taken in water (10 mL), extracted with 
EtOAc, dried, concentrated and the crude product was subjected to FCC (EtOAc-Hexane, 
1:1) to yield [
2
H3OC]-4-methoxy-3-nitroindole (167a) (33 mg, 0.17 mmol) in 54% yield. 
Pd/C (25 mg) was added to a solution of [
2
H3OC]-4-methoxy-3-nitroindole (167a) 
(25 mg, 0.13 mmol) in THF (1 mL) and EtOH (200 µL) and the reaction mixture was 
stirred under H2 at balloon pressure for 5 h. The reaction mixture was cooled to -10 °C, 
Et3N (54 µL, 0.39 mmol) and CSCl2 (12 µL, 0.16 mmol) were added and further stirred 
for 10 min. The reaction mixture was diluted with water, extracted with CH2Cl2, the 
organic phase was dried, concentrated and the crude product was subjected to FCC 
(CH2Cl2, 100%) to yield [
2
H3CO]rapalexin A (103a) (14 mg, 0.07) in 51% (Pedras and 
Yaya, 2012) (Scheme 3.20). 
HPLC tR = 16.9 min, method A.  
166 167a 103a 
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UV (CH3OH-H2O, HPLC) λmax (nm): 222, 292.  
1
H NMR (500 MHz, CDCl3) δ 7.94 (1H, s), 7.27 (1H, s), 7.16 (1H, dd, J = 8, 8 Hz), 7.07 
(1H, d, J = 3 Hz), 6.94 (1H, d, J = 8 Hz), 6.56 (1H, d, J = 8 Hz).  
HRMS-EI m/z 207.0544 [M]
+
, calcd. for C10H5
2
H3N2S 207.0546 (100%), 189.01 (52%), 
161.01 (27%).  
HPLC-ESI-MS m/z [M-H]
-
, 206.1 (100%), 188.1 (44%). 
3.4.1.21 Rapalexin A (103) 
 
Scheme 3.21 Synthesis of rapalexin A (103). Reagents and conditions: i) Pd/C, H2, 
THF, EtOH; CSCl2, Et3N, -10 °C, 59%. 
Rapalexin A (103) was synthesized from 3-nitroindole (166) by modifying the 
first synthetic route (Pedras, Zheng et al., 2007a). Pd/C (25 mg) was added to a solution 
of 4-methoxy-3-nitroindole (167) (25 mg, 0.13 mmol) in THF (1 mL) and EtOH (200 
µL) and the reaction mixture was stirred under H2 at balloon pressure for 5 h. The 
reaction mixture was cooled to -10 °C, Et3N (54 µL, 0.39 mmol) and CSCl2 (12 µL, 0.16 
mmol) were added and further stirred for 10 min. The reaction mixture was diluted with 
water, extracted with CH2Cl2, the organic phase was dried over Na2SO4 and concentrated. 
The crude product was subjected to FCC (CH2Cl2, 100%) to yield rapalexin A (103) (18 
mg, 0.09) in 69% (Pedras and Yaya, 2012) (Scheme 3.21). 
HPLC tR = 16.9 min, method A  
UV (CH3OH-H2O, HPLC) λmax (nm): 222, 292.  
FTIR (KBr, cm
-1) νmax: 3399, 2072, 1592, 1508, 1280, 1100, 1075, 774, 729.  
1
H NMR (500 MHz, CDCl3) δ 7.94 (1H, s), 7.27 (1H, s), 7.16 (1H, dd, J = 8, 8 Hz), 7.07 
(1H, d, J = 3 Hz), 6.94 (1H, d, J = 8 Hz), 6.57 (1H, d, J = 8 Hz), 3.98 (3H, s).  
103 167 
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HRMS-EI m/z 204.03541 [M]
+
, calcd. for C10H8N2OS 204.03573 (100%), 189.01 (53%), 
161.01 (28%).  
HPLC-ESI-MS m/z [M-H]
-
, 203.1 (100%), 188.1 (44%). 
3.4.1.22 [4',5',6',7'-2H4]Indole-3ꞌ-carboxaldehyde oxime (176a) 
 
Scheme 3.22 Syntheses of 176a.  Reagents and conditions: i) POCl3, DMF, 95%; ii) 
Na2CO3, NH2OH.HCl, 70 °C, 92%. 
Freshly distilled POCl3 (96 L, 1.02 mmol) was added drop wise to a solution of 
[4,5,6,7-
2
H4]indole (120a) (83 mg, 0.69 mmol) in anhydrous DMF (1 mL) at 0 ºC. The 
reaction mixture was stirred for 1 h at room temperature, basified with aq. NH3 (28%), 
diluted with water and extracted with EtOAc. The organic extract was dried over Na2SO4 
and concentrated to yield [4',5',6',7'-
2
H4]indole-3ꞌ-carboxaldehyde (175a) (98 mg, 0.65 
mmol, 95%). A solution of NH2OH.HCl (70 mg, 1.00 mmol) and Na2CO3 (53 mg, 0.50 
mmol) in water (1 mL) was added to a solution of [4',5',6',7'-
2
H4]indole-3ꞌ-
carboxaldehyde (175a) (75 mg, 0.50 mmol) in EtOH (2 mL) at 70 ºC. After 3 h the 
solvent was removed, the residue was dissolved in water and extracted with EtOAc. The 
organic phase was dried, concentrated and subjected to FCC (CH2Cl2-MeOH, 98:2) to 
yield [4',5',6',7'-
2
H4]indole-3ꞌ-carboxaldehyde oxime (176a) (76 mg, 0.46 mmol, 92%) 
(Scheme 3.22). 
HPLC-DAD, tR = 6.3 min, method A.  
UV (CH3CN-H2O) max (nm): 230, 260.   
1
H NMR (500 MHz CD3CN) 9.76 (1H, brs), 8.25 (1H, d, J = 3 Hz), 7.73 (1H, s).  
HR-EI-MS m/z 164.0885 (M
+
), calcd for C9H4
2
H4N2O 164.0887 (20%), 147.08 (100%), 
119.07 (35%).  
120a  175a  176a  
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HPLC-ESI-MS m/z [M+H]
+
 165.1 (100%), 148.1 (48%). 
3.4.1.23 N-t-Bocindole glucosinolate (204) 
 
Scheme 3.23 Synthesis of 204. Reagents and conditions: i) DMAP, (t-Boc)2O, THF 
quant.; ii) Na2CO3, NH2OH.HCl, EtOH, 60 °C, quant; iii) pyridine, NCS, DCM; 1-thio-β-
D-glucopyranose tetraacetate, NEt3, 37%; iv) ClSO3H, pyridine, DCM/ether, 66%; v) 
KOCH3, MeOH, quantitative. 
DMAP (2 mg, 0.02 mmol)) was added to a solution of indole-3ꞌ-carboxaldehyde 
(175) (300 mg, 2.06 mmol) and (t-Boc)2O (541 mg, 2.48 mmol) in dry THF (10 mL) at 0 
°C. The reaction mixture was stirred for 2 h at rt, solvent was evaporated under reduced 
pressure and residue was taken in water and extracted with EtOAc. The organic phase 
was dried over Na2SO4 and concentrated to yield N-t-Bocindole-3ꞌ-carboxaldehyde (200) 
(506 mg, 2.06 mmol) quantitatively.  
To a solution of N-t-Bocindole-3ꞌ-carboxaldehyde (200) (300 mg, 1.22 mmol) in 
MeOH (10 mL), a solution of Na2CO3 (138 mg, 1.30 mmol) and NH2OH.HCl (181 mg, 
2.6 mmol) in water (2 mL) was added and stirred at 60 °C for 2 h. Excess MeOH was 
evaporated, the reaction mixture was diluted with water and extracted with EtOAc. The 
organic layer was dried, and concentrated under reduced pressure to yield N-t-Bocindole-
3ꞌ-carboxaldehyde oxime (201) (334 mg, 1.30 mmol) quantitatively. 
NCS (120 mg, 0.90 mmol) was added to a solution of N-t-Bocindole-3ꞌ-
carboxaldehyde oxime (201) (230 mg, 0.90 mmol) in pyridine (100µL) and CH2Cl2 (2 
200 201 
202 
203 204 
190 
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mL) at 0 °C. The reaction mixture was stirred for 30 min at the rt and then 1-thio-β-D-
glucopyrasos-2,3,4,6-tetraacetate (182 mg, 0.47 mmol) and Et3N (391 µL, 2.82 mmol) 
were added and the reaction mixture was stirred for 3 h. The reaction mixture was diluted 
with water, extracted with CH2Cl2, dried, concentrated and the residue was subjected to 
FCC (EtOAc-Hexane 1:1) to yield N-t-Bocindolyl-3ꞌ-tetraacetylgluco 
carboxythiohydroxamate (202) (205 mg, 0.33 mmol) 37% from oxime (Brochard, Joseph 
et al., 1994).   
To a solution of (202) (100 mg, 0.16 mmol) in dry CH2Cl2 (500 µL) and dry 
pyridine (600 µL) at 0 °C, a solution of HSO3Cl (21 µL, 0.32 mmol) in dry ether (500 
µL) was slowly added. The reaction mixture was stirred for 24 h and neutralized with 
KHCO3 solution (100 mg/mL) to pH 7 and stirred for 1 h. The reaction mixture was 
diluted with water and extracted by CH2Cl2, dried and concentrated. The residue was 
subjected to FCC (CH2Cl2-MeOH 95:5) to yield N-t-Boctetraacetylindole glucosinolate 
(203) (74 mg, 0.11 mmol) in 67% yield. 
KOCH3 (75µL, 1mM) was added to solution of 203 (32 mg, 0.05 mmol) in 
anhydrous methanol (1mL). The reaction mixture was stirred for 30 min and neutralized 
with acetic acid. The solvent was evaporated, residue was dissolved in water, extracted 
by EtOAc and the aqueous layer was freeze dried to yield N-t-Bocindole glucosinolate 
(204), 31 mg, in quantitative yield (Viaud and Rollin, 1990) (Scheme 3.23).  
HPLC tR = 28.2 min, method B  
UV (CH3CN-H2O) λmax (nm):  220, 285, 295.  
FTIR (KBr, cm
-1) νmax: 3396, 2982, 2925, 1738, 1559, 1451, 1373, 1240, 1062, 766. 
1H NMR δ (500 MHz, D2O) 8.21 (1 H, d, J = 8 Hz), 8.18 (1H, d, J = 2 Hz), 7.87 (1H, d, J 
= 8 Hz), 7.52 (1H, dd, J = 8, 8 Hz), 7.45 (1H, dd, J = 8, 8 Hz), 4.58 (1H, d, J = 10 Hz), 
3.55-3.37 (5H, m), 3.26 (1H, dd, J = 9, 9 Hz), 2.7 (1H, m).  
13C NMR δ (125.8 MHz, D2O) 170.7, 150.7, 145.2, 136.8, 129.6, 129.1, 126.6, 124.6, 
122.3, 116.6, 83.1, 76.5, 74.4, 71.5, 69.1, 62.7, 28.7.  
HPLC-ESI-MS m/z [M]
-
 533.1 (100). 
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3.5 Administration of precursors to Thellungiella salsuginea (salt cress) 
Four-week-old potted plants were irradiated with a 30 W (UV max 254 nm) lamp 
for 60 min in a laminar flow cabinet. After UV-irradiation, plants were allowed to stand 
in flow cabinet under fluorescent light for 3 h, and then were uprooted, the leaves were 
cut at the base of the petiole and were immediately immersed in tubes containing an 
aqueous solution of the precursor (4 ml, 5  10-4 M dissolved in H2O or H2O-CH3OH-
Tween 80, 90:10:0.1, v/v). On average, leaves of two plants were used per precursor, 
experiments were conducted in triplicate and repeated at least twice for each precursor. 
Following the uptake of each precursor solution (ca. 12 h), the tubes were filled with 
H2O and leaves were further incubated for 48 h under continuous fluorescent light. The 
leaves were frozen in liq. nitrogen, extracted with methanol (20 ml), the methanol extract 
was filtered off, and was concentrated to dryness. The methanolic residue was extracted 
with CH2Cl2, the CH2Cl2 fraction was concentrated under reduced pressure, and the 
residue was dissolved in acetonitrile (500 μl) to yield the non-polar fraction containing 
mostly phytoalexins for HPLC-DAD and HPLC-ESI-MS analysis. The insoluble residue 
was dissolved in MeOH-H2O (1:1, 1 mL)) and was filtered to yield the polar fraction for 
HPLC-DAD and HPLC-ESI-MS analysis.  
3.6 Administration of precursors to Brassica napus (rutabaga) 
3.6.1 Extraction of phytoalexins 
Rutabaga tubers were cut horizontally in 10-15 mm thick discs and cylindrical 
holes (16 mm in diameter) were made on one surface of the discs with a cork-borer 
(Pedras et al., 2004). The discs were kept in tightly sealed plastic boxes and incubated at 
21-23 °C in darkness. After 24 h, the discs were UV-irradiated on the surface with holes 
for 1.5 h, and were incubated for further 24 h. Precursors (5 × 10
-4
 M) dissolved in H2O,  
H2O-CH3OH (90:10 v/v) or H2O-CH3OH-Tween 80 (90:10:0.1 v/v) were pipetted into 
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each hole (500 μL per hole) and the discs were further incubated at 21-23 °C in dark. 
Following adsorption of precursor solution, holes were filled with water. 48 h later the 
aqueous solution in the holes was harvested and was extracted with EtOAc (20 ml x 2). 
The combined organic extract was dried over Na2SO4 and solvent was removed under 
reduced pressure. The residue obtained was dissolved in CH3CN (200 μl) and was 
analyzed by HPLC-DAD, HPLC-ESI-MS, and HPLC-HRMS-ESI. Control experiments 
were similarly prepared by incubating rutabaga root tubers with non-labeled precursors or 
with carrier solution only. 
3.6.2 Extraction of glucosinolates 
Tissue around the holes was cut, soaked in CH3OH, ground inside a mortar and 
extracted with CH3OH. Extraction was carried out overnight on a shaker, after which the 
tissue was filtered off and the filtrate was concentrated under reduced pressure. The crude 
extract was dissolved in H2O-CH3OH (1:1) and analyzed by HPLC-DAD, HPLC-ESI-
MS, and HR-ESI-MS. 
3.7 Antifungal bioassays 
 Leptosphaeria maculans, Rhizoctonia solani AG 2-1, Sclerotinia sclerotiorum, 
Alternaria brassicicola were obtained from AAFC, Saskatoon, Canada. Solid cultures 
were initiated with spores of A. brassicicola and L. maculans, sclerotia of S. 
sclerotiorum, and mycelia of R. solani were grown on potato dextrose agar (PDA) plates 
at 23 ± 2 ºC, under constant light and mycelial plugs cut from the edge of actively 
growing cultures used to initiate bioassay cultures, as follows.  
 Solutions of each compound in DMSO were used to prepare sterile assay plates (6 
wells per plate, 36 mm diameter, 2 ml per well) in PDA media (5.0 × 10
-4
 M, 2.0 × 10
-4
 
M, 1.0 × 10
-4
 M). Control plates contained 1% DMSO in PDA. Plates containing test 
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solutions and the control solution were inoculated with mycelia plugs (4 mm diameter) 
placed upside down on the center of each plate, the plates were sealed with parafilm, and 
incubated at 23 ± 2 ºC under constant light for 24 h for S. sclerotiorum, 72 h for R. solani, 
120 h for L. maculans (isolates BJ-125 and Laird-2) and A. brassicicola. The radial 
growth of mycelia was measured and compared with control plates containing only 
DMSO. Each experiment was conducted in triplicate and repeated three times. 
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